P0DTC2 (SPIKE_SARS2) Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Spike glycoprotein UniProtKBInterProInteractive Modelling
1273 aa; Sequence (Fasta) ;
2 identical sequences: Severe acute respiratory syndrome coronavirus 2: A0A6G7K2L4, A0A679G9E9
Models are currently being built for this target protein.
(Depending on server load, it will take approximately 15-30 minutes before the new models are available in SWISS-MODEL Repository)
Please note that SMR updates are performed with default parameters for template selection and quality filters. If you prefer to interactively explore various models build on different templates, please use SWISS-MODEL workspace.
Available Structures
2055 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| SARS-CoV-2 Omicron variant spike in complex with Fab 9A8 (State 2) |
Heteromer | 98.18 | 16×NAG; 31×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 spike protein (2-up RBD) bound to neutralizing nanobodies P86 |
Heteromer | 99.73 | 17×NAG; 3×NAG; 6×NAG; 30×NAG; | |||
| SARS-CoV-2 Omicron variant spike in complex with Fab XGv051 |
Heteromer | 98.18 | 15×NAG; 5×NAG; 30×NAG; | |||
| SARS-CoV-2 Omicron variant spike in complex with Fab XGv264 |
Heteromer | 98.18 | 36×NAG; | |||
| SARS-CoV-2 Omicron variant spike in complex with Fab XGv286 |
Heteromer | 98.18 | 12×NAG; 6×NAG; 28×NAG; | |||
| 17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer |
Heteromer | 99.91 | 24×NAG; 3×NAG; 5×NAG; 25×NAG; | |||
| Structure of XBB.1.16 S trimer with 2 down-RBDs complex with antibody CYFN1006-1. |
Heteromer | 90.0 | ||||
| SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282 |
Heteromer | 98.18 | 16×NAG; 5×NAG; 27×NAG; | |||
| SARS-CoV-2 Omicron variant spike in complex with Fab 9A8 (State 1) |
Heteromer | 98.18 | 1×NAG; 3×NAG; 41×NAG; | |||
| SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265 |
Heteromer | 98.18 | 14×NAG; 5×NAG; 26×NAG; | |||
| SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289 |
Heteromer | 98.18 | 15×NAG; 5×NAG; 27×NAG; | |||
| SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD … |
Heteromer | 98.18 | 15×NAG; 5×NAG; 29×NAG; | |||
| SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs |
Heteromer | 98.18 | 15×NAG; 5×NAG; 29×NAG; | |||
| Neutral Omicron Spike Trimer in complex with ACE2 |
Heteromer Q9BYF1; | 98.18 | 16×NAG; 5×NAG; 34×NAG; | |||
| SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs |
Heteromer | 98.18 | 16×NAG; 5×NAG; 31×NAG; | |||
| Three RBD-down state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab… |
Heteromer | 99.91 | 6×NAG; 24×NAG; 6×NAG; 21×NAG; | |||
| An antibody from single human VH-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5… |
Heteromer | 99.91 | 16×NAG; 12×NAG; 6×NAG; 23×NAG; | |||
| SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C1 state |
Heteromer Q9BYF1; | 98.64 | ||||
| SARS-CoV-2 Beta spike in complex with two S3H3 Fabs |
Heteromer | 98.64 | ||||
| SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2B state |
Heteromer Q9BYF1; | 98.64 | ||||
| SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C2A state |
Heteromer Q9BYF1; | 98.64 | ||||
| SARS-CoV-2 spike protein in complex with ACE2, Beta variant, C3 state |
Heteromer Q9BYF1; | 98.64 | ||||
| SARS-CoV-2 Beta spike in complex with one S5D2 Fab |
Heteromer | 98.64 | ||||
| SARS-CoV-2 Beta spike in complex with two S5D2 Fabs |
Heteromer | 98.64 | ||||
| SARS-CoV-2 Beta spike in complex with three S5D2 Fabs |
Heteromer | 98.64 | ||||
| SARS-CoV-2 Beta spike in complex with three S3H3 Fabs |
Heteromer | 98.64 | ||||
| Structure of BA.2.86 spike protein in complex with ACE2. |
Heteromer Q9BYF1; | 80.0 | ||||
| The JN.1 spike protein (S) in complex with ACE2. |
Heteromer Q9BYF1; | 80.0 | ||||
| Camel nanobodies 7A3 and 8A2 broadly neutralize SARS-CoV-2 variants |
Heteromer | 99.21 | ||||
| SARS-CoV-2 spike protein complexed with two nanobodies |
Heteromer | 99.53 | 6×NAG; 25×NAG; | |||
| SARS-CoV-2 spike protein bound with a nanobody |
Heteromer | 99.45 | 5×NAG; 24×NAG; | |||
| SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21F2 |
Heteromer | 99.53 | 5×NAG; 22×NAG; | |||
| SARS-CoV-2 spike protein trimer (down conformation) bound with a nanobody |
Heteromer | 99.53 | 6×NAG; 25×NAG; | |||
| SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-02 |
Heteromer | 99.45 | 14×NAG; 1×NAG; 23×NAG; | |||
| SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21B10 |
Heteromer | 99.53 | 4×NAG; 28×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets t… |
Heteromer | 99.45 | 4×NAG; 15×NAG; 3×NAG; 27×NAG; | |||
| SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 034_32 |
Heteromer | 99.45 | 12×NAG; 23×NAG; | |||
| SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-13 |
Heteromer | 99.45 | 15×NAG; 29×NAG; | |||
| State - I: Spike 2-up RBD with THSC20.HVTR26 (Fab26) - single Fab masked |
Heteromer | 99.81 | ||||
| Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets t… |
Heteromer | 99.45 | 13×NAG; 1×NAG; 27×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1 |
Heteromer | 99.82 | 9×NAG; 25×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 D614G S with three ACE2 receptors binding (RB3) in prefusion confor… |
Heteromer Q9BYF1; | 99.91 | 3×NAG; 24×NAG; 24×NAG; | |||
| SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34 |
Heteromer | 99.82 | ||||
| COVOX-222 fab in complex with SARS-CoV-2 beta-Spike glycoprotein |
Heteromer | 98.64 | 12×NAG; 28×NAG; | |||
| Beta-43 fab in complex with SARS-CoV-2 beta-Spike glycoprotein |
Heteromer | 98.64 | 12×NAG; 29×NAG; | |||
| Beta-06 fab in complex with SARS-CoV-2 beta-Spike glycoprotein |
Heteromer | 98.55 | 12×NAG; 28×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 D614G S with one ACE2 receptor binding (RB1) in prefusion conformat… |
Heteromer Q9BYF1; | 99.91 | 21×NAG; 29×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 D614G S with two ACE2 receptors binding (RB2) in prefusion conforma… |
Heteromer Q9BYF1; | 99.91 | 18×NAG; 5×NAG; 31×NAG; | |||
| OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN |
Heteromer | 98.64 | 12×NAG; 30×NAG; | |||
| OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN |
Heteromer | 98.64 | 12×NAG; 30×NAG; | |||
| SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8 |
Heteromer | 99.82 | 4×NAG; 7×NAG; 1×NAG; 7×NAG; 1×NAG; 1×NAG; 1×NAG; 32×NAG; 1×AH2; | |||
| OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE |
Heteromer | 98.64 | 12×NAG; 28×NAG; | |||
| Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 s… |
Heteromer | 99.82 | 17×NAG; 3×NAG; 34×NAG; | |||
| XG005-bound SARS-CoV-2 S |
Heteromer | 99.81 | 45×NAG; | |||
| SARS-CoV-2 spike/Nb5 complex |
Heteromer | 99.35 | 10×NAG; 33×NAG; | |||
| Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development |
Heteromer Q9BYF1; | 98.18 | 14×NAG; 20×NAG; | |||
| S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab. |
Heteromer | 99.81 | ||||
| EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-159 |
Heteromer | 99.81 | 15×NAG; 24×NAG; | |||
| Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 s… |
Heteromer | 99.82 | 24×NAG; 30×NAG; | |||
| SARS-CoV-2 Delta S-8D3 |
Heteromer | 99.25 | ||||
| Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 s… |
Heteromer | 99.82 | 16×NAG; 2×NAG; 36×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-BQ.1 in complex with antibody O5C2 |
Heteromer | 90.0 | 18×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodo… |
Heteromer Q9BYF1; | 98.18 | 23×NAG; 24×NAG; 2×ZN; | |||
| Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8 |
Heteromer | 99.33 | 18×NAG; 24×NAG; | |||
| The state 2 complex structure of Omicron spike with Bn03 (2-up RBD, 4 nanobodies) |
Heteromer | 98.18 | 36×NAG; | |||
| SARS-CoV-2 spike protein in complex with two S2H5 Fabs on NTD-1 and NTD-2 |
Heteromer | 99.81 | 1×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 1) |
Heteromer | 99.33 | 18×NAG; 24×NAG; | |||
| Furin Site deletion of SARS-CoV-2 spike |
Heteromer | 100.0 | ||||
| The state 1 complex structure of Omicron spike with Bn03 (1-up RBD, 3 nanobodies) |
Heteromer | 98.18 | 40×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 |
Heteromer Q9BYF1; | 98.69 | 18×NAG; 28×NAG; | |||
| Cryo-EM structure of NTD-directed non-neutralizing antibody 4-33 in complex with prefusion SARS-CoV… |
Heteromer | 99.82 | 6×NAG; 33×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 |
Heteromer Q9BYF1; | 98.18 | 18×NAG; 34×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 2) |
Heteromer | 99.33 | 18×NAG; 24×NAG; | |||
| The state 3 complex structure of Omicron spike with Bn03 (2-up RBD, 5 nanobodies) |
Heteromer | 98.18 | 28×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-BQ.1 in complex with ACE2 |
Heteromer Q9BYF1; | 81.82 | 1×NAG; 31×NAG; | |||
| SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state |
Heteromer | 100.0 | 27×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein in complex with mouse ACE2 (conformation 2) |
Heteromer Q8R0I0; | 90.0 | 20×NAG; 2×NAG; 21×NAG; | |||
| SARS-CoV-2 spike protein in complex with two S2H5 Fabs on NTD-1 and NTD-3 |
Heteromer | 99.81 | 1×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectod… |
Heteromer Q9BYF1; | 99.33 | 18×NAG; 32×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 |
Heteromer Q9BYF1; | 98.69 | 18×NAG; 26×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein in complex with mouse ACE2 (conformation 1) |
Heteromer Q8R0I0; | 90.0 | 19×NAG; 1×NAG; 21×NAG; | |||
| Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed st… |
Heteromer | 100.0 | 14×NAG; 16×NAG; | |||
| Structure of the SARS-CoV-2 spike glycoprotein in complex with the macrocyclic peptide S1B3inL1 |
Heteromer | 99.44 | 13×NAG; 23×NAG; | |||
| P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein |
Heteromer | 100.0 | 15×NAG; 16×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with S309 fab |
Heteromer | 98.18 | 19×NAG; 25×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein in complex with human ACE2 |
Heteromer Q9BYF1; | 90.0 | 24×NAG; 33×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 prototype spike protein in complex with hippopotamus ACE2 |
Heteromer | 99.43 | 12×NAG; 25×NAG; 1×ZN; | |||
| XBB.1.5 spike/Nanosota-3C complex |
Heteromer | 90.0 | 15×NAG; 10×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 |
Heteromer Q9BYF1; | 98.36 | 18×NAG; 42×NAG; | |||
| Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike |
Heteromer | 99.91 | 3×NAG; 3×NAG; 1×NAG; 28×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C2 state |
Heteromer Q9BYF1; | 98.18 | ||||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.4 S-trimer in complex with fab L4.65 and L5.34 |
Heteromer | 90.0 | 3×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron Spike protein with human ACE2 receptor, C3 state |
Heteromer Q9BYF1; | 98.18 | ||||
| SARS-CoV-2 Spike Proteins Trimer in Complex with FC05 and H014 Fabs Cocktail |
Heteromer | 100.0 | 15×NAG; 16×NAG; | |||
| Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 s… |
Heteromer | 99.8 | 44×NAG; | |||
| SARS-CoV-2 Spike protein in complex with hb27 and fc05 Fab cocktail |
Heteromer | 100.0 | 14×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 |
Heteromer Q9BYF1; | 99.23 | 18×NAG; 36×NAG; | |||
| SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail |
Heteromer | 100.0 | 15×NAG; 16×NAG; | |||
| COVA2-15 fragment antigen binding in complex with SARS-CoV-2 6P-mut7 S protein |
Heteromer | 99.27 | 18×NAG; 27×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron Prototype S-trimer in complex with fab L4.65 and L5.34 |
Heteromer | 99.42 | 3×NAG; | |||
| Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike |
Heteromer | 99.82 | 28×NAG; | |||
| Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spi… |
Heteromer | 99.81 | 26×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 |
Heteromer Q9BYF1; | 98.41 | 18×NAG; 26×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with white-tailed deer ACE2 |
Heteromer A0A6J0Z472; | 98.18 | 17×NAG; 1×NAG; 31×NAG; 1×ZN; | |||
| S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab. |
Heteromer | 99.81 | ||||
| Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 |
Heteromer | 99.2 | 18×NAG; 23×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectod… |
Heteromer Q9BYF1; | 99.17 | 18×NAG; 26×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron spike protein (S-6P-RRAR) in complex with human ACE2 ectodo… |
Heteromer Q9BYF1; | 98.18 | 22×NAG; 23×NAG; 1×ZN; | |||
| Cryo-EM structure of mink variant Y453F trimeric spike protein bound to one mink ACE2 receptors |
Heteromer A0A7T0Q2W2; | 100 | ||||
| Cryo-EM structure of SARS-CoV-2 prototype spike protein in complex with white-tailed deer ACE2 |
Heteromer A0A6J0Z472; | 99.43 | 21×NAG; 23×NAG; 1×ZN; | |||
| Omicron Spike bitrimer with 6m6 antibody |
Heteromer | 98.18 | 49×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 |
Heteromer | 99.17 | 18×NAG; 21×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2… |
Heteromer Q9BYF1; | 99.17 | 18×NAG; 28×NAG; | |||
| SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 2 YB9-258 Fabs (2 RBD up) |
Heteromer | 98.18 | 12×NAG; 30×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 |
Heteromer Q9BYF1; | 99.04 | 18×NAG; 26×NAG; | |||
| S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab. |
Heteromer | 99.81 | ||||
| SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 1 YB9-258 Fab (1 RBD up) |
Heteromer | 98.18 | 12×NAG; 30×NAG; | |||
| SARS-CoV-2 S-ACE2 complex |
Heteromer Q9BYF1; | 99.81 | 18×NAG; 36×NAG; | |||
| Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutat… |
Heteromer Q9BYF1; | 98.18 | 15×NAG; 33×NAG; 3×ZN; | |||
| SARS-CoV-2 spike/nanobody mixture complex |
Heteromer | 99.35 | 12×NAG; 45×NAG; | |||
| SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 trimer) |
Heteromer | 99.72 | 45×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 |
Heteromer Q9BYF1; | 90.0 | 18×NAG; 33×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound t… |
Heteromer Q9BYF1; | 99.04 | 18×NAG; 42×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8 |
Heteromer | 90.0 | 18×NAG; 21×NAG; | |||
| S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab. |
Heteromer | 99.81 | ||||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2 |
Heteromer Q8R0I0; | 90.0 | 18×NAG; 25×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound t… |
Heteromer Q9BYF1; | 99.17 | 18×NAG; 28×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to huma… |
Heteromer Q9BYF1; | 99.17 | 18×NAG; 26×NAG; | |||
| S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab. |
Heteromer | 99.81 | ||||
| Cryo-EM structure of SARS-CoV-2 Omicron spike protein with ACE2, C1 state |
Heteromer Q9BYF1; | 98.18 | ||||
| SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 bound at 2.5 A |
Heteromer | 99.35 | 11×NAG; 25×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2… |
Heteromer Q9BYF1; | 99.17 | 18×NAG; 28×NAG; | |||
| Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutat… |
Heteromer | 98.18 | 14×NAG; 10×NAG; | |||
| SARS-CoV-2 Spike in complex with IgG 553-15 (S-553-15 dimer trimer ) |
Heteromer | 99.72 | 90×NAG; | |||
| SARS-CoV-2 spike/Nb6 complex |
Heteromer | 99.35 | 11×NAG; 39×NAG; | |||
| SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 |
Heteromer | 99.35 | 11×NAG; 25×NAG; | |||
| S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab |
Heteromer | 99.81 | ||||
| Cryo-EM structure of Omicron S-ACE2, C2 state |
Heteromer Q9BYF1; | 98.18 | ||||
| CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinemen… |
Heteromer | 99.27 | 10×NAG; 20×NAG; | |||
| Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development |
Heteromer | 98.18 | 14×NAG; 10×NAG; | |||
| SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound |
Heteromer | 99.35 | 11×NAG; 25×NAG; | |||
| Structure of the SARS-CoV-2 spike glycoprotein in complex with the 87G7 antibody Fab fragment |
Heteromer | 99.43 | 12×NAG; 27×NAG; | |||
| CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (non-uniform refinement) |
Heteromer | 99.25 | 5×NAG; 1×NAG; 29×NAG; | |||
| S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab |
Heteromer | 99.81 | ||||
| SARS-CoV-2 Delta S-ACE2-C1 |
Heteromer Q9BYF1; | 99.25 | ||||
| SARS-CoV-2 Delta S-ACE2-C2a |
Heteromer Q9BYF1; | 99.25 | ||||
| SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (3 RBD down) |
Heteromer | 98.18 | 12×NAG; 30×NAG; | |||
| SARS-CoV-2 Omicron open state spike protein in complex with S3H3 Fab |
Heteromer | 98.18 | ||||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 |
Heteromer Q8R0I0; | 98.18 | 18×NAG; 26×NAG; | |||
| Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycopro… |
Heteromer | 99.82 | 3×NAG; 18×NAG; 30×NAG; | |||
| Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development |
Heteromer Q9BYF1; | 98.18 | 14×NAG; 12×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 S-trimer in complex with fab L4.65 and L5.34 |
Heteromer | 90.0 | 32×NAG; | |||
| SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (1 RBD up) |
Heteromer | 98.18 | 12×NAG; 30×NAG; | |||
| SARS-CoV-2 Omicron closed state spike protein in complex with S3H3 Fab |
Heteromer | 98.18 | ||||
| SARS-CoV-2 Spike in complex with IgG 553-60 (1-up trimer) |
Heteromer | 99.72 | 39×NAG; | |||
| SARS-CoV-2 Kappa variant spike protein in complex with ACE2, state C2a |
Heteromer Q9BYF1; | 99.34 | ||||
| SARS-CoV-2 Delta S-ACE2-C2b |
Heteromer Q9BYF1; | 99.25 | ||||
| SARS-CoV-2 spike protein in complex with one S2H5 Fab |
Heteromer | 99.81 | 1×NAG; | |||
| SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with 3 YB13-292 Fabs (2 RBD up) |
Heteromer | 98.18 | 12×NAG; 30×NAG; | |||
| SARS-CoV-2 Spike in complex with IgG 553-60 (2-up trimer) |
Heteromer | 99.72 | 38×NAG; | |||
| SARS-CoV-2 Delta S-ACE2-C3 |
Heteromer Q9BYF1; | 99.25 | ||||
| S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with… |
Heteromer | 99.81 | ||||
| EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-159 |
Heteromer | 99.81 | 15×NAG; 24×NAG; | |||
| Nanobody C5 bound to Spike |
Heteromer | 99.81 | 15×NAG; 36×NAG; | |||
| SARS-CoV-2 S trimer with three-antibody cocktail complex |
Heteromer | 99.81 | 15×NAG; | |||
| SARS-CoV-2 S trimer with four-antibody cocktail complex |
Heteromer | 99.81 | 12×NAG; | |||
| SARS-CoV-2 Kappa variant spike protein in C2b state |
Heteromer Q9BYF1; | 99.34 | ||||
| SARS-CoV-2 Kappa variant spike protein in C3 state |
Heteromer Q9BYF1; | 99.34 | ||||
| VAS5 Spike (1 RBD up) |
Heteromer | 100.0 | 13×NAG; 31×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014 |
Heteromer | 100.0 | ||||
| SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies |
Heteromer | 99.52 | 2×NAG; 46×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike in complex with non-neutralizing NTD-directed CV3-13 Fab isol… |
Heteromer | 99.45 | 3×NAG; 36×NAG; | |||
| Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development |
Heteromer | 99.81 | 18×NAG; 30×NAG; | |||
| SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 1 conformation |
Heteromer | 98.15 | 14×NAG; 15×NAG; | |||
| S protein of SARS-CoV-2 in complex with 26434 |
Heteromer | 99.53 | 31×NAG; 24×NAG; | |||
| SARS-CoV-2 spike trimer (6P) in complex with two R1-26 Fabs |
Heteromer | 99.53 | 15×NAG; 30×NAG; | |||
| Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113… |
Heteromer | 99.81 | 16×NAG; 20×NAG; | |||
| SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-45 |
Heteromer | 99.82 | ||||
| SARS-CoV-2 spike trimer (6P) in complex with three R1-26 Fabs |
Heteromer | 99.53 | 15×NAG; 30×NAG; | |||
| SARS-CoV-2 spike glycoprotein:Fab 3D11 complex |
Heteromer | 99.81 | ||||
| Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113… |
Heteromer | 99.81 | 20×NAG; 2×NAG; 21×NAG; | |||
| SARS-CoV-2 spike trimer (6P) in complex with R1-26 Fab, head-to-head aggregate |
Heteromer | 99.53 | 30×NAG; 60×NAG; | |||
| CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45) |
Heteromer | 99.44 | 19×NAG; 35×NAG; | |||
| SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2 |
Heteromer Q9BYF1; | 99.53 | 6×NAG; 36×NAG; 3×ZN; | |||
| SARS-CoV-2 spike in complex with nanobodies E |
Heteromer | 99.81 | 51×NAG; | |||
| SARS-CoV-2 spike trimer (6P) in complex with two H18 Fabs |
Heteromer | 99.53 | 12×NAG; 33×NAG; | |||
| CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45) |
Heteromer | 99.44 | 17×NAG; 30×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 |
Heteromer Q8R0I0; | 98.15 | 22×NAG; 23×NAG; 1×ZN; | |||
| The SARS-CoV-2 spike in complex with the 2.15 neutralizing nanobody |
Heteromer | 99.72 | 5×NAG; 33×NAG; | |||
| SARS-CoV-2 spike trimer (6P) in complex with three H18 Fabs |
Heteromer | 99.53 | 12×NAG; 33×NAG; | |||
| SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 1 conformation |
Heteromer | 98.15 | 14×NAG; 15×NAG; | |||
| Beta-26 fab in complex with SARS-CoV-2 beta-Spike glycoprotein |
Heteromer | 98.52 | 13×NAG; 31×NAG; | |||
| J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 1) |
Heteromer | 99.25 | 9×NAG; 15×NAG; | |||
| SARS-CoV-2 spike trimer (6P) in complex with three H18 Fabs, head-to-head aggregate (C1 symmetry) |
Heteromer | 99.52 | 24×NAG; 66×NAG; | |||
| SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab in the class 2 conformation |
Heteromer | 98.15 | 14×NAG; 15×NAG; | |||
| J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut2 S protein (conformation 2) |
Heteromer | 99.25 | 12×NAG; 21×NAG; | |||
| SARS-CoV-2 spike trimer (6P) in complex with three H18 Fabs, head-to-head aggregate (C3 symmetry) |
Heteromer | 99.53 | 24×NAG; 66×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with 4A8 |
Heteromer | 99.81 | 6×NAG; 23×NAG; 25×NAG; | |||
| SARS-CoV-2 spike trimer (6P) in complex with two H18 and two R1-32 Fabs |
Heteromer | 99.53 | 12×NAG; 33×NAG; | |||
| SARS-CoV-2 spike trimer (6P) in complex with three H18 and three R1-32 Fabs |
Heteromer | 99.53 | 12×NAG; 33×NAG; | |||
| SARS-CoV-2 spike trimer (6P) in complex with three H18 and three R1-32 Fabs (one RBD rotated) |
Heteromer | 99.53 | 12×NAG; 33×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1) |
Heteromer | 99.81 | 12×NAG; 39×NAG; | |||
| SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57 |
Heteromer | 99.82 | 30×NAG; | |||
| The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody |
Heteromer | 99.72 | 5×NAG; 33×NAG; | |||
| SARS-CoV-2 XBB.1.16 Spike in complex with CYFN1006-1(S-CYFN1006-1 dimer trimer). |
Heteromer | 90.0 | ||||
| SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22 |
Heteromer | 99.82 | ||||
| The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody |
Heteromer | 99.72 | 5×NAG; 33×NAG; | |||
| Structure of XBB.1.16 S trimer with 3 down-RBDs complex with antibody CYFN1006-1. |
Heteromer | 90.0 | ||||
| SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 IgG. |
Heteromer | 98.15 | 15×NAG; 14×NAG; | |||
| SARS-CoV-2 Spike in complex with PVI.V6-14 Fab |
Heteromer | 99.45 | 15×NAG; 6×NAG; 6×NAG; 3×NAG; 18×NAG; | |||
| SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-57 (three down conformation) |
Heteromer | 99.54 | 28×NAG; 25×NAG; | |||
| SARS-CoV-2 Spike (6P) in complex with 1 R1-32 Fab |
Heteromer | 99.53 | 6×NAG; 24×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351) in complex with Angiotensin-converting enz… |
Heteromer Q9BYF1; | 98.45 | 31×NAG; 17×NAG; | |||
| State - II: Spike 3-up RBD with THSC20.HVTR26 (Fab26) |
Heteromer | 99.81 | ||||
| Cryo-EM structure of SARS-CoV-2 spike in complex with FSR22, an anti-SARS-CoV-2 DARPin |
Heteromer | 99.44 | 3×NAG; 9×NAG; 6×NAG; 18×NAG; | |||
| SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment |
Heteromer | 99.8 | 12×NAG; 3×NAG; 36×NAG; | |||
| SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65 |
Heteromer | 99.82 | ||||
| SARS-CoV-2 wildtype spike trimer (6P) in complex with 3 YB9-258 Fabs and 3 R1-32 Fabs (3 RBD up) |
Heteromer | 99.53 | 12×NAG; 30×NAG; | |||
| SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound |
Heteromer Q9BYF1; | 99.81 | ||||
| CryoEM structure of del68-76/del679-688 prefusion-stabilized spike in complex with the Fab of N12-9 |
Heteromer | 100 | 10×NAG; 28×NAG; | |||
| SARS-CoV-spike bound to two neutralising nanobodies |
Heteromer | 99.8 | 1×NAG; 42×NAG; | |||
| S protein of SARS-CoV-2 in complex with 2G1 |
Heteromer | 99.55 | 24×NAG; 30×NAG; 3×EIC; | |||
| Cryo-EM structure of SARS-CoV-2 spike in complex with K202.B bispecific antibody |
Heteromer | 99.42 | 32×NAG; | |||
| SARS-CoV-2 Spike (6P) in complex with 2 R1-32 Fabs |
Heteromer | 99.53 | 6×NAG; 24×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… |
Heteromer Q9BYF1; | 98.75 | 30×NAG; 1×NAG; 19×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… |
Heteromer Q9BYF1; | 98.75 | 30×NAG; 29×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) |
Heteromer | 99.81 | 9×NAG; 45×NAG; | |||
| SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction |
Heteromer Q9BYF1; | 99.81 | ||||
| Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting … |
Heteromer Q9BYF1; | 99.13 | 37×NAG; 13×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1) in complex with Angiotensin-converting enzyme… |
Heteromer Q9BYF1; | 98.75 | 29×NAG; 26×NAG; | |||
| SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound |
Heteromer Q9BYF1; | 99.81 | 23×NAG; 1×ZN; | |||
| SARS CoV2 Spike in the 2-up state in complex with Fab47. |
Heteromer | 99.62 | 7×NAG; 43×NAG; | |||
| Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development |
Heteromer | 99.81 | 18×NAG; 30×NAG; | |||
| SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in cl… |
Heteromer | 98.15 | 15×NAG; 14×NAG; | |||
| SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction |
Heteromer Q9BYF1; | 99.81 | ||||
| Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1) in complex with Angiotensin-converting … |
Heteromer Q9BYF1; | 99.13 | 31×NAG; 13×NAG; | |||
| SARS Cov2 Spike RBD in complex with Fab47 |
Heteromer | 99.44 | 7×NAG; 45×NAG; | |||
| A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses including all major Omicro… |
Heteromer | 98.15 | 10×NAG; 28×NAG; | |||
| SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal antibody 1H1 Fab in th… |
Heteromer | 98.15 | 15×NAG; 15×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4 |
Heteromer | 99.81 | 4×NAG; 33×NAG; | |||
| Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development |
Heteromer | 98.94 | 15×NAG; 24×NAG; | |||
| SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound |
Heteromer Q9BYF1; | 99.81 | ||||
| Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … |
Heteromer Q9BYF1; | 97.5 | 37×NAG; 15×NAG; | |||
| SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab in the class 2 conformation |
Heteromer | 98.15 | 15×NAG; 15×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up confor… |
Heteromer | 99.81 | 8×NAG; 45×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … |
Heteromer Q9BYF1; | 97.5 | 43×NAG; 14×NAG; | |||
| SARS Cov2 Spike in 1-up conformation complex with Fab47 |
Heteromer | 99.62 | 8×NAG; 44×NAG; | |||
| SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs |
Heteromer | 99.53 | 6×NAG; 24×NAG; | |||
| SARS-CoV-2 Kappa variant spike protein in complex wth ACE2, state C1 |
Heteromer Q9BYF1; | 99.43 | ||||
| SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23 |
Heteromer | 99.82 | ||||
| Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2) in complex with Angiotensin-converting … |
Heteromer Q9BYF1; | 97.5 | 38×NAG; 16×NAG; | |||
| SARS-CoV-2 Omicron Variant SPIKE trimer complexed with ACE2 |
Heteromer Q9BYF1; | 100.0 | 12×NAG; 21×NAG; 1×CL; 1×ZN; | |||
| SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67 |
Heteromer | 99.82 | 14×NAG; 4×NAG; 2×NAG; 32×NAG; | |||
| SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 1 conformation |
Heteromer | 99.81 | 18×NAG; 27×NAG; | |||
| SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I |
Heteromer | 99.81 | 23×NAG; | |||
| SARS-CoV-2 S-6P in complex with 9 Fabs |
Heteromer | 99.53 | ||||
| SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 2 conformation |
Heteromer | 99.81 | 17×NAG; 27×NAG; | |||
| S protein of SARS-CoV-2 in complex with 3711 |
Heteromer | 99.81 | 23×NAG; 3×NAG; 38×NAG; 3×EIC; | |||
| Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113… |
Heteromer | 99.81 | 3×NAG; 12×NAG; 18×NAG; | |||
| Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab |
Heteromer | 99.82 | 25×NAG; 2×BLA; 29×NAG; | |||
| SD1-3 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein |
Heteromer | 87.5 | 30×NAG; | |||
| SARS-CoV-2 S B.1.617.1 kappa variant + S2X303 Global Refinement |
Heteromer | 98.55 | 3×NAG; 51×NAG; | |||
| SARS-CoV-2 S (C.37 Lambda variant) plus S309, S2L20, and S2X303 Fabs |
Heteromer | 100.0 | 57×NAG; | |||
| Delta SARS-CoV-2 spike protein in complex with REGN10987 Fab homologue. |
Heteromer | 98.58 | ||||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C15… |
Heteromer | 100.0 | 12×NAG; 35×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S trimer in the early fusion intermediate conformation (E-FIC) |
Heteromer Q9BYF1; | 99.91 | 21×NAG; 3×NAG; 42×NAG; | |||
| SARS-CoV-2 Omicron BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fa… |
Heteromer | 97.67 | 1×NAG; 48×NAG; | |||
| SARS-CoV-2 S/S2M11/S2X333 Global Refinement |
Heteromer | 99.42 | 3×NAG; 6×NAG; 45×NAG; | |||
| SARS-CoV-2 S ectodomain trimer in complex with neutralizing antibody 10-5B |
Heteromer | 99.81 | ||||
| SARS-CoV-2 S/S2M11/S2M28 Global Refinement |
Heteromer | 99.42 | 3×NAG; 6×NAG; 45×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike in complex with VHH14 |
Heteromer | 99.81 | 38×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer complex with the human neutralizing antibody Fab fragment, … |
Heteromer | 100.0 | 21×NAG; 3×NAG; 6×NAG; 18×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike in complex with VHH21 |
Heteromer | 100.0 | 40×NAG; | |||
| Cryo-EM structure of NTD-directed neutralizing antibody 5-7 in complex with prefusion SARS-CoV-2 sp… |
Heteromer | 99.81 | 6×NAG; 48×NAG; | |||
| SARS-CoV-2 S + S2L20 |
Heteromer | 99.42 | 9×NAG; 3×NAG; 33×NAG; | |||
| SARS-CoV-2 S B.1.1.529 Omicron variant + S309 + S2L20 Global Refinement |
Heteromer | 98.11 | 1×NAG; 50×NAG; | |||
| SARS-CoV-2 S B.1.617.2 delta variant + S2M11 + S2L20 Global Refinement |
Heteromer | 98.42 | 3×NAG; 45×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibody A19-46.1 |
Heteromer | 98.18 | 14×NAG; 28×NAG; | |||
| SARS-CoV-2 S B.1.617.1 kappa variant + S309 + S2L20 Global Refinement |
Heteromer | 98.54 | 51×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibodies A19-46.1 and B1-182.1 |
Heteromer | 98.18 | 13×NAG; 15×NAG; | |||
| The global map of Omicron Subvariants Spike with ACE2 |
Heteromer Q9BYF1; | 71.43 | ||||
| The global map of Omicron Subvariants Spike with two antibodies |
Heteromer | 71.43 | ||||
| Omicron BA.1 Spike protein with neutralizing NTD specific mAb K501SP6 |
Heteromer | 100.0 | ||||
| SARS-CoV-2 S/S2M11/S2L28 Global Refinement |
Heteromer | 99.43 | 3×NAG; 9×NAG; 3×NAG; 39×NAG; | |||
| Structure of the SARS-CoV-2 Spike trimer with three RBDs up in complex with the Fab fragment of hum… |
Heteromer | 99.81 | 33×NAG; 21×NAG; | |||
| VIR-7229 Fab fragment bound the BA.2.86 spike trimer (global refinement) |
Heteromer | 93.02 | 10×NAG; 29×NAG; | |||
| Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of huma… |
Heteromer | 99.81 | 29×NAG; 25×NAG; | |||
| BA.5 spike/Nanosota-9 complex |
Heteromer | 100 | 8×NAG; 20×NAG; | |||
| Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with two RBDs down in complex with the Fab … |
Heteromer | 98.0 | 27×NAG; 19×NAG; | |||
| SARS-CoV-2 S Omicron Spike B.1.1.529 - 3-P2G3 and 1-P5C3 Fabs (Global) |
Heteromer | 98.0 | 14×NAG; 1×NAG; 2×NAG; 26×NAG; | |||
| Structure of SARS-CoV-2 Omicron BA.1.1.529 Spike trimer with one RBD down in complex with the Fab f… |
Heteromer | 98.0 | 20×NAG; 23×NAG; | |||
| Stabilised BA.1 SARS-CoV-2 spike with H6 nanobodies in '3 up' RBD conformation |
Heteromer | 97.54 | 12×NAG; 9×NAG; | |||
| Stabilised BA.1 SARS-CoV-2 spike with H6 nanobodies in '2 up 1 down' RBD conformation |
Heteromer | 98.0 | 11×NAG; 15×NAG; | |||
| cryo-EM structure of omicron spike in complex with de novo designed binder, full map |
Heteromer Q9VKJ9; | 98.0 | 18×NAG; 12×NAG; 16×NAG; | |||
| SARS-CoV-2 BA.2 variant spike protein in complex with Fab BD55-5840 |
Heteromer | 100 | ||||
| SARS-CoV-2 Delta Spike in complex with Fab of JE-5C |
Heteromer | 98.35 | ||||
| CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike |
Heteromer | 99.4 | 5×NAG; 13×NAG; 22×NAG; | |||
| SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations… |
Heteromer | 100 | 10×NAG; 27×NAG; | |||
| Beta-50 fab in complex with SARS-CoV-2 beta-Spike glycoprotein |
Heteromer | 99.44 | 1×NAG; 14×NAG; 2×NAG; 25×NAG; | |||
| XBB.1.5.70 spike protein in complex with ACE2 |
Heteromer Q9BYF1; | 90.0 | ||||
| cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound |
Heteromer | 99.42 | 21×NAG; 6×NAG; 18×NAG; | |||
| XBB.1.5 spike protein in complex with ACE2 |
Heteromer Q9BYF1; | 95.97 | ||||
| XBB.1.5.10 spike protein in complex with ACE2 |
Heteromer Q9BYF1; | 90.0 | ||||
| XBB.1.5 spike protein in complex with BD55-1205 |
Heteromer | 95.97 | ||||
| LM18/Nb136 bispecific tetra-nanobody immunoglobulin in complex with SARS-CoV-2-6P-Mut7 S protein (f… |
Heteromer | 99.21 | 13×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.42 | 1×NAG; 32×NAG; | |||
| Beta049 fab in complex with SARS-CoV2 beta-Spike glycoprotein, The Beta mAb response underscores th… |
Heteromer | 99.45 | 2×NAG; 14×NAG; 1×NAG; 26×NAG; | |||
| Cryo-EM Structure of SARS-CoV-2 BA.2 Spike protein in complex with BA7535 |
Heteromer | 83.33 | 12×NAG; 12×NAG; | |||
| BA.2-07 FAB IN COMPLEX WITH SARS-COV-2 BA.2.12.1 SPIKE GLYCOPROTEIN |
Heteromer | 100 | 12×NAG; 24×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051 |
Heteromer | 100.0 | 4×NAG; 27×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548 |
Heteromer | 100.0 | 5×NAG; 1×NAG; 1×NAG; 1×NAG; 26×NAG; | |||
| BA.2(S375) Spike (S6P)/hACE2 complex |
Heteromer Q9BYF1; | 100 | 3×NAG; 51×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with Fab S2M11 |
Heteromer | 99.12 | 18×NAG; 3×NAG; 30×NAG; | |||
| S728-1157 IgG in complex with SARS-CoV-2-6P-Mut7 Spike protein (focused refinement) |
Heteromer | 99.03 | 11×NAG; | |||
| SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment |
Heteromer | 99.81 | 18×NAG; 3×NAG; 30×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-3 |
Heteromer | 100.0 | 3×NAG; 45×NAG; | |||
| SD1-2 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein |
Heteromer | 100 | 30×NAG; | |||
| Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting no… |
Heteromer | 99.39 | ||||
| cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound |
Heteromer | 99.42 | 7×NAG; 2×NAG; 25×NAG; | |||
| Omicron spike trimer with 6m6 antibody |
Heteromer | 97.83 | 24×NAG; | |||
| BA.2.86 Spike in complex with bovine ACE2 (bound 1 ACE2) |
Heteromer Q2HJI5; | 75.0 | 17×NAG; 1×ZN; 1×CL; 36×NAG; | |||
| BA.2.86 S-trimer in complex with Nab XG2v046 |
Heteromer | 75.0 | 9×NAG; 4×NAG; 1×NAG; 39×NAG; | |||
| BA.2.86 S-trimer in complex with Nab XGv280 |
Heteromer | 75.0 | 54×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike protein in complex with A6 repebody |
Heteromer | 99.42 | 5×NAG; 24×NAG; | |||
| Cryo-EM structure of broadly neutralizing antibody 2-36 in complex with prefusion SARS-CoV-2 spike … |
Heteromer | 99.8 | 16×NAG; 9×NAG; | |||
| Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5 |
Heteromer Q9BYF1; | 99.8 | 4×NAG; 48×NAG; | |||
| Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5 |
Heteromer Q9BYF1; | 99.81 | 6×NAG; 56×NAG; | |||
| SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric |
Heteromer | 99.42 | 2×NAG; 1×NAG; 7×NAG; | |||
| SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation |
Heteromer | 99.41 | 12×NAG; 3×NAG; 16×NAG; | |||
| SARS-CoV-2 spike in complex with LCB1 (2RBDs open) |
Heteromer | 99.39 | 13×NAG; 33×NAG; | |||
| SARS-CoV-2 S (Spike Glycoprotein) D614G with Three (3) RBDs Up, Bound to Antibody 2-7 scFv, composi… |
Heteromer | 99.71 | 3×NAG; 45×NAG; | |||
| 3D model of the 3-RBD up single trimeric spike protein of SARS-CoV2 in the presence of synthetic pe… |
Heteromer | 99.81 | 39×NAG; | |||
| The state 1 of Omicron Spike with bispecific antibody FD01 |
Heteromer | 97.78 | 28×NAG; | |||
| The state 2 of Omicron Spike with bispecific antibody FD01 |
Heteromer | 97.78 | 23×NAG; | |||
| State - I: Spike 2-up RBD with THSC20.HVTR04 (Fab4) |
Heteromer A0A6V7AL95; | 99.81 | 35×NAG; | |||
| Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 |
Heteromer Q9BYF1; | 99.81 | 8×NAG; 55×NAG; | |||
| The state 3 of Omicron Spike with bispecific antibody FD01 |
Heteromer | 97.78 | 21×NAG; | |||
| The state 4 of Omicron Spike with bispecific antibody FD01 |
Heteromer | 97.78 | 23×NAG; | |||
| The state 5 of Omicron Spike with bispecific antibody FD01 |
Heteromer | 97.78 | 18×NAG; | |||
| The state 6 of Omicron Spike with bispecific antibody FD01 |
Heteromer | 97.78 | ||||
| SARS-CoV-2 Omicron 1-RBD up Spike trimer complexed with three XG005 molecules |
Heteromer | 97.67 | ||||
| SARS-CoV-2 Omicron 2-RBD up Spike trimer complexed with three XG005 molecules |
Heteromer | 97.67 | ||||
| Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4 |
Heteromer Q9BYF1; | 99.8 | 4×NAG; 53×NAG; | |||
| SARS-CoV-2 Omicron 1-RBD up spike trimer complexed with two XG005 Fab |
Heteromer | 97.67 | ||||
| CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike |
Heteromer | 99.42 | 11×NAG; 4×NAG; 1×NAG; 29×NAG; | |||
| SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation |
Heteromer | 99.81 | 10×NAG; 4×NAG; 1×NAG; 1×NAG; 29×NAG; | |||
| SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation |
Heteromer | 99.81 | 11×NAG; 4×NAG; 1×NAG; 19×NAG; | |||
| SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation. |
Heteromer | 99.81 | 4×NAG; 8×NAG; 3×NAG; 1×NAG; 19×NAG; | |||
| XBB.1.5 spike/Nb5 complex |
Heteromer | 87.5 | 12×NAG; 33×NAG; | |||
| SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation |
Heteromer | 99.42 | 10×NAG; 4×NAG; 1×NAG; 1×NAG; 28×NAG; | |||
| Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5 |
Heteromer Q9BYF1; | 99.8 | 6×NAG; 44×NAG; | |||
| SARS-CoV-2 S trimer with two RBDs in the open state and complexed with two H014 Fab |
Heteromer | 99.8 | 15×NAG; 30×NAG; | |||
| SARS-CoV-2 S trimer with three RBD in the open state and complexed with three H014 Fab |
Heteromer | 99.81 | 15×NAG; 30×NAG; | |||
| Complex of SARS-CoV-2 spike trimer with its neutralizing antibody HB27 |
Heteromer | 99.8 | 15×NAG; 29×NAG; | |||
| CryoEM structure of SARS-CoV-2 Spike in complex with Nb17 |
Heteromer | 99.29 | ||||
| SARS-CoV-2 EG.5.1 Spike in complex with CYFN1006-2(S-CYFN1006-2 dimer trimer). |
Heteromer | 100 | ||||
| Structure of EG.5.1 S trimer with 3 down-RBDs complex with antibody CYFN1006-2. |
Heteromer | 100 | ||||
| SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34 |
Heteromer | 99.81 | 12×NAG; 50×NAG; | |||
| Structure of EG.5.1 S trimer with 2 down-RBDs complex with antibody CYFN1006-2. |
Heteromer | 100 | ||||
| JN.1 spike/Nanosota-9 complex |
Heteromer | 97.56 | 16×NAG; | |||
| Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 |
Heteromer Q9BYF1; | 99.8 | 5×NAG; 46×NAG; | |||
| SARS-CoV-2 S trimer with one RBD in the open state and complexed with one H014 Fab. |
Heteromer | 99.51 | 15×NAG; 30×NAG; | |||
| SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1) |
Heteromer Q9BYF1; | 100 | 9×NAG; 1×ZN; 1×CL; 49×NAG; | |||
| SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2) |
Heteromer Q9BYF1; | 100 | 9×NAG; 53×NAG; 2×ZN; 2×CL; | |||
| SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1) |
Heteromer | 100 | 9×NAG; 2×NAG; 45×NAG; | |||
| SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2) |
Heteromer | 100 | 9×NAG; 3×NAG; 45×NAG; | |||
| SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3) |
Heteromer | 100 | 2×NAG; 45×NAG; | |||
| A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses including all major Omicro… |
Heteromer | 97.05 | 12×NAG; 25×NAG; | |||
| BA.5 Spike complex with CR9 |
Heteromer | 100 | ||||
| Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting no… |
Heteromer | 99.4 | ||||
| cryo-EM structure of Omicron BA.5 S protein in complex with XGv282 |
Heteromer | 100 | 18×NAG; 33×NAG; | |||
| cryo-EM structure of Omicron BA.5 S protein in complex with XGv289 |
Heteromer | 100 | 18×NAG; 33×NAG; | |||
| SARS-CoV-2 Delta Spike in complex with JM-1A |
Heteromer | 97.5 | ||||
| cryo-EM structure of Omicron BA.5 S protein in complex with S2L20 |
Heteromer | 100 | 3×NAG; 18×NAG; 30×NAG; | |||
| SARS-CoV2 Omicron BA.1 spike in complex with CAB-A17 antibody |
Heteromer | 96.8 | 15×NAG; 22×NAG; | |||
| CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation |
Heteromer | 99.8 | 20×NAG; 26×NAG; | |||
| SARS-CoV-2 spike in prefusion state |
Heteromer | 99.75 | 16×NAG; 4×NAG; 7×NAG; 18×NAG; 2×MAN; 3×DMS; | |||
| Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three F61 Fab |
Heteromer | 99.41 | 24×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-28 |
Heteromer | 100.0 | 39×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31 |
Heteromer | 100.0 | 3×NAG; 39×NAG; | |||
| A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses including all major Omicro… |
Heteromer | 97.05 | 13×NAG; 24×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-34 |
Heteromer | 100.0 | 42×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, HSW-1 |
Heteromer | 100.0 | 2×NAG; 34×NAG; | |||
| SARS-CoV-2 Omicron BA.4 spike trimer (6P) in complex with D1F6 Fab, head-to-head aggregate |
Heteromer | 97.62 | 20×NAG; | |||
| Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab … |
Heteromer | 99.79 | 10×NAG; 3×NAG; 1×NAG; 1×NAG; 1×NAG; 1×MAN; 28×NAG; 3×FUC; 2×MAN; | |||
| SARS-CoV-2 Spike protein in complex with the single chain fragment scFv76 |
Heteromer | 99.41 | 12×NAG; 27×NAG; | |||
| SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation) |
Heteromer | 100.0 | 14×NAG; 21×NAG; 3×NAG; 3×NAG; 3×NAG; | |||
| Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.8 | 28×NAG; | |||
| SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab |
Heteromer | 99.8 | 13×NAG; 23×NAG; | |||
| Structure of the SARS-CoV-2 BA.1 spike with UT28-RD |
Heteromer | 97.56 | 8×NAG; 34×NAG; | |||
| Complex structure of BD-218 and Spike protein |
Heteromer | 99.42 | 2×NAG; 32×NAG; | |||
| SARS-CoV-2 Spike in complex with Fab of m31A7 |
Heteromer | 99.71 | 2×NAG; 8×NAG; 2×NAG; 4×NAG; 3×NAG; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 19×NAG; | |||
| Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.8 | 3×NAG; 1×NAG; 1×NAG; 26×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzym… |
Heteromer Q9BYF1; | 100.0 | 29×NAG; 26×NAG; | |||
| SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation) |
Heteromer | 100.0 | 12×NAG; 21×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; | |||
| SARS-CoV-2 spike glycoprotein in complex with the ICO-hu23 neutralizing antibody Fab fragment |
Heteromer | 99.8 | 12×NAG; 30×NAG; | |||
| Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutat… |
Heteromer | 99.8 | 22×NAG; | |||
| Beta-32 fab in complex with SARS-CoV-2 beta-Spike glycoprotein |
Heteromer | 98.83 | 15×NAG; 30×NAG; | |||
| SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6 |
Heteromer | 99.8 | 12×NAG; 30×NAG; | |||
| Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutat… |
Heteromer | 99.8 | 20×NAG; | |||
| J08 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (conformation 3) |
Heteromer | 99.19 | 7×NAG; 16×NAG; | |||
| SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6 |
Heteromer | 99.8 | 18×NAG; 27×NAG; | |||
| SARS-CoV-2 Spike in complex with neutralizing Fab SARS2-38 (three down conformation) |
Heteromer | 99.4 | 15×NAG; 33×NAG; | |||
| SARS-CoV-2 spike + IMCAS-123 |
Heteromer | 99.8 | 2×NAG; 15×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the M1 conformation, D4 |
Heteromer | 99.76 | 12×NAG; 22×NAG; | |||
| Cryo-EM structure of Antibody 12-16 in complex with prefusion SARS-CoV-2 Spike glycoprotein |
Heteromer | 99.71 | 48×NAG; | |||
| SARS-Cov2 Omicron varient S protein structure in complex with neutralizing monoclonal antibody 002-… |
Heteromer | 97.62 | 13×NAG; 28×NAG; | |||
| Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab f… |
Heteromer | 99.69 | 9×NAG; 1×NAG; 2×NAG; 1×NAG; 30×NAG; | |||
| Beta-53 fab in complex with SARS-CoV-2 beta-Spike glycoprotein |
Heteromer | 99.37 | 2×NAG; 11×NAG; 15×NAG; | |||
| SARS-CoV-2 B.1.1.7 S-ACE2 complex |
Heteromer Q9BYF1; | 100 | 16×NAG; 27×NAG; | |||
| Cryo-EM structure of Antibody 12-19 in complex with prefusion SARS-CoV-2 Spike glycoprotein |
Heteromer | 99.7 | 47×NAG; | |||
| SARS-CoV-2 WT Spike in complex with R15 Fab and P14 Nanobody |
Heteromer | 99.6 | 15×NAG; 33×NAG; | |||
| Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab f… |
Heteromer | 99.69 | 9×NAG; 3×NAG; 3×NAG; 24×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 down RBD, state1) |
Heteromer | 99.4 | 27×NAG; | |||
| Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with two T6 F… |
Heteromer | 99.4 | 25×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2) |
Heteromer | 99.4 | 27×NAG; | |||
| Structure of SARS-CoV-2 Omicron BA.1 Spike complexed with antibody PW5-570 |
Heteromer | 97.62 | ||||
| Cryo-EM structure of South African (B.1.351) SARS-CoV-2 spike glycoprotein in complex with three T6… |
Heteromer | 99.4 | 25×NAG; | |||
| Alpha SARS-CoV-2 spike protein in complex with REGN10987 Fab homologue. |
Heteromer | 100.0 | 31×NAG; 16×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3) |
Heteromer | 99.4 | 27×NAG; | |||
| Mink Cluster 5-associated SARS-CoV-2 spike protein(S-GSAS-D614G-delFV) missing the S1 subunit and S… |
Heteromer | 100 | 1×NAG; 27×NAG; | |||
| SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab |
Heteromer | 99.8 | ||||
| Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.8 | 15×NAG; 27×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.8 | 15×NAG; 30×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.7 | 1×NAG; 2×NAG; | |||
| SARS-CoV-2 S-trimer (3 RBDs up) bound to TriSb92, fitted into cryo-EM map |
Heteromer | 99.8 | 6×NAG; 39×NAG; | |||
| Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.69 | 10×NAG; 21×NAG; | |||
| CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 nanobody complex |
Heteromer | 99.8 | 19×NAG; 28×NAG; | |||
| Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.7 | 13×NAG; 34×NAG; | |||
| CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 nanobody complex |
Heteromer | 99.8 | 20×NAG; 26×NAG; | |||
| Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 8D2 |
Heteromer | 99.47 | ||||
| cryoEM structure of SARS-CoV2 Spike trimer in complex with Fab23 |
Heteromer | 99.4 | ||||
| SARS-CoV-2 Delta Spike in complex with IS-9A |
Heteromer | 99.05 | 4×NAG; 24×NAG; | |||
| Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down- and 2 up RBDs) |
Heteromer | 97.56 | 2×NAG; 27×NAG; | |||
| Spike protein from SARS-CoV2 with Fab fragment of enhancing antibody 2490 |
Heteromer | 99.47 | ||||
| Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.69 | 13×NAG; 1×NAG; 1×NAG; 33×NAG; | |||
| SARS-CoV-2 Omicron BA.2 spike trimer (6P) in complex with 3 D1F6 Fabs (1 RBD up) |
Heteromer | 96.45 | 15×NAG; 2×NAG; 24×NAG; | |||
| Cryo-EM structure of the Omicron S in complex with 35B5 Fab(1 down-, 1 up- and 1 invisible RBDs) |
Heteromer | 97.56 | 27×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three D2 Fab |
Heteromer | 99.41 | 32×NAG; | |||
| EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab |
Heteromer | 99.8 | 11×NAG; 27×NAG; | |||
| SARS-CoV-2 Omicron BA.4 spike trimer (6P) in complex with 3 D1F6 Fabs (1 RBD up) |
Heteromer | 97.62 | 11×NAG; 28×NAG; | |||
| SARS-CoV-2 Omicron BA.2 spike trimer (6P) in complex with 3 D1F6 Fabs (2 RBD up) |
Heteromer | 96.46 | 18×NAG; 21×NAG; | |||
| SARS-CoV-2 Omicron BA.2 spike trimer (6P) in complex with D1F6 Fab, head-to-head aggregate |
Heteromer | 96.46 | 7×NAG; 22×NAG; | |||
| EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-88 Fab |
Heteromer | 99.8 | 15×NAG; 1×NAG; 2×NAG; 30×NAG; | |||
| SARS-CoV-2 Omicron BA.4 spike trimer (6P) in complex with 3 D1F6 Fabs (2 RBD up) |
Heteromer | 97.62 | 12×NAG; 24×NAG; | |||
| EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-316 Fab |
Heteromer | 99.8 | 15×NAG; 3×NAG; 25×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to two copies of domain-swapped antibody 2G12 |
Heteromer | 99.79 | 8×NAG; 2×NAG; 2×NAG; 2×NAG; 25×NAG; | |||
| Structure of human SARS-CoV-2 spike glycoprotein trimer bound by neutralizing antibody C1C-A3 Fab (… |
Heteromer | 99.35 | 3×NAG; 45×NAG; | |||
| Structure of the SARS-CoV-2 spike glycoprotein in complex with nanobody 7F |
Heteromer | 99.29 | 42×NAG; | |||
| SARS-CoV-2 BA.1 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C |
Heteromer | 97.44 | 3×NAG; | |||
| EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab |
Heteromer | 99.8 | 11×NAG; 27×NAG; | |||
| SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound |
Heteromer Q9BYF1; | 99.8 | 24×NAG; 42×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer complex with the human neutralizing antibody Fab fragment, … |
Heteromer | 99.4 | 2×NAG; | |||
| SARS-CoV-2 spike glycoprotein trimer complexed with Fab fragment of anti-RBD antibody E7 |
Heteromer | 99.4 | 7×NAG; 14×NAG; | |||
| SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound |
Heteromer Q9BYF1; | 99.8 | 20×NAG; 40×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 100.0 | 45×NAG; | |||
| Cryo-EM Structure of SARS-CoV-2 Spike : H11-D4 Nanobody Complex |
Heteromer | 99.8 | 20×NAG; 26×NAG; | |||
| EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-40 Fab |
Heteromer | 99.8 | 11×NAG; 27×NAG; | |||
| CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 1Up2Down conformation |
Heteromer | 99.8 | 20×NAG; 26×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound to one copy of domain-swapped antibody 2G12 |
Heteromer | 99.79 | 10×NAG; 1×NAG; 1×NAG; 1×NAG; 31×NAG; | |||
| Cryo-EM structure of mink variant Y453F trimeric spike protein bound to one mink ACE2 receptors at … |
Heteromer A0A7T0Q2W2; | 100 | ||||
| SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound |
Heteromer Q9BYF1; | 99.79 | 17×NAG; 36×NAG; | |||
| CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 nanobody complex |
Heteromer | 99.8 | 20×NAG; 26×NAG; | |||
| Cryo-EM structure of mink variant Y453F trimeric spike protein bound to two mink ACE2 receptors |
Heteromer A0A7T0Q2W2; | 100 | ||||
| EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-384 Fab |
Heteromer | 99.8 | 15×NAG; 30×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 2P S ectodomain bound domain-swapped antibody 2G12 from masked 3D r… |
Heteromer | 99.79 | 10×NAG; 1×NAG; 1×NAG; 1×NAG; 32×NAG; | |||
| Structure of the SARS-CoV-2 Omicron BA.1 S 6P trimer in complex with the mouse antibody Fab fragmen… |
Heteromer | 97.62 | 3×NAG; 27×NAG; | |||
| EM structure of SARS-CoV-2 Spike glycoprotein (one RBD up) in complex with COVOX-253H55L Fab |
Heteromer | 99.8 | 10×NAG; 1×NAG; 27×NAG; | |||
| Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab |
Heteromer | 99.8 | 12×NAG; 35×NAG; | |||
| SARS-CoV-2 Spike ectodomain with Fab FI3A |
Heteromer | 99.8 | 11×NAG; 27×NAG; | |||
| Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1041 |
Heteromer | 99.7 | 11×NAG; 6×NAG; 17×NAG; | |||
| EM structure of SARS-CoV-2 Spike glycoprotein (all RBD down) in complex with COVOX-253H55L Fab |
Heteromer | 99.8 | 14×NAG; 1×NAG; 32×NAG; | |||
| Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting no… |
Heteromer | 99.39 | ||||
| EM structure of SARS-CoV-2 Spike glycoprotein in complex with COVOX-253H165L Fab |
Heteromer | 99.8 | 10×NAG; 1×NAG; 27×NAG; | |||
| SARS CoV2 Spike ectodomain with engineered trimerized VH binder |
Heteromer | 99.8 | ||||
| Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052 |
Heteromer | 99.79 | 14×NAG; 31×NAG; | |||
| Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1050.1 |
Heteromer | 99.8 | 15×NAG; 33×NAG; | |||
| Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1047 |
Heteromer | 99.38 | 13×NAG; 2×NAG; 24×NAG; | |||
| CryoEM structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1042 |
Heteromer | 99.7 | 1×NAG; 12×NAG; 33×NAG; | |||
| CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 nanobody complex |
Heteromer | 99.8 | 20×NAG; 26×NAG; | |||
| H11-H4 bound to Spike |
Heteromer | 99.8 | 20×NAG; 26×NAG; | |||
| Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.8 | 28×NAG; | |||
| Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.8 | 23×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B |
Heteromer | 99.8 | 22×NAG; 26×NAG; | |||
| S-ECD (Omicron XBB.1) in complex with PD of ACE2 |
Heteromer Q9BYF1; | 98.0 | 38×NAG; 28×NAG; | |||
| Cryo EM structure of SARS-CoV-2 spike in complex with TAU-2212 mAbs in conformation 4 |
Heteromer | 99.8 | 33×NAG; | |||
| SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (2u1d) |
Heteromer | 99.8 | 17×NAG; 20×NAG; | |||
| S-ECD (Omicron) in complex with PD of ACE2 |
Heteromer Q9BYF1; | 100.0 | 23×NAG; 45×NAG; | |||
| SARS-CoV-2 Omicron Variant S Trimer complexed with one JMB2002 Fab |
Heteromer | 97.62 | 2×NAG; 33×NAG; | |||
| SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound |
Heteromer | 97.08 | 2×NAG; 35×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P36-5D2(state2) |
Heteromer | 99.5 | 17×NAG; 28×NAG; | |||
| SARS-CoV-2 Omicron Variant S Trimer complexed with two JMB2002 Fab |
Heteromer | 97.62 | 2×NAG; 36×NAG; | |||
| Omicron BA.4/5 SARS-CoV-2 S in complex with TH027 Fab |
Heteromer | 96.97 | 37×NAG; | |||
| SARS-CoV-2 spike protein in complex with a trivalent nanobody |
Heteromer | 99.29 | ||||
| S protein of SARS-CoV-2 in complex bound with P36-5D2 (state1) |
Heteromer | 99.5 | ||||
| Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30 |
Heteromer | 99.38 | 13×NAG; 27×NAG; | |||
| SARS-CoV-2 Omicron Variant S Trimer complexed with three JMB2002 Fab |
Heteromer | 97.62 | 2×NAG; 35×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.38 | 11×NAG; 26×NAG; | |||
| overall structure of hu33 and spike |
Heteromer | 98.71 | 3×NAG; 10×NAG; 26×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs |
Heteromer | 99.4 | 5×NAG; 31×NAG; | |||
| CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWA9 Fab |
Heteromer | 98.99 | ||||
| State 2 of SARS-CoV-2 XBB Variant Spike protein trimer complexed with antibody PW5-5 |
Heteromer | 99.14 | ||||
| Omicron BA.4/5 SARS-CoV-2 S in complex with TH132 Fab |
Heteromer | 96.97 | 36×NAG; | |||
| Omicron BA.4/5 SARS-CoV-2 S in complex with TH236 Fab |
Heteromer | 96.97 | 37×NAG; | |||
| Omicron BA.4/5 SARS-CoV-2 S in complex with TH272 Fab |
Heteromer | 96.97 | 36×NAG; | |||
| S protein of Delta variant in complex with ZWD12 |
Heteromer | 100.0 | 23×NAG; 25×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032 |
Heteromer | 100.0 | 4×NAG; 1×NAG; 22×NAG; | |||
| Structure of XBB spike protein (S) dimer-trimer in complex with bispecific antibody G7-Fc at 3.75 A… |
Heteromer | 99.14 | ||||
| S protein of Delta variant in complex with ZWC6 |
Heteromer | 100.0 | 23×NAG; 25×NAG; | |||
| SARS-CoV 2 Spike Protein bound to LY-CoV555 |
Heteromer | 99.27 | 3×NAG; 16×NAG; | |||
| BA.4/5-5 FAB IN COMPLEX WITH SARS-COV-2 BA.4 SPIKE GLYCOPROTEIN |
Heteromer | 97.53 | 12×NAG; 27×NAG; | |||
| SARS-CoV-2 spike in complex with LCB3 (2RBDs open) |
Heteromer | 99.49 | 13×NAG; 33×NAG; | |||
| Omicron BA.4/5 SARS-CoV-2 S in complex with TH281 Fab |
Heteromer | 96.97 | 36×NAG; | |||
| Omicron BA.4/5 SARS-CoV-2 S in complex with TH027/132 Fab |
Heteromer | 96.97 | 37×NAG; | |||
| CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWC11 Fab |
Heteromer | 99.0 | ||||
| Omicron BA.4/5 SARS-CoV-2 S in complex with TH272/281 Fab |
Heteromer | 96.97 | 37×NAG; | |||
| State 1 of SARS-CoV-2 XBB Variant Spike protein trimer complexed with antibody PW5-5 |
Heteromer | 99.14 | ||||
| Structure of SARS-CoV-2 XBB Variant Spike protein complexed with broadly neutralizing antibody PW5-… |
Heteromer | 99.14 | ||||
| BD23-Fab in complex with the S ectodomain trimer |
Heteromer | 99.79 | 5×NAG; 1×NAG; 32×NAG; | |||
| cryo-EM structure of D614 spike in complex with de novo designed binder |
Heteromer Q9VKJ9; | 99.7 | 7×NAG; 32×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron spike glycoprotein in complex with three F61 Fab and three … |
Heteromer | 97.62 | 31×NAG; | |||
| Omicron BA.4/5 SARS-CoV-2 S in complex with TH003 Fab |
Heteromer | 96.97 | 37×NAG; | |||
| The structure of HKU1-B S protein with bsAb1 |
Heteromer | 96.97 | ||||
| Cryo-EM structure of SARS-CoV-2 spike ectodomain (HexaPro, Omicron BA.2 variant) in complex with Ce… |
Heteromer | 97.95 | 27×NAG; | |||
| S protein of SARS-CoV-2 in complex with GW01 |
Heteromer | 99.5 | 23×NAG; 25×NAG; | |||
| Conformation 1 of S-ACE2-B0AT1 ternary complex |
Heteromer Q695T7; Q9BYF1; | 99.8 | 58×NAG; 64×NAG; 2×LEU; 2×ZN; | |||
| S-ECD (Omicron BA.2) in complex with PD of ACE2 |
Heteromer Q9BYF1; | 97.2 | 38×NAG; 28×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 |
Heteromer A0A5C2GJG2; | 99.81 | 7×NAG; 3×NAG; 2×NAG; 36×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike ectodomain (HexaPro, Omicron BA.5 variant) in complex with Ce… |
Heteromer | 97.82 | 4×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-2F11_2B |
Heteromer A0A5C2G1U0; P01834; P0DP01; V9HW68; | 99.8 | 21×NAG; 2×NAG; 28×NAG; | |||
| S-ECD (Omicron BA.3) in complex with three PD of ACE2 |
Heteromer Q9BYF1; | 100.0 | 38×NAG; 28×NAG; | |||
| SARS-CoV-2 Omicron BA.1 Spike in complex with IY-2A |
Heteromer | 97.62 | ||||
| Cryo-EM structure of SARS-CoV-2 spike ectodomain (HexaPro, Omicron BA.5 variant) in complex with Ce… |
Heteromer | 97.85 | 21×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-2F11_3B |
Heteromer A0A5C2G1U0; P01834; P0DP01; V9HW68; | 99.8 | 22×NAG; 3×NAG; 27×NAG; | |||
| S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound) |
Heteromer Q9BYF1; | 99.8 | 27×NAG; 28×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.4 | 33×NAG; | |||
| SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with one mouse ACE2 Bound |
Heteromer Q8R0I0; | 97.62 | 37×NAG; 1×ZN; | |||
| S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound) |
Heteromer Q9BYF1; | 99.8 | 26×NAG; 30×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-6 |
Heteromer | 100.0 | 48×NAG; | |||
| SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound |
Heteromer Q9BYF1; | 97.08 | 39×NAG; 2×CL; 2×ZN; | |||
| Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and … |
Heteromer Q9BYF1; | 99.8 | 27×NAG; 28×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25 |
Heteromer | 99.8 | 27×NAG; 21×NAG; | |||
| SARS-CoV-2 Omicron BA.1 Variant Spike Trimer with two mouse ACE2 Bound |
Heteromer Q8R0I0; | 97.62 | 39×NAG; 2×ZN; | |||
| Cryo-EM structure of SARS-CoV-2 S-D614G variant in complex with neutralizing antibodies, RBD-chAb15… |
Heteromer | 99.7 | 27×NAG; 21×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45 |
Heteromer | 99.8 | 24×NAG; 24×NAG; | |||
| S-ECD (Omicron BA.5) in complex with PD of ACE2 |
Heteromer Q9BYF1; | 97.5 | 38×NAG; 28×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with T-ACE2 |
Heteromer Q9BYF1; | 99.8 | 35×NAG; 34×NAG; | |||
| S-ECD (Omicron BA.3) in complex with two PD of ACE2 |
Heteromer Q9BYF1; | 100.0 | 33×NAG; 27×NAG; | |||
| SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound |
Heteromer Q9BYF1; | 97.08 | 39×NAG; 3×CL; 3×ZN; | |||
| Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and … |
Heteromer Q9BYF1; | 99.8 | 32×NAG; 29×NAG; | |||
| Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and … |
Heteromer Q9BYF1; | 99.8 | 32×NAG; 29×NAG; | |||
| Furin Cleaved Alpha Variant SARS-CoV-2 Spike in complex with 3 ACE2 |
Heteromer Q9BYF1; | 100.0 | 3×NAG; 48×NAG; 3×ZN; | |||
| SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound |
Heteromer Q8R0I0; | 97.08 | 34×NAG; 1×ZN; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B |
Heteromer | 99.8 | 21×NAG; 27×NAG; | |||
| S-ECD (Omicron BA.2.75) in complex with PD of ACE2 |
Heteromer Q9BYF1; | 96.9 | 37×NAG; 29×NAG; | |||
| SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (3U) |
Heteromer | 99.8 | 18×NAG; 18×NAG; | |||
| SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two mouse ACE2 Bound |
Heteromer Q8R0I0; | 97.08 | 37×NAG; 2×ZN; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-3A1 |
Heteromer | 99.8 | 22×NAG; 26×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017 |
Heteromer | 100.0 | 6×NAG; 19×NAG; | |||
| S-ECD (Omicron BF.7) in complex with PD of ACE2 |
Heteromer Q9BYF1; | 97.5 | 38×NAG; 28×NAG; | |||
| S-ECD (Omicron) in complex with STS165 |
Heteromer | 100.0 | 19×NAG; 33×NAG; | |||
| SARS-CoV-2 Omicron spike in complex with 5817 Fab |
Heteromer | 97.15 | 2×NAG; 36×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P2B-1A1 |
Heteromer A0A5C2GM57; P01825; Q5EFE5; Q8N5F4; | 99.8 | 23×NAG; 28×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B |
Heteromer P01594; P0DOX5; P0DP02; Q8TCD0; | 99.8 | 20×NAG; 31×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B |
Heteromer A0A5C2GCZ2; A0A5C2GG81; Q6GMX6; Q8TCD0; | 99.8 | 20×NAG; 31×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-1B9 |
Heteromer A0A5C2G1U0; P01825; Q6GMX6; Q8TCD0; | 99.8 | 19×NAG; 33×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with FabP5A-2G7 |
Heteromer A0A0C4DH41; A0A5C2G2G8; Q6IPQ0; V9HW68; | 99.8 | 20×NAG; 29×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with FabP5A-1B8 |
Heteromer A0A5C2GCZ2; A0A5C2GF00; Q6GMX6; Q8TCD0; | 99.8 | 21×NAG; 28×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B |
Heteromer P01594; P0DOX5; P0DP02; Q8TCD0; | 99.8 | 21×NAG; 28×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-2G9 |
Heteromer A0A5C2GMM2; P01772; P0DOX5; Q8N5F4; | 99.8 | 21×NAG; 28×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-2G7 |
Heteromer A0A0C4DH41; A0A5C2G2G8; Q6IPQ0; V9HW68; | 99.8 | 21×NAG; 28×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B |
Heteromer A0A5C2GCZ2; A0A5C2GG81; Q6GMX6; Q8TCD0; | 99.8 | 20×NAG; 30×NAG; | |||
| S protein of SARS-CoV-2 in complex bound with P2B-1A10 |
Heteromer A0A5C2GF00; P01594; P0DOX5; Q8TCD0; | 99.8 | 21×NAG; 28×NAG; | |||
| SARS-CoV-2 Spike trimer in complex with XG014 Fab |
Heteromer | 99.8 | 24×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C17… |
Heteromer | 100.0 | 6×NAG; 1×NAG; 27×NAG; | |||
| SARS-CoV-2 S trimer in complex with 1F Fab |
Heteromer | 99.8 | 15×NAG; 26×NAG; | |||
| SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) |
Heteromer | 99.8 | 12×NAG; 36×NAG; | |||
| SARS-CoV-2 Omicron BQ.1.1 Variant Spike Protein Complexed with MO11 Fab |
Heteromer | 100 | 9×NAG; 3×NAG; 3×NAG; 21×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragmen… |
Heteromer | 99.4 | 15×NAG; 33×NAG; | |||
| SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement |
Heteromer | 99.3 | 3×NAG; 6×NAG; 39×NAG; | |||
| SARS-CoV-2 spike in complex with neutralizing antibody NIV-11 |
Heteromer | 99.4 | 12×NAG; 36×NAG; | |||
| SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment |
Heteromer | 99.4 | 15×NAG; 33×NAG; | |||
| Structure of SARS-CoV-2 XBB.1 spike glycoprotein in complex with ACE2 (1-up state) |
Heteromer Q9BYF1; | 100 | 8×NAG; 1×NAG; 1×NAG; 36×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1) |
Heteromer | 100.0 | 39×NAG; | |||
| SARS-CoV-2 Omicron BA.1 spike trimer (x2-4P) in complex with 3 D1F6 Fabs (0 RBD up) |
Heteromer | 97.56 | 12×NAG; 24×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron EG.5.1 spike protein(6P) in complex with human ACE2 |
Heteromer Q9BYF1; | 100 | 36×NAG; 1×ZN; | |||
| SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open) |
Heteromer | 99.8 | 11×NAG; 36×NAG; | |||
| Structure of the SARS-CoV-2 Spike trimer with one RBD down in complex with the Fab fragment of huma… |
Heteromer | 99.8 | 23×NAG; 28×NAG; | |||
| Structure of the SARS-CoV-2 Spike trimer with all RBDs down in complex with the Fab fragment of hum… |
Heteromer | 99.8 | 21×NAG; 30×NAG; | |||
| SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024 |
Heteromer | 100 | 15×NAG; 9×NAG; 24×NAG; | |||
| P5C3 is a potent fab neutralizer |
Heteromer | 99.4 | ||||
| Structure of the SARS-CoV-2 Spike trimer with two RBDs down in complex with the Fab fragment of hum… |
Heteromer | 99.8 | 21×NAG; 30×NAG; | |||
| SARS-CoV-2 S glycoprotein in complex with S2X259 Fab |
Heteromer | 99.35 | 12×NAG; 30×NAG; | |||
| Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4) |
Heteromer | 99.4 | 2×NAG; 27×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron Spike protein in complex with BA7208 fab |
Heteromer | 97.62 | 11×NAG; 16×NAG; | |||
| SARS-CoV-2 spike in complex with AHB2-2GS-SB175 |
Heteromer | 99.39 | 12×NAG; 36×NAG; | |||
| SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment |
Heteromer | 99.8 | 12×NAG; 3×NAG; 33×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43 |
Heteromer | 99.8 | 6×NAG; 3×NAG; 31×NAG; | |||
| Structure of SARS-CoV-2 spike glycoprotein in complex with NT-108 scFv (1-up state) |
Heteromer | 99.38 | 2×NAG; 19×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7054 and BA7125 fab |
Heteromer | 98.81 | 12×NAG; 12×NAG; | |||
| Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein in complex with ACE2 (1-up state) |
Heteromer Q9BYF1; | 100 | 8×NAG; 1×NAG; 1×NAG; 33×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7 |
Heteromer | 99.74 | 6×NAG; 30×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 spike protein in complex with white-tailed deer ACE2 |
Heteromer A0A6J0Z472; | 100.0 | 14×NAG; 25×NAG; 2×ZN; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron JN.1 spike protein in complex with human ACE2 |
Heteromer Q9BYF1; | 100 | 6×NAG; 13×NAG; 3×ZN; 37×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15 |
Heteromer | 99.8 | 7×NAG; 1×NAG; 1×NAG; 31×NAG; | |||
| Structure of SARS-CoV-2 spike in complex with antibody Fab COVIC-154 |
Heteromer | 99.45 | 9×NAG; 21×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Delta Spike protein in complex with BA7208 and BA7125 fab |
Heteromer | 100.0 | 12×NAG; 12×NAG; | |||
| SARS-CoV-2 Delta Spike in complex with JL-8C |
Heteromer | 99.03 | ||||
| Spike Trimer of BA.2.86 in complex with one hACE2 |
Heteromer Q9BYF1; | 97.56 | 17×NAG; 35×NAG; 1×ZN; 1×CL; | |||
| Spike Trimer of BA.2.86 in complex with two hACE2s |
Heteromer Q9BYF1; | 97.56 | 15×NAG; 41×NAG; 2×ZN; 2×CL; | |||
| BA.2.86 Spike in complex with bovine ACE2 (bound 2 ACE2) |
Heteromer Q58DD0; | 98.04 | 12×NAG; 1×NAG; | |||
| SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (two receptor-bindin… |
Heteromer | 99.39 | 8×NAG; 37×NAG; | |||
| SARS-CoV-2 Delta Spike in complex with FP-12A |
Heteromer | 98.31 | 7×NAG; 21×NAG; | |||
| Cryo-EM structure of SARS-CoV2 Omicron BA.5 spike in complex with 8-9D Fabs |
Heteromer | 97.56 | 27×NAG; | |||
| SARS-CoV-2 BA.4 variants S ectodomain trimer in complex with neutralizing antibody 10-5B and 6-2C |
Heteromer | 97.44 | 3×NAG; | |||
| SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2) |
Heteromer | 99.36 | 8×NAG; 27×NAG; | |||
| Structure of SARS-CoV-2 Omicron BA.1 spike in complex with antibody Fab 1C3 |
Heteromer | 97.67 | 3×NAG; 18×NAG; | |||
| Conformation 1 of SARS-CoV-2 Omicron BA.1 Variant Spike protein complexed with MO1 Fab |
Heteromer | 97.56 | 22×NAG; | |||
| Conformation 2 of SARS-CoV-2 Omicron BA.1 Variant Spike protein complexed with MO1 Fab |
Heteromer | 97.56 | 28×NAG; | |||
| SARS-CoV-2 Spike (BA.1) in complex with Fab of JH-8B |
Heteromer | 97.73 | 4×NAG; 1×NAG; 7×NAG; | |||
| Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab f… |
Heteromer | 99.79 | 12×NAG; 3×NAG; 33×NAG; | |||
| Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab f… |
Heteromer | 99.79 | 10×NAG; 1×NAG; 1×NAG; 35×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2.86 spike protein(6P) in complex with human ACE2 |
Heteromer Q9BYF1; | 97.37 | 1×NAG; 5×NAG; 1×ZN; 33×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron HV.1 spike protein(6P) in complex with human ACE2 |
Heteromer Q9BYF1; | 97.09 | 29×NAG; 1×ZN; | |||
| Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (3-up state) |
Heteromer Q9BYF1; | 97.44 | 6×NAG; 3×NAG; 3×NAG; 45×NAG; | |||
| Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (1-up state) |
Heteromer Q9BYF1; | 98.99 | 8×NAG; 1×NAG; 1×NAG; 35×NAG; | |||
| Structure of SARS-CoV-2 XBB.1.5 spike glycoprotein in complex with ACE2 (2-up state) |
Heteromer Q9BYF1; | 98.99 | 9×NAG; 2×NAG; 2×NAG; 42×NAG; | |||
| Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up state) |
Heteromer Q9BYF1; | 97.44 | 10×NAG; 2×NAG; 2×NAG; 38×NAG; | |||
| Structure of SARS-CoV-2 BA.2.86 spike glycoprotein in complex with ACE2 (2-up and 1-down state) |
Heteromer Q9BYF1; | 97.56 | 7×NAG; 2×NAG; 1×NAG; 1×NAG; 32×NAG; | |||
| Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map |
Heteromer | 100.0 | ||||
| Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map |
Heteromer | 100.0 | ||||
| A neutralizing nanobody VHH60 against wt SARS-CoV-2 |
Heteromer | 99.4 | 6×NAG; 20×NAG; | |||
| VFLIP Spike Trimer with GAR03 |
Heteromer | 98.37 | ||||
| SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD and NTD (Local) |
Heteromer | 98.0 | 1×NAG; 2×NAG; 2×NAG; | |||
| Protective effect of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 … |
Heteromer | 100 | 1×NAG; 2×NAG; | |||
| Structure of the SARS-CoV-2 S1 subunit in complex with antibody N-612-004 |
Heteromer | 100.0 | ||||
| Local refinement of SARS-CoV-2 spike/nanobody mixture complex around NTD |
Heteromer | 99.79 | 35×NAG; | |||
| CryoEM structure of SARS-CoV-2 spike monomer in complex with neutralising antibody P008_60 |
Heteromer | 100.0 | 8×NAG; 1×3Q9; | |||
| Omicron spike variant BA.1 with Bn03 |
Heteromer | 97.67 | ||||
| Monomer state of SARS-CoV-2 XBB Variant Spike protein trimer complexed with antibody PW5-5 |
Heteromer | 99.14 | ||||
| XBB spike protein (S) in complex with monoclonal antibody 6I18 |
Heteromer | 99.14 | ||||
| Omicron spike variant XBB with Bn03 |
Heteromer | 99.06 | ||||
| Omicron spike variant XBB with n3130v-Fc |
Heteromer | 99.06 | ||||
| Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) |
Heteromer Q9BYF1; | 100.0 | 1×NAG; 7×NAG; 1×ZN; | |||
| Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 |
Heteromer Q9BYF1; | 100 | 1×ZN; 7×NAG; | |||
| Structure of the SARS-CoV-2 S S1 doamin in complex with the mouse antibody Fab fragment, HSW-2 |
Heteromer | 100.0 | 4×NAG; | |||
| Omicron spike variant BQ.1.1 with n3130v-Fc |
Heteromer | 100 | ||||
| SARS-CoV-2 S1 in complex with H18 and R1-32 Fab |
Heteromer | 100.0 | 1×NAG; | |||
| Dimer of SARS-CoV-2 S1 in complex with H18 and R1-32 Fabs |
Heteromer | 100.0 | 2×NAG; | |||
| Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement) |
Heteromer | 100.0 | 2×NAG; | |||
| SARS-CoV-2 wildtype S1 in complex with YB9-258 Fab and R1-32 Fab |
Heteromer | 100.0 | 1×NAG; | |||
| local refinement of SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound |
Heteromer | 99.83 | 12×NAG; | |||
| SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 (local refinement) |
Heteromer | 100.0 | 2×NAG; | |||
| SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 (local refinement) |
Heteromer | 100.0 | 7×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S trimer in the early fusion intermediate conformation (E-FIC) (foc… |
Heteromer Q9BYF1; | 100.0 | 7×NAG; 1×NAG; 7×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 D614G S with three ACE2 receptors binding (RB3) in prefusion confor… |
Heteromer Q9BYF1; | 100 | 6×NAG; 9×NAG; | |||
| SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with YB9-258 Fab, focused refinement of Fab re… |
Heteromer | 94.01 | 7×NAG; | |||
| SARS-CoV-2 Omicron BA.1 spike trimer (6P) complex with YB9-258 Fab, focused refinement of RBD-dimer… |
Heteromer | 98.18 | 7×NAG; | |||
| SARS-CoV-2 spike trimer RBD in complex with Fab NA8 |
Heteromer | 100.0 | 4×NAG; | |||
| SARS-CoV-2 spike trimer RBD in complex with Fab NE12 |
Heteromer | 100.0 | 3×NAG; | |||
| SARS-CoV-2 S protein bound to neutralising antibody UZGENT_A3 |
Heteromer | 100.0 | 2×NAG; 3×NAG; 1×NAG; | |||
| SARS-CoV-2 S protein bound to human neutralising antibody UZGENT_G5 |
Heteromer | 100.0 | 3×NAG; 3×NAG; | |||
| Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement) |
Heteromer | 100.0 | 2×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, f… |
Heteromer | 98.18 | 1×NAG; 1×NAG; 5×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike (HexaPro variant) in complex with nanobody W25 (map 3, focus … |
Heteromer | 100 | 3×NAG; 1×NAG; 1×NAG; | |||
| SARS-CoV-2 NTD in complex with N9 Fab |
Heteromer | 100.0 | ||||
| local refinement of XBB.1.5 spike/Nanosota-3C complex |
Heteromer | 100 | ||||
| Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab (state1, local refinement of the … |
Heteromer | 100.0 | 2×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement) |
Heteromer | 100.0 | 4×NAG; | |||
| Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-813 Fab and BD-744 Fab |
Heteromer | 98.36 | ||||
| Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-804 Fab |
Heteromer | 98.36 | 1×NAG; | |||
| Local CryoEM of the SARS-CoV-2 S6PV2 in complex with BD-667 |
Heteromer | 98.36 | 1×NAG; | |||
| Crystal structure of a chimeric protein mimic of SARS-CoV-2 Spike HR1 in complex with HR2 |
Heteromer | 84.21 | ||||
| SARS-CoV-2 Spike S2 bound to Fab 54043-5 |
Heteromer | 97.98 | 3×NAG; 15×NAG; | |||
| Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation |
Heteromer | 97.97 | 3×NAG; 15×NAG; | |||
| Structure of the SARS-CoV-2 NTD in complex with C1520, local refinement |
Heteromer | 100.0 | 3×NAG; 4×NAG; | |||
| Structure of viral peptides IPB19/N52 |
Heteromer | 100 | ||||
| Crystal structure of the N-terminal domain of SARS-CoV-2 beta variant spike glycoprotein in complex… |
Heteromer | 98.64 | 2×NAG; 1×NAG; 2×NAG; 6×CL; 1×PEG; 3×GOL; 1×PO4; 7×NAG; 1×PG4; | |||
| SARS-CoV-2 S NTD B.1.617.1 kappa variant S2L20 Local Refinement |
Heteromer | 98.78 | 1×NAG; 5×NAG; | |||
| Dissecting human monoclonal antibody responses from mRNA and protein-based booster vaccinations aga… |
Heteromer | 90.0 | 1×NAG; 1×NAG; 3×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4-8 (focused refineme… |
Heteromer | 98.17 | 6×NAG; | |||
| SARS-CoV-2 S NTD B.1.1.529 Omicron variant + S309 Local Refinement |
Heteromer | 98.11 | 6×NAG; | |||
| SARS-CoV-2 S + S2L20 (local refinement of NTD and S2L20 Fab variable region) |
Heteromer | 100.0 | 1×NAG; 1×NAG; 4×NAG; | |||
| SARS-CoV-2 S NTD B.1.617.2 delta variant + S2L20 Local Refinement |
Heteromer | 97.66 | 1×NAG; 4×NAG; | |||
| SARS-CoV-2 Omicron Variant Spike Glycoprotein Fusion Core (Q954H) |
Heteromer | 98.18 | ||||
| Crystal structure of SARS-CoV-2 S NTD bound to S2M28 Fab |
Heteromer | 99.64 | 2×NAG; 2×NAG; 1×NAG; 2×NAG; 1×UNX; 1×XYL; 1×SO4; | |||
| SARS-CoV-2 S NTD B.1.617.1 kappa variant S2X303 Local Refinement |
Heteromer | 98.84 | 1×NAG; 6×NAG; | |||
| SARS-CoV-2 S NTD (C.37 Lambda variant) plus S2L20 and S2X303 Fabs, local refinement |
Heteromer | 100.0 | 1×NAG; 2×NAG; 5×NAG; | |||
| SARS-CoV-2 Spike NTD in complex with neutralizing Fab SARS2-57 (local refinement) |
Heteromer | 100.0 | 2×NAG; 4×NAG; | |||
| Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-termina… |
Heteromer | 100.0 | 1×NAG; 6×NAG; 23×CA; 3×ACT; 1×PGE; | |||
| Structure of the SARS-CoV-2 S 6P trimer complex with the human neutralizing antibody Fab fragment, … |
Heteromer | 100.0 | 3×NAG; | |||
| an engineered 5-helix bundle derived from SARS-CoV-2 S2 in complex with HR2P |
Heteromer | 81.25 | ||||
| Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with extended HR2 |
Heteromer | 100 | ||||
| Structure of the SARS-CoV-2 Omicron spike post-fusion bundle |
Heteromer | 95.78 | ||||
| Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex |
Heteromer | 100 | ||||
| Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with D936Y mutation |
Heteromer | 98.59 | ||||
| Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with L938F mutation |
Heteromer | 98.59 | ||||
| Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with S940F mutation |
Heteromer | 98.59 | ||||
| Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with A942S mutation |
Heteromer | 98.59 | ||||
| Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with V1176F mutation |
Heteromer | 100 | ||||
| Cryo-EM structure of the SARS-CoV-2 Omicron HR1-42G complex |
Heteromer | 95.78 | ||||
| Cryo-EM structure of the N-terminal domain of Omicron BA.1 in complex with nanobody N235 and S2L20 … |
Heteromer | 97.83 | 5×NAG; | |||
| SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 (Local Refinement of the NTD/S2L20) |
Heteromer | 100.0 | 5×NAG; | |||
| XBB-4 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein |
Heteromer | 93.93 | ||||
| Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with Fab 4A8 (focused refineme… |
Heteromer | 98.04 | 1×NAG; 5×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with Fab 4A8 (focused refinem… |
Heteromer | 90.0 | 1×NAG; 4×NAG; | |||
| SARS-CoV-2 Spike Protein N terminal domain in Complex with N11 Fab |
Heteromer | 100.0 | ||||
| SARS-CoV-2 Spike in complex with PVI.V6-14 Fab |
Heteromer A0A5C2FYK4; | 100 | 2×NAG; 3×NAG; | |||
| A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2 |
Heteromer | 100.0 | ||||
| Local CryoEM structure of del68-76/del679-688 prefusion-stabilized spike in complex with the Fab of… |
Heteromer | 100 | ||||
| SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction) |
Heteromer | 100 | 5×NAG; | |||
| SARS-CoV-2 spike in complex with the ZB8 neutralizing antibody Fab (focused refinement on Fab-RBD) |
Heteromer | 100 | ||||
| The local refined map of SARS-CoV-2 XBB Variant Spike protein complexed with antibody PW5-535 |
Heteromer | 92.03 | ||||
| SARS-CoV-2 Beta spike SD1 in complex with S3H3 Fab |
Heteromer | 100 | ||||
| SARS-CoV-2 Omicron spike protein SD1 in complex with S3H3 Fab |
Heteromer | 100 | ||||
| SARS-CoV-2 spike/Nb2 complex with 1 RBD up (local refinement at 5.6 A) |
Heteromer | 100.0 | ||||
| sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with S309 fab (local refinement) |
Heteromer | 94.05 | 1×NAG; | |||
| Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) |
Heteromer Q9BYF1; | 99.6 | 1×ZN; 8×NAG; | |||
| Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) |
Heteromer Q9BYF1; | 100.0 | 1×NAG; 7×NAG; 1×ZN; | |||
| Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) |
Heteromer Q9BYF1; | 99.6 | 1×ZN; 6×NAG; | |||
| Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement) |
Heteromer Q9BYF1; | 98.8 | 7×NAG; 1×ZN; | |||
| SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 |
Heteromer | 100.0 | 1×NAG; | |||
| Cryo-EM structure of spike binding to Fab of neutralizing antibody (locally refined) |
Heteromer | 100.0 | 1×NAG; | |||
| SARS-CoV-2 S-NTD + Fab CM25 |
Heteromer | 100.0 | ||||
| Antibody A7V3 bound to N-terminal domain of the spike |
Heteromer | 100.0 | 5×NAG; | |||
| Local refinement of SARS-CoV-2 (HP-GSAS-Mut7) spike NTD in complex with TXG-0078 Fab |
Heteromer | 100.0 | 1×NAG; 2×NAG; | |||
| SARS-CoV-2 S/S2M11/S2L28 Local Refinement |
Heteromer | 100.0 | 1×NAG; 1×NAG; | |||
| OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement) |
Heteromer | 98.78 | 1×NAG; | |||
| SARS-CoV-2 S/S2M11/S2X333 Local Refinement |
Heteromer | 100.0 | 1×NAG; 1×NAG; | |||
| Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab |
Heteromer | 100 | 1×NAG; 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 WT RBD in complex with W328-6H2 (local refinement) |
Heteromer | 100.0 | 2×NAG; | |||
| Crystallographic structure of two neutralizing nanobodies in complex with SARS-CoV-2 spike receptor… |
Heteromer | 99.5 | 1×NAG; 1×NAG; 3×PEG; 2×GOL; | |||
| Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development |
Heteromer | 93.12 | ||||
| Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a neutralizing antibo… |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 spike in complex with the 17T2 neutralizing antibody Fab fragment (local refinement of R… |
Heteromer | 92.86 | 2×NAG; | |||
| SARS-CoV-2 Spike:5A6 Fab complex I focused refinement |
Heteromer | 100 | 4×NAG; | |||
| SARS-CoV-2 Spike:Fab 3D11 complex focused refinement |
Heteromer | 100 | 2×NAG; | |||
| The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody… |
Heteromer | 100 | 1×NAG; | |||
| Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a potent neutralizing… |
Heteromer | 100 | 1×NAG; | |||
| CC6.33 IgG in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refinement) |
Heteromer | 100.0 | 1×NAG; 1×NAG; | |||
| SARS Cov2 Spike RBD in complex with Fab47 |
Heteromer | 99.51 | ||||
| Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development |
Heteromer | 100 | 1×NAG; | |||
| immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 7D6 |
Heteromer | 100 | 1×NAG; 1×NAG; | |||
| Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113 |
Heteromer | 100 | 1×NAG; | |||
| Local refinement of BA.5 spike/Nanosota-9 complex |
Heteromer | 91.67 | ||||
| Local refinement of JN.1 spike/Nanosota-9 complex |
Heteromer | 86.36 | ||||
| Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immuni… |
Heteromer Q9BYF1; | 99.51 | 1×NAG; 8×CL; 1×SO4; 4×NA; 1×PG5; 1×ZN; 4×NAG; 1×PGE; | |||
| Structure of RBD directed antibody DH1047 in complex with SARS-CoV-2 spike: Local refinement of RBD… |
Heteromer | 100 | 2×NAG; | |||
| Cryo-EM of RBD(EG5.1)/1301B7 Fab Complex |
Heteromer | 89.16 | 1×NAG; 1×NAG; | |||
| Structure of sybody SR31 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD) |
Heteromer | 100 | 1×NAG; 13×FMT; 5×GOL; 2×ACT; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with human ACE2 (focused refi… |
Heteromer Q9BYF1; | 92.04 | 7×NAG; | |||
| SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv347 |
Heteromer | 94.03 | ||||
| The interface structure of Omicron RBD binding to 5817 Fab |
Heteromer | 92.54 | 1×NAG; | |||
| SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv265 |
Heteromer | 92.54 | ||||
| SARS-CoV-2 Spike RBD in complex with the single chain fragment scFv76 (Focused Refinement) |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv289 |
Heteromer | 94.03 | ||||
| Structure of the SARS-CoV-2 BA.1 RBD with UT28-RD |
Heteromer | 92.54 | ||||
| SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv051 |
Heteromer | 92.54 | ||||
| Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein in complex with human ACE2 (focused r… |
Heteromer Q9BYF1; | 99.5 | 7×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinemen… |
Heteromer Q9BYF1; | 92.54 | 7×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectod… |
Heteromer Q9BYF1; | 99.5 | 5×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 (focused re… |
Heteromer Q9BYF1; | 98.51 | 7×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein in complex with human ACE2 (focused refin… |
Heteromer Q9BYF1; | 98.51 | 7×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 (focused… |
Heteromer Q9BYF1; | 99.5 | 7×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein in complex with human ACE2 (focused… |
Heteromer Q9BYF1; | 99.0 | 7×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain bound to human ACE2 ectod… |
Heteromer Q9BYF1; | 100 | 7×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein in complex with human ACE2 (focused… |
Heteromer Q9BYF1; | 99.0 | 7×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain bound to human ACE2… |
Heteromer Q9BYF1; | 99.5 | 7×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain bound t… |
Heteromer Q9BYF1; | 98.51 | 7×NAG; | |||
| Local refinement of SARS-CoV-2 S-Beta variant (B.1.351) RBD and Angiotensin-converting enzyme 2 (AC… |
Heteromer Q9BYF1; | 98.51 | 3×NAG; 5×NAG; | |||
| Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 … |
Heteromer Q9BYF1; | 99.0 | 2×NAG; 1×NAG; 4×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain bound to human ACE2… |
Heteromer Q9BYF1; | 99.5 | 7×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-45 (Focused refi… |
Heteromer | 100.0 | ||||
| The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody… |
Heteromer | 100 | 1×NAG; 1×NAG; 1×NAG; | |||
| SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432 |
Heteromer Q9BYF1; | 100 | 7×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to huma… |
Heteromer Q9BYF1; | 99.0 | 7×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-25 (Focused refi… |
Heteromer | 100.0 | ||||
| SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293 |
Heteromer Q9BYF1; | 100 | 7×NAG; | |||
| Local refinement of SARS-CoV-2 S-Gamma variant (P.1) RBD and Angiotensin-converting enzyme 2 (ACE2)… |
Heteromer Q9BYF1; | 98.51 | 5×NAG; 3×NAG; | |||
| SARS-CoV-2 S-RBD + Fab 54042-4 |
Heteromer | 100 | ||||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein in complex with mouse ACE2 (focused refi… |
Heteromer Q8R0I0; | 92.04 | 3×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound t… |
Heteromer Q9BYF1; | 98.51 | 7×NAG; | |||
| SARS-CoV-2 Omicron variant spike RBD in complex with Fab 9A8 |
Heteromer | 92.54 | ||||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.1 spike protein in complex with mouse ACE2 (focused refi… |
Heteromer Q8R0I0; | 92.54 | 3×NAG; | |||
| Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development |
Heteromer Q9BYF1; | 92.54 | 7×NAG; | |||
| Local refinement of SARS-CoV-2 S-Delta variant (B.1.617.2) RBD and Angiotensin-converting enzyme 2 … |
Heteromer Q9BYF1; | 99.0 | 1×NAG; 4×NAG; 3×NAG; | |||
| Neutral Omicron Spike Trimer in complex with ACE2. |
Heteromer Q9BYF1; | 92.54 | 5×NAG; | |||
| SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv282 |
Heteromer | 92.54 | ||||
| Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab |
Heteromer | 100 | 8×DMS; 5×MLI; 2×NAG; 1×1PE; | |||
| SARS-CoV-2 Beta RBD in complex with human ACE2 and S304 Fab and S309 Fab |
Heteromer Q9BYF1; | 98.5 | 2×NAG; 30×EDO; 22×CL; 2×ZN; 13×NAG; | |||
| SARS-CoV-2 RBD in complex with Fab 15033-7 |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 RBD in complex with Fab 15033 |
Heteromer | 100 | 1×NAG; | |||
| A neutralizing MAb targeting receptor-binding-domain of SARS-CoV-2 |
Heteromer | 100 | 1×NAG; | |||
| A human neutralizing antibody targeting SARS-CoV-2 RBD |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of S309-RBD-RBD-S309 in the S309-bound Omicron spike protein (local refinement) |
Heteromer | 92.5 | 2×NAG; | |||
| Local refinement of the SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab |
Heteromer | 100 | 1×NAG; 1×NAG; | |||
| Local refinement of SARS-CoV-2 Omicron BA.2.86 S complexed with Abs G7-Fc |
Heteromer | 86.93 | ||||
| The SARS-CoV-2 receptor binding domain bound with an Fv-clasp form of a human neutralizing antibody… |
Heteromer | 100 | 1×NAG; | |||
| Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development |
Heteromer | 100 | ||||
| SARS-CoV-2 S RBD B.1.617.1 kappa variant S309 Local Refinement |
Heteromer | 98.5 | 1×NAG; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3 |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 spike RBD with A8 and H3 nanobodies bound |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BQ.1.1 variant spike protein… |
Heteromer Q9BYF1; | 89.95 | 3×NAG; 1×NAG; 1×NAG; 1×ZN; 1×NAG; | |||
| SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2E12 Fab, S309 Fab, and S304 Fab |
Heteromer | 100 | 1×NAG; 2×CL; | |||
| Structure of the SARS-CoV-2 RBD in complex with the mouse antibody Fab fragment, HSW-2 |
Heteromer | 100 | 1×NAG; | |||
| Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide |
Heteromer | 100 | 1×NAG; | |||
| The local refined map of XBB spike protein (S) in complex with bispecific antibody G7-Fc |
Heteromer | 88.94 | ||||
| Structure of SARS-CoV-2 XBB.1.5 spike RBD in complex with ACE2 |
Heteromer Q9BYF1; | 88.94 | 1×NAG; 1×NAG; 1×NAG; 4×NAG; | |||
| The interface of JMB2002 Fab binds to SARS-CoV-2 Omicron Variant S |
Heteromer | 92.46 | ||||
| Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (down state) |
Heteromer Q9BYF1; | 86.84 | 1×NAG; 1×NAG; 1×NAG; 5×NAG; | |||
| Local refinement of SARS-CoV-2 spike/nanobody mixture complex around RBD |
Heteromer | 100 | ||||
| H6 and F2 nanobodies bound to SARS-CoV-2 spike RBD |
Heteromer | 98.48 | 1×NAG; 3×GOL; | |||
| B5-5 nanobody bound to SARS-CoV-2 spike RBD (Wuhan) |
Heteromer | 100 | 1×NAG; 4×EDO; 2×GOL; 1×NO3; | |||
| Structure of sybody MR17-SR31 fusion in complex with the SARS-CoV-2 S Receptor Binding domain (RBD) |
Heteromer | 100.0 | 1×NAG; 5×GOL; 14×ACT; 2×1PE; 5×BU2; 17×CD; | |||
| Nanobody F2 bound to RBD |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 |
Heteromer Q9BYF1; | 99.5 | 1×NAG; 4×NAG; 3×EDO; 1×ZN; | |||
| Crystal structure of SARS-CoV-2 Spike RBD in complex with FP-12A Fab |
Heteromer | 100 | 1×NAG; | |||
| Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by st… |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of S43 bound to SARS-CoV-2 RBD |
Heteromer | 100 | 1×NAG; 1×NAG; | |||
| Crystal structure of a neutralizing monoclonal antibody (Ab08) in complex with SARS-CoV-2 receptor-… |
Heteromer | 100 | 1×NAG; 3×MPD; 1×CA; 1×CL; | |||
| SARS-CoV-2 Omicron RBD in complex with human ACE2 and S304 Fab and S309 Fab |
Heteromer Q9BYF1; | 92.42 | 4×EDO; 11×CL; 1×ZN; 6×NAG; | |||
| Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizin… |
Heteromer | 98.48 | 1×NAG; 5×EDO; 11×SO4; | |||
| Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody N-612-056 |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 omicron variant spike receptor-binding domain (RBD) in complex with… |
Heteromer | 92.35 | 7×SO4; | |||
| SIT1-ACE2-BA.5 RBD |
Heteromer Q9BYF1; Q9NP91; | 91.41 | 16×NAG; 6×NAG; 6×3PH; 2×ZN; | |||
| Omicron RBDs bound with P3E6 Fab (one up and one down) |
Heteromer | 92.42 | ||||
| The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody… |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein in complex with mouse ACE2 (focused refinemen… |
Heteromer Q8R0I0; | 88.89 | 1×NAG; 1×NAG; 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein in complex with human ACE2 (focused refinemen… |
Heteromer Q9BYF1; | 88.89 | 2×NAG; 5×NAG; | |||
| The local refined map of Omicron spike with bispecific antibody FD01 |
Heteromer | 92.42 | ||||
| The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody… |
Heteromer | 100 | 1×NAG; 1×NAG; | |||
| Local refinement of RBD-ACE2 |
Heteromer Q9BYF1; | 92.42 | 1×NAG; 6×NAG; 1×ZN; | |||
| Three RBD-down state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab… |
Heteromer | 100 | 1×NAG; | |||
| Local refinement of SARS-CoV-2 vaccine induced antibody DH1338 bound to SARS-CoV-2 HexaPro RBD Spik… |
Heteromer | 100.0 | 1×NAG; | |||
| The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody… |
Heteromer | 100 | 1×NAG; | |||
| Local refinement of SARS-CoV-2 Omicron S trimer complexed with XG005 |
Heteromer | 92.42 | ||||
| The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody… |
Heteromer | 100 | 1×NAG; | |||
| SIT1-ACE2-BA.2 RBD |
Heteromer Q9BYF1; Q9NP91; | 91.92 | 16×NAG; 6×NAG; 6×3PH; 2×ZN; | |||
| SARS-CoV-2 Omicron BA.2 Variant RBD complexed with human ACE2 |
Heteromer Q9BYF1; | 91.92 | 1×CL; 1×ZN; 3×NAG; | |||
| SARS-CoV-2 Omicron Variant RBD complexed with ACE2 |
Heteromer Q9BYF1; | 92.42 | 3×NAG; 1×CL; 1×ZN; | |||
| The second RBD of SARS-CoV-2 Omicron Variant in complexed with RBD-ACE2 |
Heteromer Q9BYF1; | 92.39 | 2×NAG; 1×CL; 1×ZN; 3×NAG; | |||
| Nanobody H3 AND C1 bound to RBD with Kent mutation |
Heteromer | 99.49 | 1×NAG; 1×CIT; 1×CL; | |||
| Crystal structure of synthetic nanobody (Sb14+Sb68) complexes with SARS-CoV-2 receptor binding doma… |
Heteromer | 100 | 3×EDO; 1×GOL; | |||
| Nanobody H3 AND C1 bound to RBD |
Heteromer | 100 | 1×NAG; 1×CIT; 1×CL; | |||
| Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG48 Fab |
Heteromer | 100 | 1×NAG; 1×SO4; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody… |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 receptor binding domain in complex with WNb-2 |
Heteromer | 100.0 | 1×NAG; 1×PG4; | |||
| Crystal structure of SARS-CoV-2 Spike RBD in complex with MW01 Fab |
Heteromer | 100 | 1×CIT; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv |
Heteromer | 100 | 1×CA; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutr… |
Heteromer | 100 | 1×NAG; | |||
| Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral … |
Heteromer | 100 | 1×NAG; | |||
| H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of BD55-1403 and SARS-CoV-2 Omicron RBD |
Heteromer | 92.39 | 1×NAG; | |||
| Crystal structure of human ACE2 bound to the spike receptor-binding domain from a cave bat sarbecov… |
Heteromer Q9BYF1; | 96.95 | 1×NAG; 6×NAG; 4×SO4; 1×TRS; 5×PEG; 1×ZN; 2×CL; 1×GOL; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody… |
Heteromer | 100 | ||||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody… |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A … |
Heteromer | 100 | 1×NAG; 1×PO4; | |||
| Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab (crystal for… |
Heteromer | 100 | ||||
| SARS-CoV-2 Omicron S monomer complexed with 553-49 |
Heteromer | 92.39 | ||||
| SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv264 |
Heteromer | 92.39 | ||||
| Structure of SARS-CoV-2 spike RBD in complex with NT-108 scFv |
Heteromer | 100.0 | 1×NAG; | |||
| Dissecting human monoclonal antibody responses from mRNA and protein-based booster vaccinations aga… |
Heteromer | 87.31 | 1×NAG; | |||
| SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv286 |
Heteromer | 92.39 | ||||
| Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (focused… |
Heteromer | 99.49 | 1×NAG; | |||
| SARS-CoV-2 BA.1 spike ectodomain trimer in complex with the S2X324 neutralizing antibody Fab fragme… |
Heteromer | 92.39 | 1×NAG; | |||
| RBD-1 of SARS-CoV-2 Beta spike in complex with S5D2 Fab |
Heteromer | 98.48 | ||||
| Cryo-EM structure of SARS-CoV-2 BA.2 RBD in complex with BA7535 fab (local refinement) |
Heteromer | 91.88 | ||||
| The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody… |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with golden hamster ACE2 (local refinem… |
Heteromer A0A1U7QTA1; | 91.88 | 1×ZN; 6×NAG; | |||
| Nanobody C5 bound to RBD |
Heteromer | 100 | 1×NAG; 1×ACT; | |||
| SARS-CoV-2 BQ.1.1 RBD bound to the S2V29 and the S2H97 Fab fragments |
Heteromer | 89.8 | 9×EDO; 1×NAG; 1×NI; 1×TRS; | |||
| The crystal structure of RBD-Nanobody complex, DL4 (SA4) |
Heteromer | 100 | 1×NAG; 8×GOL; 8×ACT; | |||
| Crystal structure of nanobody 1-2C7 with SARS-CoV-2 RBD |
Heteromer | 98.47 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 RBD in complex with aRBD5 |
Heteromer | 100 | 1×NAG; | |||
| Crystallographic structure of neutralizing antibody P14-44 in complex with SARS-CoV-2 spike recepto… |
Heteromer | 100 | 1×NAG; 3×GOL; | |||
| Nanobody H11-B5 and H11-F2 bound to RBD |
Heteromer | 100 | 1×NAG; 5×PEG; | |||
| Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 3B4 |
Heteromer | 100 | 1×NAG; 3×EDO; | |||
| Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neu… |
Heteromer | 100 | 1×NAG; 16×EDO; | |||
| Crystal structure of JM-1A in complex with SARS-CoV-2 RBD |
Heteromer | 100.0 | 1×NAG; 1×CL; 1×PO4; | |||
| Crystal structure of SARS-CoV-2 Receptor Binding Domain bound to A6 repebody |
Heteromer | 100 | 1×NAG; | |||
| Crystal Structure of SARS-CoV-2 S delta variant receptor-binding domain (RBD) in complex CoV11 Fab … |
Heteromer | 98.98 | 1×NAG; 1×CIT; | |||
| The crystal structure of the SARS-CoV-2 receptor binding domain in complex with the neutralizing na… |
Heteromer | 100 | 1×NAG; 2×SO4; | |||
| Structure of the SARS-CoV-2 RBD in complex with the mouse antibody Fab fragment, M8a-34 |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of synthetic nanobody (Sb45) complexes with SARS-CoV-2 receptor binding domain |
Heteromer | 100 | ||||
| RBD domain of SARS-CoV2 in complex with neutralizing nanobody NM1226 |
Heteromer | 100 | 1×NAG; 1×PO4; 3×PEG; | |||
| Nanobody H11-A10 and F2 bound to RBD |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 spike receptor-binding domain (RBD) in complex with NCV2SG53 Fab |
Heteromer | 100 | 3×SO4; 1×NAG; | |||
| Fab arm of antibodies 4G1-C2 and 10G4 bound to CoV-2 receptor binding domain (RBD) |
Heteromer Q6GMX0; | 100 | 6×GOL; 2×NAG; | |||
| SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 93 |
Heteromer | 100 | 1×NAG; 1×GOL; | |||
| Crystal structure of nanobody 3-2A2-4 with SARS-CoV-2 RBD |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV0… |
Heteromer | 100 | 8×EDO; 1×NAG; 10×SO4; | |||
| Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895 |
Heteromer | 100 | 6×GOL; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing … |
Heteromer | 100 | 1×NAG; | |||
| Nanobody H11 and F2 bound to RBD |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary comp… |
Heteromer | 99.49 | 1×NAG; 3×IMD; 5×CL; 1×GLU; 3×GLY; 1×PGE; 1×GOL; 1×PG4; | |||
| Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing IGHV3-53-encoded antibody EH3 … |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2-Beta-RBD and CB6-092-Fab complex |
Heteromer | 98.47 | ||||
| Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing ant… |
Heteromer | 100 | 1×NAG; 2×NI; 2×EDO; | |||
| Fab arms of antibodies GAR03 and 10G4 bound to the receptor binding domain of SARS-CoV-2 in a 1:1:1… |
Heteromer | 100.0 | 1×NAG; 2×CL; | |||
| SARS-CoV-2-prototyped-RBD and CB6-092-Fab complex |
Heteromer | 100 | ||||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6 |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV2 RBD bound to Fab06 |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the SARS-CoV-2 RBD in complex with the ultrapotent antibody CV2.1169 and CR3022 |
Heteromer | 99.49 | 1×NAG; 1×SO4; | |||
| SARS-CoV-2-Beta-RBD and B38-GWP/P-VK antibody complex |
Heteromer | 98.45 | 1×NAG; | |||
| The crystal structure of RBD-Nanobody complex, DL28 (SC4) |
Heteromer | 100 | 1×NAG; 2×GOL; | |||
| Structure of the SARS-CoV-2 RBD in complex with neutralizing antibodies BG4-25 and CR3022 |
Heteromer | 100 | 1×NAG; | |||
| Soaking competent crystal form of the SARS-CoV-2 Receptor Binding Domain (RBD):CR3022 complex. |
Heteromer | 100 | 1×NAG; | |||
| Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody… |
Heteromer | 100 | 1×NAG; | |||
| Structure of SARS-CoV-2 spike receptor-binding domain complexed with high affinity ACE2 mutant 3N39 |
Heteromer Q9BYF1; | 100 | 2×NAG; 2×NAG; 1×NAG; 1×NAG; 1×ZN; 1×SO4; | |||
| Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with SARS-CoV-2 reactive human a… |
Heteromer | 100 | 1×NAG; | |||
| Local refinement of cryo-EM structure of the interface of the Omicron RBD in complex with antibodie… |
Heteromer | 92.35 | 1×NAG; | |||
| SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (interface) |
Heteromer | 91.33 | 1×NAG; | |||
| cryo-EM structure of omicron spike in complex with de novo designed binder, local |
Heteromer Q9VKJ9; | 92.35 | 1×NAG; | |||
| Local refinement of SARS-CoV-2 BA.2.86 Spike and XBB-7 Fab |
Heteromer | 86.75 | ||||
| XBB.1.5.10 RBD in complex with ACE2 |
Heteromer Q9BYF1; | 88.27 | 4×NAG; | |||
| VIR-7229 Fab fragment bound the SARS-CoV-2 BA.2.86 spike trimer (local refinement of the BA 2.86 RB… |
Heteromer A0A7S5BYU0; | 87.67 | 2×NAG; | |||
| Structure of JN.1 RBD protein in complex with ACE2. |
Heteromer Q9BYF1; | 86.67 | ||||
| Locally refined region of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1 |
Heteromer | 100 | 1×NAG; | |||
| MaP OF P5C3RBD Interface |
Heteromer | 100 | ||||
| SARS-CoV-2 spike trimer (6P) in complex with R1-26 Fab, focused refinement of RBD-Fab region |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 XBB.1.5.70 in complex with ACE2 |
Heteromer Q9BYF1; | 87.75 | 4×NAG; | |||
| XBB.1.5 RBD in complex with ACE2 |
Heteromer Q9BYF1; | 88.78 | 5×NAG; | |||
| SARS-CoV-2 Spike RBD (dimer) in complex with two Fu2 nanobodies |
Heteromer | 100 | 2×NAG; | |||
| 17B10 fab in complex with up-RBD of SARS-CoV-2 Spike G614 trimer |
Heteromer | 100 | 1×NAG; | |||
| The local refined map of SARS-CoV-2 Omicron BA.1 Spike complexed with antibody PW5-570 |
Heteromer | 92.35 | ||||
| CryoEM structure of SARS CoV-2 RBD and Aptamer complex |
Heteromer | 100 | 1×NAG; | |||
| Locally refined SARS-CoV-2 BA-2.86 Spike receptor binding domain (RBD) complexed with angiotensin c… |
Heteromer Q9BYF1; | 86.75 | 6×NAG; | |||
| SARS-CoV-2 (wuhan variant) Spike protein in complex with the single chain fragment scFv76-77 (focus… |
Heteromer | 100.0 | 1×NAG; | |||
| Local CryoEM structure of the SARS-CoV-2 S6P in complex with 7B3 Fab |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets t… |
Heteromer | 100 | 1×NAG; 1×NAG; | |||
| The complex structure of Omicron BA.4 RBD with BD604, S309, and S304 |
Heteromer | 91.33 | 1×NAG; | |||
| SARS-CoV-2 Spike RBD (dimer) in complex with two 2S-1244 nanobodies |
Heteromer | 91.53 | ||||
| Structure of XBB.1.16 RBD in complex with antibody CYFN1006-1. |
Heteromer | 88.78 | ||||
| Local CryoEM structure of the SARS-CoV-2 S6P in complex with 14B1 Fab |
Heteromer | 100 | 1×NAG; | |||
| Structure of EG.5.1 RBD in complex with antibody CYFN1006-2. |
Heteromer | 88.27 | ||||
| SARS-CoV-2 S B.1.1.529 Omicron variant (RBD + S309 Local Refinement) |
Heteromer | 93.37 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Delta RBD in complex with BA7054 and BA7125 fab (local refinement) |
Heteromer | 98.98 | ||||
| Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets t… |
Heteromer | 100 | 1×NAG; | |||
| The SARS-CoV-2 spike protein receptor binding domain bound to neutralizing nanobodies WNb 2 and WNb… |
Heteromer | 100 | ||||
| CryoEM structure of SARS CoV-2 RBD and Aptamer complex |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 Omicron BA.4 spike trimer (6P) in complex with D1F6 Fab, focused refinement of RBD region |
Heteromer | 91.33 | 2×NAG; | |||
| Cryo-EM structure of neutralizing antibody 8G3 in complex with BA.1 RBD |
Heteromer | 92.35 | ||||
| Local refine of Omicron spike bitrimer with 6m6 antibody |
Heteromer | 92.35 | 2×NAG; | |||
| XBB.1.5 RBD in complex with BD55-1205 |
Heteromer | 88.78 | ||||
| BA.2.86 RBD protein in complex with ACE2. |
Heteromer Q9BYF1; | 87.33 | ||||
| RBD of SARS-CoV2 spike protein with ACE2 decoy |
Heteromer Q9BYF1; | 100 | 2×NAG; 2×NAG; 1×NAG; 1×NAG; 1×ZN; 1×SO4; | |||
| Crystal structure of neutralizing VHH P17 in complex with SARS-CoV-2 Alpha variant spike receptor-b… |
Heteromer | 99.49 | 1×NAG; 12×EDO; | |||
| Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutr… |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 21B6 |
Heteromer | 100 | 1×NAG; 8×SO4; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with C… |
Heteromer | 99.49 | 1×NAG; 19×EDO; 3×NO3; 1×PEG; 1×SO4; 1×CL; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4 |
Heteromer | 100 | 1×NAG; 5×MPD; | |||
| THSC20.HVTR26 Fab bound to SARS-CoV-2 Receptor Binding Domain |
Heteromer | 100 | 1×NAG; 1×EPE; | |||
| H11-D4 complex with SARS-CoV-2 RBD |
Heteromer | 100 | 1×NAG; 12×EDO; 4×ACT; | |||
| SARS-CoV-2 spike receptor-binding domain (RBD) in complex with S2X35 Fab and S309 Fab |
Heteromer | 100 | 1×NAG; 23×SO4; 3×GOL; 3×CL; 2×POL; | |||
| Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody |
Heteromer | 100.0 | 1×NAG; | |||
| H11-H4 complex with SARS-CoV-2 |
Heteromer | 100 | 1×NAG; 1×SO4; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobodies VHH E and U |
Heteromer | 100 | 1×NAG; 5×EDO; | |||
| Fab arm of antibody 10G4 bound to CoV-2 receptor binding domain (RBD) |
Heteromer | 100 | 1×NAG; 1×NAG; 2×MG; 3×CL; | |||
| SARS-CoV-2 Omicron BA.4/5 RBD in complex with Beta-27 Fab and C1 nanobody |
Heteromer | 90.77 | 10×GOL; 6×IPA; 1×NAG; 1×PG4; | |||
| The crystal structure of the SARS-CoV-2 receptor binding domain in complex with the neutralizing na… |
Heteromer | 100 | 1×NAG; 1×MPO; | |||
| immune complex of SARS-CoV-2 RBD and cross-neutralizing antibody 6D6 |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobodies VHH-F04 and VHH-G09 |
Heteromer | 99.48 | 1×NAG; 5×CL; | |||
| Crystal structure of the SARS-CoV-2 receptor binding domain in complex with VNAR 2C02 |
Heteromer | 100 | 2×EDO; 1×NAG; 1×CL; | |||
| Crystal structure of the SARS-CoV-2 neutralizing VHH 7A9 bound to the spike receptor binding domain |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing … |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of monoclonal antibody complexed with SARS-CoV-2 RBD |
Heteromer | 100 | ||||
| Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD |
Heteromer | 98.44 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with 6-2C Fab |
Heteromer | 100.0 | 1×NAG; | |||
| SARS-CoV-2 receptor binding domain bound to Fab WCSL 119 |
Heteromer | 100 | 1×NAG; | |||
| Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B12 Fab) |
Heteromer | 100 | 1×NAG; | |||
| Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-F10 Fab) |
Heteromer | 100 | 1×NAG; | |||
| Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-C2 Fab) |
Heteromer | 100 | 1×NAG; | |||
| Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2. |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of antibody Ab246 in complex with SARS-CoV-2 receptor binding domain |
Heteromer | 100 | 1×CL; 6×GOL; 1×NAG; | |||
| Complex between the Fab arm of AB-3467 and the SARS-CoV-2 receptor binding domain (RBD) |
Heteromer | 100 | 1×NAG; 2×CL; 3×SCN; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with C… |
Heteromer | 99.49 | 2×NAG; 2×GOL; 2×TRS; | |||
| Crystal structure of SARS-CoV-2 RBD binding to pangolin ACE2 |
Heteromer A0A8M0FGR3; | 100 | 2×NAG; 1×ZN; | |||
| Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.2325 |
Heteromer | 99.49 | 1×NAG; 1×NA; 3×CL; | |||
| Crystal structure of SARS-CoV-2 BA.2 receptor binding domain in complex with neutralizing antibody … |
Heteromer | 91.8 | 1×NAG; 3×EDO; 1×GOL; 1×GLY; 1×PEG; | |||
| Crystal structure of nanobody Tnb04-1 with antibody 1F11 fab and SARS-CoV-2 RBD |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with C… |
Heteromer | 99.49 | 1×NAG; 2×GOL; 4×CL; 1×PG4; | |||
| Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with human ACE2 |
Heteromer Q9BYF1; | 99.49 | 4×NAG; 1×ZN; | |||
| The receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein in complex with Beta-5… |
Heteromer | 91.49 | 1×NAG; 9×GOL; 2×ACT; 1×CL; | |||
| Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody… |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with C… |
Heteromer | 99.49 | 1×NAG; 2×GOL; 6×FMT; | |||
| SARS-CoV-2 S protein RBD in complex with A5-10 Fab |
Heteromer | 100 | 1×NAG; | |||
| Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2 |
Heteromer Q9BYF1; | 100 | 4×NAG; 1×ZN; | |||
| Crystal structure of SARS CoV-2 Spike Receptor Binding Domain in complex with shark neutralizing VN… |
Heteromer | 100 | 1×NAG; 1×GOL; | |||
| Crystal structure of ZW2G10 Fab in complex with omicron RBD |
Heteromer | 92.31 | 1×NAG; | |||
| Crystal structure of synthetic nanobody (Sb16) complexes with SARS-CoV-2 receptor binding domain |
Heteromer | 100 | ||||
| Structure of the SARS-CoV-2 RBD in complex with neutralizing antibody C099 and CR3022 |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of the T478K mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in c… |
Heteromer | 98.97 | 1×NAG; 1×NAG; 3×GOL; 5×CL; | |||
| Structure of SARS-CoV-2 Beta variant spike receptor-binding domain complexed with human ACE2 |
Heteromer Q9BYF1; | 98.46 | 1×NAG; 5×NAG; 1×ZN; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022 |
Heteromer | 100.0 | 1×NAG; | |||
| Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with human ACE2 |
Heteromer Q9BYF1; | 99.49 | 4×NAG; 1×ZN; | |||
| Crystal structure of Omicron BA.3 RBD complexed with hACE2 |
Heteromer Q9BYF1; | 92.31 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 3×NAG; | |||
| Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic… |
Heteromer | 100.0 | 1×NAG; | |||
| Structure of sybody MR17 in complex with the SARS-CoV-2 S receptor-binding domain (RBD) |
Heteromer | 100 | 1×NAG; 1×GOL; | |||
| Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B3 Fab) |
Heteromer | 100 | 1×NAG; | |||
| Structure of SARS-CoV-2 Gamma variant spike receptor-binding domain complexed with human ACE2 |
Heteromer Q9BYF1; | 98.46 | 1×NAG; 5×NAG; 1×ZN; | |||
| Crystal structure of Nanobody nb112 and SARS-CoV-2 RBD |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.… |
Heteromer | 100 | 1×NAG; | |||
| Structure of SARS-CoV-2 Alpha variant spike receptor-binding domain complexed with human ACE2 |
Heteromer Q9BYF1; | 99.49 | 1×NAG; 4×NAG; 1×ZN; | |||
| The crystal structure of SARS-CoV-2 Omicron BA.1 variant RBD in complex with equine ACE2 |
Heteromer F6V9L3; | 92.31 | 1×ZN; 6×BR; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies eCR3022.20 and C… |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant in complex with IMCAS7… |
Heteromer | 98.97 | 1×NAG; | |||
| Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022 |
Heteromer | 100.0 | 1×NAG; | |||
| SARS-CoV-2-Omicron-RBD and B38-GWP/P-VK antibody complex |
Heteromer | 92.31 | ||||
| Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutral… |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 RBD and horse ACE2 |
Heteromer F6V9L3; | 100 | 5×NAG; | |||
| Crystal structure of T6 Fab bound to theSARS-CoV-2 RBD of B.1.351 |
Heteromer | 98.44 | 2×NAG; | |||
| Crystal structure of Omicron BA.2 RBD complexed with hACE2 |
Heteromer Q9BYF1; | 91.8 | 1×NAG; 2×NAG; 1×ZN; 3×NAG; | |||
| Structure of SARS-CoV-2 Omicron BA.2.75 RBD in complex with human ACE2 |
Heteromer Q9BYF1; | 91.28 | 1×NAG; 1×NAG; 1×ZN; 3×NAG; | |||
| Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing … |
Heteromer | 100 | 1×NAG; | |||
| Structure of sybody MR17-K99Y in complex with the SARS-CoV-2 S Receptor-binding domain (RBD) |
Heteromer | 100 | 1×NAG; 1×GOL; | |||
| THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain |
Heteromer | 100 | 1×NAG; 2×SO4; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with the Fab fragments of neutra… |
Heteromer | 100 | 1×NAG; | |||
| Fab HbnC3t1p1_C6 bound to SARS-CoV-2 RBD |
Heteromer Q6PIL8; | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 RBD binding to dog ACE2 |
Heteromer | 100 | 1×ZN; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and A… |
Heteromer | 100 | 2×PO4; 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron variant spike glycoprotein i… |
Heteromer Q9BYF1; | 92.31 | 1×NAG; 5×NAG; 1×ZN; | |||
| Crystal structure of Omicron BA.1.1 RBD complexed with hACE2 |
Heteromer Q9BYF1; | 91.8 | 6×NAG; 1×ZN; | |||
| Crystal structure of monoclonal antibody complexed with SARS-CoV-2 RBD |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing … |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022 |
Heteromer | 100 | 1×GOL; 2×SO4; 1×NAG; | |||
| Crystal structure of the complex of Wuhan SARS-CoV-2 RBD (319-541) with P2C5 nanobody |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1 |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of neutralizing antibody 80 in complex with SARS-CoV-2 receptor binding domain |
Heteromer | 100 | 2×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in co… |
Heteromer Q9BYF1; | 97.95 | 5×NAG; | |||
| Structural basis for cross-species recognition of COVID-19 virus spike receptor binding domain to b… |
Heteromer E2DHI3; | 100 | 1×ZN; | |||
| Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 Receptor Binding Domain in complex with the monoclonal antibody m31… |
Heteromer | 100 | 1×NAG; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-3B11 Fab |
Heteromer | 99.47 | ||||
| Crystal structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with civet ACE2 |
Heteromer Q56NL1; | 92.31 | 1×NAG; 4×NAG; 1×ZN; | |||
| Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing … |
Heteromer | 100 | 1×NAG; | |||
| H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor-binding domain in complex with intermediate horseshoe bat … |
Heteromer A0A7D7FA76; | 100 | 1×ZN; 1×NAG; | |||
| Ternary complex CR3022 H11-H4 and RBD (SARS-CoV-2) |
Heteromer | 100 | ||||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike glycoprotein in … |
Heteromer Q9BYF1; | 98.97 | 1×NAG; 1×NAG; 4×NAG; 1×ZN; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9 |
Heteromer | 100 | 1×NAG; 1×SO4; 1×BCN; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.4/5 variant spike protein… |
Heteromer Q9BYF1; | 91.28 | 2×NAG; 2×NAG; 1×ZN; 1×NAG; | |||
| Crystal structure of BF.7 RBD complexed with human ACE2 |
Heteromer Q9BYF1; | 90.77 | 1×NAG; 1×ZN; 3×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-… |
Heteromer | 100 | 3×NAG; | |||
| A neutralizing nanobody VHH60 against wt SARS-CoV-2 |
Heteromer | 100.0 | ||||
| Crystal structure of JE-5C in complex with SARS-CoV-2 RBD |
Heteromer | 100.0 | 1×NAG; 2×SO4; | |||
| Crystal structure of BQ.1.1 RBD complexed with human ACE2 |
Heteromer Q9BYF1; | 89.74 | 1×NAG; 1×ZN; 4×NAG; | |||
| Crystal structure of antibody WRAIR-2123 in complex with SARS-CoV-2 receptor binding domain |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of antibody WRAIR-2123 in complex with SARS-CoV-2 receptor binding domain |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody COVA309-22 |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 receptor binding domain bound to Fab PDI 210 |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of neutralizing antibody D29 Fab in complex with SARS-CoV-2 spike receptor bindin… |
Heteromer | 100.0 | ||||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody WRAIR… |
Heteromer | 100 | 1×NAG; 2×GOL; | |||
| Cryo-EM structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab… |
Heteromer | 100.0 | ||||
| Cryo-EM structure of cat ACE2 and SARS-CoV-2 RBD |
Heteromer Q56H28; | 100 | 1×ZN; | |||
| The structure of fox ACE2 and Omicron BF.7 RBD complex |
Heteromer A0A3Q7RAT9; | 90.77 | 1×ZN; | |||
| Structure of RBD directed antibody DH1042 in complex with SARS-CoV-2 spike: Local refinement of RBD… |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor minke wha… |
Heteromer A0A452CBT6; | 100 | 1×ZN; | |||
| SARS-CoV-2 RBD + IMCAS-123 + IMCAS-72 Fab |
Heteromer | 100 | 1×NAG; | |||
| Cocktail GC2050-GC2225 |
Heteromer | 88.72 | ||||
| SARS-CoV-2 RBD + IMCAS-364 + hACE2 |
Heteromer Q9BYF1; | 100 | 4×NAG; 1×ZN; | |||
| Cryo-EM structure of the SARS-CoV-2 S-6P in complex with Fab30 (local refinement of the RBD and Fab… |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain in complex with sea lion ACE2 |
Heteromer A0A6J2EID0; | 100 | 1×ZN; 1×NAG; | |||
| SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2B04 (local refinement) |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron RBD in complex with human ACE2 ectodomain (local refinement) |
Heteromer Q9BYF1; | 92.31 | 1×NAG; 1×ZN; 6×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8 (focused … |
Heteromer | 99.49 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron spike receptor-binding domain in complex with mouse ACE2 |
Heteromer Q8R0I0; | 92.31 | 1×ZN; 1×NAG; | |||
| SARS-CoV-2 RBD + IMCAS-364 (Local Refinement) |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 Omicron BA.4 RBD + IMCAS-316 + ACE2 |
Heteromer Q9BYF1; | 91.28 | 1×NAG; 6×NAG; 1×ZN; | |||
| SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2H04 (local refinement) |
Heteromer | 100.0 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 receptor binding domain in complex with K202.B bispecific antibody |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of human ACE2 complexed with SARS-CoV-2 Omicron RBD |
Heteromer Q9BYF1; | 92.31 | 4×NAG; 1×ZN; | |||
| The complex structure of Omicron BA.1 RBD with BD604, S309,and S304 |
Heteromer | 92.31 | 1×NAG; | |||
| RBD in complex with Fab14 |
Heteromer P0DOX5; | 100 | 1×NAG; | |||
| SARS-CoV-2 Spike RBD in complex with Mab-23 (Fab) |
Heteromer | 100 | ||||
| Cryo-EM structure of RBD/E77-Fab complex |
Heteromer | 99.49 | 1×NAG; | |||
| C98C7 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction) |
Heteromer | 100 | ||||
| Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(state2, local refinement of the R… |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of Omicron RBD complexed with ACE2 and 304 Fab |
Heteromer Q9BYF1; | 92.31 | 1×NAG; 5×NAG; 1×ZN; | |||
| G32Q4 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction) |
Heteromer | 100 | ||||
| Cryo-EM structure of SARS-CoV-2 prototype spike protein receptor-binding domain in complex with hip… |
Heteromer A0AAN0NPC9; | 100 | 1×ZN; 1×NAG; | |||
| Structure of the SARS-CoV-2 spike S1 protein in complex with CR3022 Fab |
Heteromer | 100 | ||||
| SARS-CoV-2 (wuhan variant) Spike protein in complex with the single chain fragment scFv41N (focused… |
Heteromer | 100.0 | 1×NAG; | |||
| SARS-CoV-2 Omicron BA.2 RBD complexed with BD-604 and S304 Fab |
Heteromer | 91.53 | ||||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with mouse ACE2 (local refinement) |
Heteromer Q8R0I0; | 91.8 | 3×NAG; 1×ZN; | |||
| JN.1 RBD with Q493E in complex with ACE2 |
Heteromer Q9BYF1; | 86.67 | 1×ZN; 1×CL; 6×NAG; | |||
| Structure of SARS-CoV-2 XBB.1 spike RBD in complex with ACE2 |
Heteromer Q9BYF1; | 88.72 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2.12.1 RBD in complex with human ACE2 (local refinement) |
Heteromer Q9BYF1; | 91.28 | 1×NAG; 1×NAG; 5×NAG; 1×ZN; | |||
| Cryo-EM structure of SARS-CoV-2 XBB.1.5 receptor-binding domain (RBD) complexed with CB6 mutant,S30… |
Heteromer | 88.72 | 1×NAG; | |||
| Cryo-EM structure of the 123-316 scDb/PT-RBD complex |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 Omicron BQ.1.1 RBD complexed with human ACE2 |
Heteromer Q9BYF1; | 89.74 | 1×NAG; 1×NAG; 5×NAG; 1×ZN; | |||
| Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 (focused ref… |
Heteromer | 99.49 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with rat ACE2 (local refinement) |
Heteromer Q5EGZ1; | 91.8 | 1×ZN; 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 receptor-binding domain (RBD) complexed with CB6 mutant,S309, and S… |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 Omicron BQ.1 RBD complexed with human ACE2 |
Heteromer Q9BYF1; | 90.26 | 1×NAG; 1×NAG; 5×NAG; 1×ZN; | |||
| BA.2.86 RBD in complex with hACE2 (local refinement) |
Heteromer Q9BYF1; | 87.33 | 1×ZN; 1×CL; 6×NAG; | |||
| The structure of fox ACE2 and PT RBD complex |
Heteromer A0A3Q7RAT9; | 100 | 1×ZN; | |||
| Structure of SARS-CoV-2 BA.2.86 spike RBD in complex with ACE2 (up state) |
Heteromer Q9BYF1; | 86.75 | 2×NAG; 1×NAG; 1×NAG; 4×NAG; | |||
| SARS-CoV-spike RBD bound to two neutralising nanobodies. |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 prototype spike protein receptor-binding domain in complex with whi… |
Heteromer A0A6J0Z472; | 100 | 3×NAG; 1×ZN; | |||
| SARS-CoV-2 Omicron XBB RBD complexed with human ACE2 |
Heteromer Q9BYF1; | 88.72 | 1×NAG; 6×NAG; 1×ZN; | |||
| SARS-CoV-2 Omicron XBB.1.5 RBD complexed with human ACE2 and S304 |
Heteromer Q9BYF1; | 88.72 | 1×NAG; 1×NAG; 5×NAG; 1×ZN; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 RBD in complex with human ACE2 (local refinement) |
Heteromer Q9BYF1; | 91.28 | 1×NAG; 1×NAG; 5×NAG; 1×ZN; | |||
| SARS-CoV-2 Omicron HV.1 RBD in complex with human ACE2 (local refinement from the spike protein) |
Heteromer Q9BYF1; | 87.69 | 6×NAG; 1×ZN; | |||
| Nanobody E bound to Spike-RBD in a localized reconstruction |
Heteromer | 100 | 1×NAG; | |||
| Structure of SARS-CoV-2 spike receptor-binding domain F486L mutation complexed with American mink A… |
Heteromer A0A8C7BTF2; | 99.49 | 1×ZN; | |||
| Cryo-EM structure of hACE2-bound SARS-CoV-2 Omicron spike protein with L371S, P373S and F375S mutat… |
Heteromer Q9BYF1; | 93.85 | 1×NAG; 5×NAG; 1×ZN; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with human ACE2 (local refinement) |
Heteromer Q9BYF1; | 91.8 | 1×ZN; 7×NAG; | |||
| SARS-CoV-2 Omicron EG.5.1 RBD in complex with human ACE2 (local refined from the spike protein) |
Heteromer Q9BYF1; | 88.2 | 1×NAG; 5×NAG; 1×ZN; | |||
| SARS-CoV-2 Omicron BF.7 RBD complexed with human ACE2 |
Heteromer Q9BYF1; | 90.77 | 1×NAG; 1×NAG; 5×NAG; 1×ZN; | |||
| Structure of SARS-CoV-2 JN.1 spike RBD in complex with ACE2 (up state) |
Heteromer Q9BYF1; | 86.09 | 2×NAG; 1×NAG; 1×NAG; 2×NAG; | |||
| SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(interface) |
Heteromer Q9BYF1; | 91.28 | ||||
| Cryo-EM structure of SARS-CoV-2 Omicron Prototype RBD in complex with fab L4.65 and L5.34 |
Heteromer | 100 | 1×NAG; | |||
| Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of neutralizing antibodies REG… |
Heteromer | 100 | 1×NAG; | |||
| BA.2.86-V483 RBD in complex with bACE2 |
Heteromer Q2HJI5; | 87.69 | 1×CL; 7×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with VH domain F6 (focused … |
Heteromer | 98.46 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 (focused refinement of N… |
Heteromer | 100 | 1×NAG; | |||
| Locally refined region of SARS-CoV-2 spike in complex with antibody A19-46.1 |
Heteromer | 92.31 | 1×NAG; | |||
| Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting no… |
Heteromer | 100 | ||||
| Cryo-EM structure of SARS-CoV-2 Delta RBD in complex with BA7208 and BA7125 fab (local refinement) |
Heteromer | 98.97 | ||||
| SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of t… |
Heteromer | 100.0 | 1×NAG; | |||
| BA.2.86 Spike in complex with bovine ACE2 (Local refinement) |
Heteromer Q2HJI5; | 87.33 | 7×NAG; 1×ZN; 1×CL; | |||
| SARS-CoV-2 spike in complex with AHB2-2GS-SB175 (local refinement of the RBD and AHB2) |
Heteromer | 100 | 1×NAG; | |||
| Nanobody H11-H6 bound to RBD |
Heteromer | 100 | 1×NAG; 1×GOL; | |||
| Nanobody H11-H4 Q98R H100E bound to RBD |
Heteromer | 100 | 1×NAG; 3×GOL; 2×NO3; | |||
| Crystal structure of the SARS-CoV-2 S RBD in complex with pT1611 scFV |
Heteromer | 100 | 1×NAG; | |||
| Nanobody C5 bound to Kent variant RBD (N501Y) |
Heteromer | 99.48 | 1×NAG; 1×GOL; | |||
| Crystal structure of the SARS-CoV-2 S RBD in complex with pT1375 scFV |
Heteromer | 100 | 1×NAG; | |||
| LY-CoV488 neutralizing antibody against SARS-CoV-2 |
Heteromer | 100 | 1×NAG; 1×GOL; 1×PRO; | |||
| LY-CoV481 neutralizing antibody against SARS-CoV-2 |
Heteromer | 100 | 2×GOL; 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in c… |
Heteromer | 98.45 | 1×NAG; 13×GOL; 14×CL; 14×K; 3×TAR; | |||
| SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 |
Heteromer | 100 | 1×NAG; 14×GOL; 1×PG4; | |||
| Crystal structure of the SARS-CoV-2 RBD with the antibody Cv2.3194 |
Heteromer Q6PJF2; | 99.48 | 1×NAG; 1×PRO; 2×GOL; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain N501Y mutant in complex with neutralizing n… |
Heteromer | 99.48 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.2 variant spike protein i… |
Heteromer | 92.27 | 1×GOL; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Delta variant spike protein in compl… |
Heteromer | 98.97 | 1×NAG; 2×GOL; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in c… |
Heteromer | 98.45 | 1×NAG; 1×CL; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.… |
Heteromer | 100 | 1×NAG; 1×EDO; | |||
| Crystal structure of the K417T mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in c… |
Heteromer | 98.97 | 1×NAG; 3×GOL; 4×PEG; 12×SO4; 1×CIT; 7×CL; | |||
| Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody… |
Heteromer | 100 | ||||
| SARS-CoV-2 receptor binding domain bound to Fab PDI 42 |
Heteromer | 100.0 | 1×NAG; 6×GOL; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with C… |
Heteromer | 99.48 | 1×NAG; 3×PEG; 3×GOL; 2×SO4; 6×CL; 1×TRS; | |||
| Crystal structure of the SARS-CoV-2 S RBD in complex with pT1631 scFV |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1 |
Heteromer | 100 | 1×NAG; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody BIOLS56 |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody Fab |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 Spike RBD in complex with IS-9A Fab |
Heteromer | 100 | ||||
| Structure of sybody SR4 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD) |
Heteromer | 100 | 8×GOL; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P2S-2E9 Fab |
Heteromer | 98.93 | ||||
| Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12… |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2-Beta-RBD and BD-236-GWP/P-VK antibody complex |
Heteromer | 98.45 | ||||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3… |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 receptor binding domain bound to Fab WCSL 129 and Fab PDI 96 |
Heteromer | 100 | 1×NAG; 1×MPD; 2×GOL; | |||
| Crystal structure of SARS-CoV-2 spike protein receptor-binding domain complexed with a pre-pandemic… |
Heteromer | 100 | 1×NAG; 4×EDO; 2×SO4; 2×PGE; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody… |
Heteromer | 100 | 1×NAG; 2×GOL; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with C… |
Heteromer | 99.48 | 1×NAG; 3×NO3; 5×CL; | |||
| Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobody VHH-12 |
Heteromer | 99.48 | 1×NAG; 3×CL; 3×GOL; 1×SO4; | |||
| SARS-CoV-2 Delta-RBD complexed with Omi-42 and Beta-49 Fabs |
Heteromer | 98.97 | 1×NAG; 3×GOL; 1×SO4; 1×CL; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K288.2 |
Heteromer | 100 | 3×CAC; | |||
| Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-300 |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 delta variant spike receptor-binding domain (RBD) in complex with N… |
Heteromer | 98.97 | 1×NAG; | |||
| SARS-CoV-2-Omicron-RBD and BD-236-GWP/P-VK antibody complex |
Heteromer | 92.27 | ||||
| Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in c… |
Heteromer | 98.97 | 10×SO4; 3×GOL; 1×NAG; 1×PEG; 1×CL; | |||
| Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 antibody P22A-1D1 with RBD |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of the SARS-CoV-2 S RBD in complex with BD-623 Fab |
Heteromer | 100.0 | ||||
| Crystal structure of the SARS-Cov-2 RBD in complex with Fab 2303 |
Heteromer | 100 | 1×NAG; | |||
| LY-CoV1404 neutralizing antibody against SARS-CoV-2 |
Heteromer | 100 | 1×NAG; | |||
| The crystal structure of nanobody Nb4 in complex with receptor binding domain (RBD) of BA.1 Spike p… |
Heteromer | 92.27 | ||||
| Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 |
Heteromer Q9BYF1; | 100 | 1×ZN; 1×CL; 5×NAG; | |||
| Crystal structure of SARS-CoV-2 RBD in complex with the ridge-binding nAb EH8 isolated from a nonva… |
Heteromer | 100 | 1×NAG; 1×NAG; 1×NA; | |||
| SARS-CoV-2 receptor binding domain bound to Fab PDI 37 |
Heteromer | 100 | 1×NAG; 1×SO4; 1×CL; 1×GOL; | |||
| Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (T2… |
Heteromer Q9BYF1; | 100 | 5×NAG; | |||
| Crystal structure of R14 bound to SARS-CoV-2 RBD |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary comp… |
Heteromer | 99.48 | 1×NAG; 1×ACT; 1×GOL; 1×NAG; | |||
| Crystal structure of the SARS-CoV-2 receptor binding domain in complex with neutralizing antibody W… |
Heteromer | 100 | 5×GOL; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 antibody P5A-1D2 with RBD |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutr… |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 omicron RBD and human ACE2 |
Heteromer Q9BYF1; | 92.27 | 1×NAG; 1×ZN; 1×CL; 4×NAG; | |||
| Crystal structure of synthetic nanobody (Sb45+Sb68) complexes with SARS-CoV-2 receptor binding doma… |
Heteromer | 100 | ||||
| SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 3 Bound to P2B-2F6 Fab |
Heteromer | 95.88 | 1×NAG; | |||
| Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in ternary complex wi… |
Heteromer | 100 | 1×NAG; 5×CL; 1×MG; | |||
| SARS-CoV-2 RBD and Nb22 |
Heteromer | 100 | 1×PG4; | |||
| Crystal structure of the SARS-CoV-2 RBD in complex with BD-604 Fab and BD-368-2 Fab |
Heteromer | 100.0 | ||||
| Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S1… |
Heteromer Q9BYF1; | 100 | 5×NAG; | |||
| Structure of SARS-CoV-2 Gamma variant receptor-binding domain complexed with high affinity human AC… |
Heteromer Q9BYF1; | 98.45 | 1×ZN; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-… |
Heteromer | 100 | 1×NAG; 5×SO4; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH W and antibody … |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADG20 |
Heteromer | 100 | 1×NAG; 5×SO4; 1×CIT; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibodi… |
Heteromer | 100 | 3×GOL; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-1H1 Fab |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.6264 |
Heteromer | 99.48 | 1×NAG; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12… |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADI-5… |
Heteromer | 100 | 1×NAG; 9×SO4; | |||
| crystal structure of SARS-CoV-2 antibody with RBD |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 Spike RBD in complex with IY-2A Fab |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizin… |
Heteromer | 98.45 | 1×NAG; 13×SO4; 2×EDO; | |||
| Crystal structure of the SARS-CoV-2 S RBD in complex with pT1511 scFV |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 RBD bound to neutralizing antibody Fab ICO-hu23 |
Heteromer | 100 | 1×GOL; 1×ZN; 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in c… |
Heteromer | 98.45 | 1×NAG; 3×SO4; | |||
| SARS-CoV-2 Delta RBD and Nb22 |
Heteromer | 98.97 | ||||
| SARS-CoV-2 Omicron BA.2 RBD in complex with COVOX-150 Fab |
Heteromer | 91.75 | ||||
| Crystal structure of SARS-CoV-2 antibody P2C-1F11 with RBD |
Heteromer | 100.0 | 1×NAG; | |||
| Complex Structure of antibody BD-503 and RBD-E484K of COVID-19 |
Heteromer | 99.48 | 1×NAG; | |||
| Complex Structure of antibody BD-503 and RBD-501Y.V2 of COVID-19 |
Heteromer | 98.45 | 1×NAG; | |||
| Complex Structure of antibody BD-503 and RBD of COVID-19 |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with nanobody N19 |
Heteromer | 100 | ||||
| Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunoc… |
Heteromer Q9BYF1; | 96.91 | 1×NAG; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 1×NAG; | |||
| SARS-CoV-2 Omicron RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs |
Heteromer | 92.27 | 1×NAG; | |||
| SARS-CoV-2 receptor binding domain bound to Fab PDI 231 |
Heteromer | 100 | 1×NAG; 1×SO4; | |||
| Crystal structure of the SARS-CoV-2 S RBD in complex with BD-515 Fab |
Heteromer | 100.0 | ||||
| SARS-CoV-2 Omicron RBD in complex with Omi-3 and EY6A Fabs |
Heteromer | 92.27 | 4×GOL; 2×IPA; | |||
| SARS-CoV-2 Delta-RBD complexed with BA.4/5-2 and Beta-49 Fabs |
Heteromer | 98.94 | 1×NAG; | |||
| Crystal structure of antibody WRAIR-2134 in complex with SARS-CoV-2 receptor binding domain |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of antibody WRAIR-2134 in complex with SARS-CoV-2 receptor binding domain |
Heteromer | 100 | 1×NAG; | |||
| Epitope-based selection of SARS-CoV-2 neutralizing antibodies from convalescent patients |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1 |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in c… |
Heteromer | 98.45 | 1×NAG; 1×NAG; 15×SO4; | |||
| SARS-CoV-2 Omicron BA.2 RBD in complex with COVOX-150 Fab (P21) |
Heteromer | 91.75 | 1×NAG; | |||
| Crystal structure of the SARS-CoV-2 spike receptor-binding domain (RBD) with nanobody Nb20 |
Heteromer | 100 | 2×CAC; | |||
| BA.2/AZD1061/AZD3152 structure analysis |
Heteromer | 91.75 | ||||
| Crystal structure of SARS-CoV-2 BA.4 RBD and human ACE2 |
Heteromer Q9BYF1; | 91.75 | 2×NAG; 4×NAG; | |||
| Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD |
Heteromer | 100 | 1×NAG; | |||
| Bovine Fab SKD in complex with Sars COV-2 receptor binding domain |
Heteromer P0DOX5; P0DOY2; | 100 | 1×NAG; | |||
| Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab and BD-368-2 Fab |
Heteromer | 100.0 | ||||
| SARS-CoV-2 Omicron BA.2 RBD in complex with ACE2 |
Heteromer Q9BYF1; | 91.75 | 6×NAG; 1×ZN; | |||
| SARS-CoV-2 Receptor Binding Domain in Complex with Ab17 |
Heteromer | 100.0 | ||||
| SARS-CoV-2 Delta-RBD complexed with BA.2-10 and EY6A Fabs |
Heteromer | 98.45 | ||||
| Molecular basis for neutralizing antibody 2B11 targeting SARS-CoV-2 RBD |
Heteromer | 100.0 | ||||
| Complex Structure of antibody BD-503 and RBD-S477N of COVID-19 |
Heteromer | 99.48 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 BF.7 RBD and human ACE2 complex |
Heteromer Q9BYF1; | 91.24 | 2×NAG; 2×NAG; 2×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in c… |
Heteromer | 98.45 | 1×NAG; | |||
| SARS-CoV-2 delta RBD complexed with XBB-6 and beta-49 Fabs |
Heteromer | 98.97 | 1×NAG; | |||
| Crystal structure of the Wuhan SARS-CoV-2 RBD (333-541) complexed with P2C5 nanobody |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 delta RBD complexed with BA.4/5-9 Fab |
Heteromer | 98.97 | 1×NAG; 1×SO4; | |||
| Crystal structure of SARS-CoV-2 RBD with P2C-1F11 and P2B-1G5 |
Heteromer | 100 | 2×NAG; | |||
| SARS-CoV-2 Omicron RBD in complex with Omi-9 Fab and nanobody F2 |
Heteromer | 93.19 | ||||
| SARS-CoV-2 Omicron RBD in complex with Omi-6 and COVOX-150 Fabs |
Heteromer | 92.27 | ||||
| SARS-CoV-2 Omicron RBD in complex with Omi-12 and Beta-54 Fabs |
Heteromer | 93.01 | ||||
| Cryo-EM structure of SARS-CoV-2 Omicron spike protein with human ACE2 (focus refinement on RBD-1/AC… |
Heteromer Q9BYF1; | 92.27 | ||||
| SARS-CoV-2 Omicron BA.1 Variant RBD with mouse ACE2 Bound |
Heteromer Q8R0I0; | 92.27 | 1×NAG; 1×ZN; 2×NAG; | |||
| SARS-CoV-2 receptor binding domain bound to Fab PDI 222 |
Heteromer | 100 | 1×NAG; | |||
| Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-8 |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 receptor binding domain in complex with AZ090 Fab |
Heteromer | 100 | 2×NAG; | |||
| Locally refined region of SARS-CoV-2 spike in complex with antibodies 9G11 and 3E2. |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 Delta S-RBD-8D3 |
Heteromer | 98.97 | ||||
| cryoEM structure of a broadly neutralizing anti-SARS-CoV-2 antibody STI-9167 |
Heteromer | 100 | 1×NAG; | |||
| Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies |
Heteromer | 100 | 1×NAG; | |||
| Association of three complexes of largely structurally disordered Spike ectodomain with bound EY6A … |
Heteromer | 100 | 3×NAG; | |||
| SARS-COV-2 Spike RBDMACSp6 binding to hACE2 |
Heteromer Q9BYF1; | 99.48 | 5×NAG; | |||
| The interface of H014 Fab binds to SARS-CoV-2 S |
Heteromer | 100.0 | ||||
| SARS-COV-2 Spike RBDMACSp25 binding to hACE2 |
Heteromer Q9BYF1; | 98.97 | 5×NAG; | |||
| SARS-CoV-2 S RBD (C.37 Lambda variant) plus S309 Fab, local refinement |
Heteromer | 98.37 | 1×NAG; | |||
| Binding interface of SARS-CoV-2 RBD and its neutralizing antibody HB27 |
Heteromer | 100 | ||||
| SARS-CoV-2 Delta S-RBD-ACE2 |
Heteromer Q9BYF1; | 98.97 | ||||
| SARS-COV-2 Spike RBDMACSp36 binding to hACE2 |
Heteromer Q9BYF1; | 98.45 | 5×NAG; | |||
| CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb21 and Nb36 |
Heteromer | 100 | ||||
| RBD of SARS-CoV-2 Spike protein in complex with pan-sarbecovirus nanobodies 2-10, 2-67, 2-62 and 1-… |
Heteromer | 100 | ||||
| SARS-COV-2 Spike RBDMACSp36 binding to mACE2 |
Heteromer Q8R0I0; | 98.45 | 3×NAG; | |||
| SARS-CoV-2 Delta S-RBD-ACE2 complex |
Heteromer Q9BYF1; | 98.97 | ||||
| Local refinement of the SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab |
Heteromer | 92.23 | ||||
| The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody… |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 S bound to S2X259 Fab (local refinement of the RBD/S2X259 variable domains) |
Heteromer | 100.0 | 1×NAG; | |||
| SARS-CoV-2 Delta S-RBD-ACE2 |
Heteromer Q9BYF1; | 98.97 | ||||
| Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-11 |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 spike in complex with LCB3 (local refinement of the RBD and LCB3) |
Heteromer | 100 | 1×NAG; | |||
| G32A4 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction) |
Heteromer | 100 | ||||
| Interface of SARS-CoV-2 WT Spike in complex with R15 Fab and P14 Nanobody |
Heteromer | 100 | ||||
| Association of two complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 spike protein RBD and P17 fab complex |
Heteromer | 100 | ||||
| Structure of the SARS-CoV-2 spike glycoprotein in complex with the 10D12 heavy-chain-only antibody … |
Heteromer | 100 | ||||
| KP.3 RBD in complex with ACE2 |
Heteromer Q9BYF1; | 85.91 | 2×NAG; | |||
| SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab |
Heteromer | 100 | 1×NAG; 1×MES; | |||
| SARS-CoV-2 Spike RBD in complex with DMAbs 2130 and 2196 |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 Spike RBD in complex with DMAb 2196 |
Heteromer | 100 | 1×NAG; | |||
| Local refined cryo-EM structure of Omicron BA.5 RBD in complex with 8-9D Fab |
Heteromer | 90.96 | ||||
| Cryo-EM structure of SARS-CoV-2 spike protein in complex with three nAbs X01, X10 and X17 |
Heteromer | 100.0 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 alpha variant spike protein in complex with raccoon dog ACE2 (local… |
Heteromer B4XEP4; | 99.48 | 4×NAG; 1×ZN; 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Delta variant spike protein in complex with three nAbs X01, X10 and… |
Heteromer | 98.97 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.4 RBD in complex with fab L4.65 and L5.34 |
Heteromer | 91.24 | 1×NAG; | |||
| CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb21 and Nb105 |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 prototype RBD in complex with rabbit ACE2 (local refinement) |
Heteromer G1TEF4; | 100 | 1×NAG; 1×ZN; | |||
| SARS-CoV-2 Omicron BA.1 spike protein receptor-binding domain in complex with white-tailed deer ACE2 |
Heteromer A0A6J0Z472; | 92.27 | 1×NAG; 1×NAG; 4×NAG; 1×ZN; | |||
| The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody… |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 Delta-RBD complexed with Fabs BA.2-36, BA.2-23, EY6A and COVOX-45 |
Heteromer | 98.97 | ||||
| SARS-CoV-2 spike protein in complex with three human neutralizing antibodies |
Heteromer A0A5C2G4I7; A0A5C2GTV1; A0A5C2GVU3; | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 spike protein receptor-binding domain in complex wit… |
Heteromer A0A6J0Z472; | 91.24 | 5×NAG; 1×ZN; | |||
| Local refinement of SARS-CoV-2 Omicron BA.1 Spike glycoprotein in complex with rabbit monoclonal an… |
Heteromer | 92.27 | ||||
| Cryo-EM structure of SARS-CoV-2 BA.3 RBD in complex with golden hamster ACE2 (local refinement) |
Heteromer A0A1U7QTA1; | 92.27 | 1×NAG; 1×ZN; 2×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 prototype RBD in complex with raccoon dog ACE2 (local refinement) |
Heteromer B4XEP4; | 100 | 4×NAG; 1×ZN; 1×NAG; | |||
| The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody… |
Heteromer | 100 | 1×NAG; | |||
| CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb17 and Nb105 |
Heteromer | 100 | ||||
| ACE2-RBD in SARS-CoV-2 Kappa variant S-ACE2 complex |
Heteromer Q9BYF1; | 98.97 | 1×ZN; 5×NAG; | |||
| Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-15 |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD) |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of the RBD-ACE2 interface of the SARS-CoV-2 trimeric spike protein bound to ACE2 … |
Heteromer A0A7T0Q2W2; | 99.46 | 1×NAG; 1×NAG; 2×NAG; | |||
| The structure of FC08 Fab-hA.CE2-RBD complex |
Heteromer Q9BYF1; | 100 | 5×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 8H12 and 3E2 (local refin… |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of the RBD-ACE2 interface of the SARS-CoV-2 trimeric spike protein bound to ACE2 … |
Heteromer A0A7T0Q2W2; | 99.48 | ||||
| The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody… |
Heteromer | 100 | 1×NAG; | |||
| RBD/XG005 local refinement |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 8H12 and 1C4 (local refin… |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of … |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 Omicron variant spike in complex with three human neutralizing antibodies |
Heteromer A0A5C2G4I7; A0A5C2GTV1; A0A5C2GVU3; | 92.27 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 BA.4/5 spike protein in complex with 1G11 (local refinement) |
Heteromer | 91.24 | ||||
| Cryo-EM structure of SARS-CoV-2 Delta RBD in complex with golden hamster ACE2 (local refinement) |
Heteromer A0A1U7QTA1; | 98.97 | 2×NAG; 1×ZN; 2×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 3E2 and 1C4 (local refine… |
Heteromer | 100.0 | 1×NAG; | |||
| SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3) |
Heteromer | 100 | 1×NAG; | |||
| Local refinement of the SARS-CoV-2 BA.1 Spike trimer in complex with 55A8 Fab and 58G6 Fab |
Heteromer | 92.23 | ||||
| Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex |
Heteromer Q9BYF1; | 99.48 | 1×ZN; 1×CL; 5×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs XMA01 and 3E2 (local refi… |
Heteromer | 100 | 1×NAG; | |||
| SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD) |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 spike in complex with the Ab1 neutralizing antibody (focused refinement on Fab-RBD) |
Heteromer | 100 | 1×NAG; | |||
| Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-60 |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 Omicron BA.2 Variant RBD complexed with mouse ACE2 |
Heteromer Q8R0I0; | 91.75 | 1×NAG; 1×ZN; 2×NAG; | |||
| SARS-CoV-2 BQ.1.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody F… |
Heteromer Q9BYF1; | 89.84 | 1×NAG; 5×NAG; 1×ZN; | |||
| The structure of Banal-52 RBD and hACE2 complex |
Heteromer Q9BYF1; | 97.42 | ||||
| Cryo-EM structure of Delta RBD complexed with ConD-852, P2C-1F11 and S304 Fabs |
Heteromer | 98.97 | 1×NAG; | |||
| Cryo-EM structure of the Omicron RBD in complex with 35B5 Fab( local refinement of the RBD and 35B5… |
Heteromer | 92.27 | 1×NAG; | |||
| ACE2-RBD in SARS-CoV-2 Beta variant S-ACE2 complex |
Heteromer Q9BYF1; | 98.45 | 1×ZN; 5×NAG; | |||
| Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor… |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.2 variant spike protein i… |
Heteromer | 92.71 | 1×GOL; | |||
| CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD) in complex with 1D1 Fab |
Heteromer | 100.0 | 1×NAG; 5×GOL; 1×TRS; | |||
| Crystal structure of SARS-CoV-2 S RBD in complex with a stapled peptide |
Heteromer | 100 | 1×29N; | |||
| SARS-CoV-2 Receptor-Binding Domain SPEEDesign Immunogen 1 Bound to C144 scFv |
Heteromer | 95.86 | ||||
| Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with neutralizing nanobody… |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron XBB.1.5 variant spike protei… |
Heteromer | 88.6 | 1×GOL; 1×NA; | |||
| Crystal Structure of SARS-CoV-2 S receptor-binding domain (RBD) in complex CoV11 Fab |
Heteromer | 100 | 1×NAG; 5×SO4; 4×ACT; | |||
| Crystal structure of the SARS-CoV-2 S RBD in complex with pT1580 scFV |
Heteromer | 100 | 1×NAG; | |||
| LY-CoV555 neutralizing antibody against SARS-CoV-2 |
Heteromer | 100 | 1×GOL; | |||
| Crystal structure of SARS-CoV-2 RBD and NIV-10 complex |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BA.5 variant spike protein i… |
Heteromer | 92.15 | 2×GOL; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with C… |
Heteromer | 100 | 7×CL; 10×SO4; 3×GOL; 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 spike protein in complex with Ce9 |
Heteromer | 100 | 1×NAG; 3×GOL; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Alpha variant spike protein in compl… |
Heteromer | 99.48 | 1×NAG; | |||
| Crystal structure of the K417N mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in c… |
Heteromer | 99.48 | 3×GOL; 1×NAG; 13×SO4; 1×CL; 1×CIT; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2… |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of chimeric omicron RBD (strain BA.2) complexed with human ACE2 |
Heteromer Q9BYF1; | 84.57 | 2×NAG; 1×ZN; 1×CL; 5×NAG; 1×NA; | |||
| SARS-CoV-2 BA.2.12.1 RBD in complex with Beta-27 Fab and C1 nanobody |
Heteromer | 90.91 | 1×NAG; 12×GOL; 1×PO4; | |||
| Crystal structure of nanobody Nb70 with antibody 1F11 fab and SARS-CoV-2 RBD |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in c… |
Heteromer | 98.45 | 1×NAG; 4×GOL; 4×CL; 4×IOD; 2×PEG; | |||
| The co-crystal structure of BA.1-RBD with Fab-5549 |
Heteromer | 91.19 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Alpha variant spike protein in compl… |
Heteromer | 99.48 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 B.1.351 variant Spike glycoprotein i… |
Heteromer | 98.45 | 19×SO4; 2×GOL; 1×NAG; 2×PEG; | |||
| Crystal structure of chimeric SARS-CoV-2 RBD complexed with chimeric raccoon dog ACE2 |
Heteromer B4XEP4; Q9BYF1; | 88.08 | 1×NAG; 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 P.1 variant Spike glycoprotein in co… |
Heteromer | 98.45 | 15×SO4; 2×GOL; 1×NAG; 1×PEG; | |||
| Complex Structure of antibody BD-503 and RBD-N501Y of COVID-19 |
Heteromer | 99.48 | ||||
| Crystal structure of Omicron BA.4/5 in complex with a neutralizing antibody scFv D1 |
Heteromer | 91.67 | ||||
| SARS-CoV-2 Delta-RBD complexed with BA.2-13 Fab and C1 nanobody |
Heteromer | 98.96 | 1×NAG; 5×GOL; 1×PG0; | |||
| Crystal structure of chimeric omicron RBD (strain BA.2) complexed with chimeric mouse ACE2 |
Heteromer Q9BYF1; | 84.57 | 1×NAG; 1×ZN; 1×CL; 3×NAG; 5×EDO; | |||
| SARS-CoV-2 Omicron BA.2.75 RBD in complex with ACE2 |
Heteromer Q9BYF1; | 91.19 | 12×GOL; 6×NAG; 1×CL; 1×PGE; | |||
| Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-2B10 |
Heteromer | 100 | ||||
| Crystal structure of the SARS-CoV-2 S RBD in complex with BD-508 Fab |
Heteromer | 100.0 | ||||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with F… |
Heteromer | 100 | 1×NAG; 3×SO4; 2×NO3; 2×CL; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in c… |
Heteromer | 98.45 | 1×NAG; 2×GOL; 14×SO4; 1×PEG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with F… |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 Y453F-RBD bound to mink ACE2 |
Heteromer A0A8C7BTF2; | 99.46 | 1×NAG; 1×NAG; 2×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in c… |
Heteromer | 98.45 | 1×NAG; | |||
| Crystal structure of the SARS-COV-2 RBD with neutralizing-VHHs Re30H02 and Re21D01 |
Heteromer | 99.48 | ||||
| Crystal structure of the SARS-CoV-2 S RBD in complex with pT1616 Fab |
Heteromer | 100 | ||||
| Crystal structure of FD20, a neutralizing single-chain variable fragment (scFv) in complex with SAR… |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in c… |
Heteromer | 98.45 | 1×NAG; 1×NAG; | |||
| Crystal structure of the SARS-CoV-2 S RBD in complex with BD-604 Fab |
Heteromer | 100.0 | ||||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with F… |
Heteromer | 100.0 | 1×NAG; 2×PO4; | |||
| Crystal structure of neutralizing antibody 10-28 in complex with SARS-CoV-2 spike receptor binding … |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2… |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 Delta-RBD complexed with BA.4/5-1 and EY6A Fabs |
Heteromer | 98.96 | 1×NAG; | |||
| Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 … |
Heteromer Q9BYF1; | 100.0 | 6×NAG; 1×ZN; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in c… |
Heteromer | 98.45 | ||||
| BA.5 RBD in complex with CR9 |
Heteromer | 91.19 | ||||
| Local CryoEM structure of the SARS-CoV-2 S6P(B.1.1.529) in complex with BD55-3152 Fab |
Heteromer | 91.98 | 1×NAG; | |||
| Model and map from local refinement of a CAB-A17 - Omicron Ba.1 spike complex |
Heteromer | 92.63 | ||||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 RBD in complex with fab L4.65 and L5.34 |
Heteromer | 91.71 | 1×NAG; | |||
| Omicron BA.4/5 SARS-CoV-2 S RBD in complex with TH027 Fab |
Heteromer | 91.19 | ||||
| SARS-CoV-2 BN.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fab… |
Heteromer Q9BYF1; | 89.73 | 1×NAG; 5×NAG; | |||
| Structure of SARS-CoV-2 spike with antibody Fabs 2A10 and 1H2 (Local refinement of the RBD and Fabs… |
Heteromer | 100 | 1×NAG; | |||
| Omicron BA.4/5 SARS-CoV-2 S RBD in complex with TH132 Fab |
Heteromer | 91.19 | ||||
| SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region |
Heteromer Q9BYF1; | 100 | 1×ZN; 4×NAG; | |||
| Local CryoEM structure of the SARS-CoV-2 S6P(B.1.1.529) in complex with BD55-4637 Fab |
Heteromer | 91.98 | 1×NAG; | |||
| Omicron BA.4/5 SARS-CoV-2 S RBD in complex with TH236 Fab |
Heteromer | 91.19 | ||||
| Local CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWA9 Fab |
Heteromer | 98.94 | ||||
| Local structure of BD55-1239 Fab and SARS-COV2 Omicron RBD complex |
Heteromer | 91.98 | ||||
| Omicron BA.4/5 SARS-CoV-2 S RBD in complex with TH272 Fab |
Heteromer | 91.19 | ||||
| Omicron BA.4/5 SARS-CoV-2 S RBD in complex with TH272 Fab |
Heteromer | 91.19 | ||||
| SARS-CoV-2 spike in complex with the S2D106 neutralizing antibody Fab fragment (local refinement of… |
Heteromer | 100.0 | 1×NAG; | |||
| Structure of the SARS-CoV-2 EG.5.1 spike RBD in complex with ACE2 |
Heteromer Q9BYF1; | 88.08 | 2×NAG; 1×NAG; 1×NAG; 3×NAG; | |||
| Cryo-EM structure of CX1 receptor binding domain in complex with human ACE2 |
Heteromer Q9BYF1; | 97.41 | 7×NAG; 1×ZN; | |||
| Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with American mink A… |
Heteromer A0A8C7BTF2; | 99.48 | 1×NAG; 1×ZN; | |||
| BA.4/5 SARS-CoV-2 Spike bound to human ACE2 (local) |
Heteromer Q9BYF1; | 91.19 | 6×NAG; 1×ZN; | |||
| Beta SARS-CoV-2 Spike bound to mouse ACE2 (local) |
Heteromer Q8R0I0; | 98.45 | 1×NAG; 1×NAG; | |||
| Local CryoEM structure of the SARS-CoV-2 S6P(B.1.617.2) in complex with SWC11 Fab |
Heteromer | 98.94 | ||||
| BA.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) |
Heteromer Q8R0I0; | 92.23 | 1×NAG; 1×NAG; | |||
| SARS-CoV-2 spike in complex with LCB1 (local refinement of the RBD and LCB1) |
Heteromer | 100 | 1×NAG; | |||
| BA.2.12.1 SARS-CoV-2 Spike bound to mouse ACE2 (local) |
Heteromer Q8R0I0; | 91.19 | 1×NAG; 1×NAG; | |||
| BA.4/5 SARS-CoV-2 Spike bound to mouse ACE2 (local) |
Heteromer Q8R0I0; | 91.19 | 1×NAG; 1×NAG; | |||
| SARS-CoV2 Omicron BA.1 RBD in complex with CAB-A17 antibody |
Heteromer | 92.63 | ||||
| the complex structure of the H4B6 Fab with the RBD of Omicron BA.5 S protein |
Heteromer | 91.19 | ||||
| Local structure of BD55-3546 Fab and SARS-COV2 Delta RBD complex |
Heteromer | 98.94 | 1×NAG; | |||
| Neutralization antibody ZCP4C9 bound with SARS-CoV-2 Omicron BA.5 RBD |
Heteromer | 80.85 | ||||
| Neutralization antibody ZCP3B4 bound with SARS-CoV-2 Omicron BA.5 RBD |
Heteromer | 80.85 | ||||
| Local structure of BD55-3500 and omicron RBD complex |
Heteromer | 91.98 | 1×NAG; | |||
| SARS-CoV-2 receptor binding domain bound to Fab PDI 215 |
Heteromer | 100 | 1×NAG; 2×IPA; | |||
| Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a highly pote… |
Heteromer | 100.0 | 1×NAG; 2×GOL; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH V and antibody … |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.… |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12… |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193 |
Heteromer | 100.0 | 1×NAG; | |||
| Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1antibodies |
Heteromer | 100 | 1×NAG; 1×CL; | |||
| Crystal structure of SARS-CoV-2 BQ.1.1 RBD and human ACE2 |
Heteromer Q9BYF1; | 90.1 | ||||
| SARS-CoV-2 spike omicron (BA.1) RBD ectodomain dimer-of-trimers in complex with SC27 Fabs |
Heteromer | 91.94 | 2×NAG; | |||
| SARS-CoV-2 spike omicron (BA.1) ectodomain trimer in complex with SC27 Fab, local refinement |
Heteromer | 91.94 | 1×NAG; | |||
| Local CryoEM structure of the SARS-CoV-2 BA.5 in complex with ORB10 Fab |
Heteromer | 91.15 | ||||
| SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (local refinement of… |
Heteromer | 100.0 | 1×NAG; | |||
| Local structure of BD55-5514 and BD55-5840 Fab and Omicron BA.1 RBD complex |
Heteromer | 92.19 | 1×NAG; | |||
| Local resolution of BD55-5840 Fab and SARS-COV2 Omicron RBD |
Heteromer | 91.89 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR22, and two antibody F… |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike in complex with FSR22, an anti-SARS-CoV-2 DARPin (Local refin… |
Heteromer | 100 | ||||
| Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR16m, and two antibody … |
Heteromer | 100 | 1×NAG; | |||
| ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2… |
Heteromer Q9BYF1; | 100 | 2×NAG; 5×NAG; | |||
| Crystal structure of the SARS-CoV-2 S RBD in complex with pT1610 scFV |
Heteromer | 100 | 1×NAG; | |||
| CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD-beta variant) in complex with 3D2 Fab |
Heteromer | 98.84 | 1×NAG; 4×GOL; | |||
| Crystal Structure of SARS-CoV-2 S delta variant receptor-binding domain (RBD) in complex CoV11 Fab … |
Heteromer | 98.94 | 1×NAG; 2×PO4; 2×MPD; | |||
| Crystal structure of Omicron BA.4/5 RBD in complex with a neutralizing antibody scFv |
Heteromer | 91.1 | ||||
| Crystal structure of SARS-CoV-2 Spike RBD in complex with MW07 Fab |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 delta variant spike receptor-binding domain (RBD) in complex with N… |
Heteromer | 98.95 | ||||
| SARS-CoV-2 Beta RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs |
Heteromer | 98.43 | 1×NAG; | |||
| SARS-CoV-2 Omicron RBD in complex with Omi-25 Fab |
Heteromer | 92.43 | ||||
| KP.2 RBD in complex with ACE2 |
Heteromer Q9BYF1; | 85.23 | 2×NAG; | |||
| SARS-CoV-2 (B.1.1.529/Omicron variant) Spike protein in complex with the single chain fragment scFv… |
Heteromer | 92.15 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 antibody P5A-3C8 with RBD |
Heteromer | 100.0 | 1×NAG; | |||
| S-RBD (Omicron BF.7) in complex with PD of ACE2 |
Heteromer Q9BYF1; | 90.06 | 6×NAG; 1×NAG; | |||
| S-RBD (Omicron XBB.1) in complex with PD of ACE2 |
Heteromer Q9BYF1; | 87.98 | 6×NAG; 1×NAG; | |||
| XBB 1.0 RBD bound to P4J15 (Local) |
Heteromer | 88.42 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody nCoV6… |
Heteromer | 100 | ||||
| SARS-CoV-2 S protein in complex with pT1696 Fab |
Heteromer | 100 | 1×NAG; | |||
| Structure of SARS-CoV-2 spike receptor-binding domain complexed with its receptor equine ACE2 |
Heteromer F6V9L3; | 100 | 1×ZN; 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 20A7 |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of the SARS-CoV-2 RBD (Wuhan) with neutralizing VHHs Ma6F06 and Re21H01 |
Heteromer | 99.47 | 1×P4G; 2×EDO; | |||
| SARS-CoV-2 Spike RBD in complex with neutralizing Fab SARS2-38 (local refinement) |
Heteromer | 100 | 1×NAG; | |||
| Structure of the SARS-CoV-2 spike glycoprotein in complex with nanobody 7F (local refinement) |
Heteromer | 98.94 | ||||
| Crystal structure of SARS-CoV-2 Beta RBD complexed with P36-5D2 Fab |
Heteromer | 98.28 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 Spike RBD in complex with the D27 neutralizing antibody Fab fragment |
Heteromer | 100 | ||||
| SARS-CoV-2 delta RBD complexed with XBB-2 Fab and NbC1 |
Heteromer | 98.92 | 1×NAG; 6×GOL; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with C… |
Heteromer | 100 | 1×NAG; 2×GOL; 2×CL; 2×PO4; 4×PRO; | |||
| SARS-CoV-2 Delta RBD in complex with XBB-9 Fab and an anti-Fab nanobody |
Heteromer | 98.92 | ||||
| SARS-CoV-2 Omicron BA.1 spike trimer (6P) in complex with YB13-292 Fab, focused refinement of Fab r… |
Heteromer | 91.94 | 1×NAG; | |||
| Ternary Crystal Complex Structure of RBD with NB1B5 and NB1C6 |
Heteromer | 100 | ||||
| Crystallographic structure of two neutralizing antibodies in complex with SARS-CoV-2 spike receptor… |
Heteromer | 100 | 1×TRS; 1×NAG; 2×GOL; | |||
| The receptor binding domain of SARS-CoV-2 spike glycoprotein in complex with Beta-55 and EY6A Fabs |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2.86 RBD in complex with human ACE2 |
Heteromer Q9BYF1; | 87.08 | 2×NAG; 1×NAG; 1×ZN; 5×NAG; | |||
| Delta-RBD complex with BA.2-07 fab, SARS1-34 fab and C1 nanobody |
Heteromer | 98.92 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron JN.1 RBD in complex with human ACE2 (local refinement from … |
Heteromer Q9BYF1; | 86.39 | 2×NAG; 3×NAG; 1×ZN; 3×NAG; | |||
| Crystal structure of the SARS-CoV-2 BA.1 RBD with neutralizing-VHHs Ma16B06 and Ma3F05 |
Heteromer | 90.76 | ||||
| Crystal structure of the L452R mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in c… |
Heteromer | 99.46 | 1×NAG; 1×NAG; 9×GOL; 1×PEG; 1×CL; 1×TRS; 1×PO4; | |||
| Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody… |
Heteromer | 100 | 1×NAG; | |||
| SARS-CoV-2 Delta-RBD complexed with BA.4/5-35 Fab |
Heteromer | 98.91 | 1×NAG; | |||
| SARS-CoV-2 spike RBD in complex with neutralizing antibody UT28K |
Heteromer | 100.0 | ||||
| Cryo-EM map of SARS-CoV-2 Omicron BA.2 spike in complex with 2130-1-0114-112 |
Heteromer | 90.81 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.4/5 RBD in complex with rabbit ACE2 (local refinement) |
Heteromer G1TEF4; | 90.76 | 1×ZN; 1×NAG; | |||
| Structure Determination of the RBD-NB1A7 |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the SARS-CoV-2 RBD in complex with STE90-C11 Fab |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the N501Y mutant receptor binding domain of SARS-CoV-2 Spike glycoprotein in c… |
Heteromer | 99.45 | 1×NAG; 5×GOL; 3×SO4; | |||
| A SARS-CoV-2 neutralizing antibody |
Heteromer | 100 | 1×NAG; | |||
| Crystal structure of the SARS-CoV-2 S RBD in complex with BD-629 Fab |
Heteromer | 100 | ||||
| Crystal structure of the SARS-CoV-2 S RBD in complex with BD-629 Fab and BD-368-2 Fab |
Heteromer | 100 | ||||
| A SARS-CoV-2 neutralizing antibody |
Heteromer | 100 | ||||
| The receptor binding domain of SARS-CoV-2 spike glycoprotein in complex with COVOX-58 and COVOX-158… |
Heteromer | 100 | 2×GOL; 1×NAG; 1×NA; | |||
| Crystal structure of Omicron BA.1 in complex with a neutralizing antibody scFv T11 |
Heteromer | 91.8 | ||||
| Crystallographic structure of neutralizing antibody 2-15 in complex with SARS-CoV-2 spike receptor-… |
Heteromer | 100.0 | ||||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary comp… |
Heteromer | 100 | 1×NAG; 1×NAG; 1×GOL; 4×ACT; | |||
| CC6.30 fragment antigen binding in complex with SARS-CoV-2-6P-Mut7 S protein (RBD/Fv local refineme… |
Heteromer | 100.0 | 1×NAG; 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK1628x in complex with three neutraliz… |
Heteromer | 97.27 | 1×NAG; 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK in complex with three neutralizing a… |
Heteromer | 100 | 1×NAG; 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Delta S6P trimer in complex with neutralizing antibody VacW-209 (lo… |
Heteromer A0A5C2GQT9; | 99.39 | 1×NAG; | |||
| Cryo-EM structure of human ACE2 receptor bound to protein encoded by vaccine candidate BNT162b1 |
Heteromer Q9BYF1; | 100 | ||||
| Cryo-EM structure of SARS-CoV-2 S2P trimer in complex with neutralizing antibody VacW-209 (local re… |
Heteromer A0A5C2GQT9; | 100 | 1×NAG; | |||
| Local structure of BD55-3372 and delta spike |
Heteromer | 98.91 | ||||
| Local map of Omicron Subvariant JN.1 RBD with ACE2 |
Heteromer Q9BYF1; | 86.39 | ||||
| local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-812 Fab and BD-836 Fab |
Heteromer | 98.36 | ||||
| The 2019-nCoV RBD/ACE2-B0AT1 complex |
Heteromer Q695T7; Q9BYF1; | 100 | 14×NAG; 2×NAG; 10×NAG; 2×LEU; 2×ZN; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron S6P trimer in complex with neutralizing antibody VacW-209 (… |
Heteromer A0A5C2GQT9; | 91.8 | 1×NAG; | |||
| Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-771 Fab and BD-821 Fab |
Heteromer | 98.36 | ||||
| local structure of hu33 and spike |
Heteromer | 98.36 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Mu S6P trimer in complex with neutralizing antibody VacW-209 (local… |
Heteromer A0A5C2GQT9; | 98.36 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2.86 RBD in complex with human ACE2 and S309 Fab |
Heteromer Q9BYF1; | 87.25 | 1×NAG; 2×NAG; 1×NAG; 3×NAG; 1×ZN; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 beta variant spike glycoprotein in c… |
Heteromer | 98.35 | 1×NAG; 1×PG0; 2×GOL; 2×PEG; 1×CL; | |||
| Crystal structure of The SARS-COV-2 BA.2.75 RBD with neutralizing-VHHs Re32D03 and Ma3B12 |
Heteromer | 91.38 | ||||
| A SARS-CoV-2 neutralizing antibody |
Heteromer | 97.04 | 1×NAG; | |||
| SARS-CoV-2 S protein RBD in complex with A8-1 Fab |
Heteromer | 100 | ||||
| SARS-CoV-2 Omicron RBD in complex with Omi-32 Fab and nanobody C1 |
Heteromer | 91.28 | ||||
| SARS-CoV-2 S protein in complex with pT1644 Fab |
Heteromer | 100 | 1×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 C.1.2 S6P trimer in complex with neutralizing antibody VacW-209 (lo… |
Heteromer A0A5C2GQT9; | 98.35 | 1×NAG; | |||
| Crystal structure of the SARS-CoV-2 RBD with neutralizing-VHHs Re5D06 and Re9F06 |
Heteromer | 100.0 | 1×DMX; 1×SO4; | |||
| SARS-CoV-2 RBD in complex with a Fab fragment of a neutralising antibody mRBD2 |
Heteromer | 100.0 | 6×SO4; | |||
| Structure Determination of the NB1B11-RBD Complex |
Heteromer | 100.0 | 3×ZN; | |||
| Crystal Structure of SARS-CoV Spike Receptor-Binding Domain Complexed with Neutralizing Antibody |
Heteromer | 100.0 | ||||
| Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor bindi… |
Heteromer | 100.0 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 RBD Q498Y complexed with human ACE2 |
Heteromer Q9BYF1; | 99.43 | 3×NAG; 1×ZN; 1×EDO; 1×CL; | |||
| Crystal structure of SARS-CoV-2 Alpha RBD in complex with the D27LEY neutralizing antibody Fab frag… |
Heteromer | 99.45 | ||||
| CryoEM structure of RBD domain of COVID-19 in complex with Legobody |
Heteromer P06654; P99134; | 100.0 | 1×GLC; | |||
| SARS-CoV-2 spike glycoprotein trimer complexed with Fab fragment of anti-RBD antibody E7 (focused r… |
Heteromer | 100.0 | ||||
| Antibody N3-1 bound to RBDs in the up and down conformations |
Heteromer | 100.0 | ||||
| SARS-CoV-2 BA.2 spike RBD in complex bound with VacBB-551 |
Heteromer | 91.16 | ||||
| Antibody N3-1 bound to RBD in the up conformation |
Heteromer | 100.0 | ||||
| SARS-CoV-2 XBB.1 spike RBD bound to the human ACE2 ectodomain and the S309 neutralizing antibody Fa… |
Heteromer Q9BYF1; | 88.27 | 1×NAG; 5×NAG; | |||
| Cryo-EM structure of Omicron BA.1 RBD complexed with ConBA-998,S309 and S304Fabs |
Heteromer | 91.16 | 1×NAG; | |||
| Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary comp… |
Heteromer | 100.0 | 1×NAG; 2×IMD; 4×GOL; 6×BR; 1×PG6; | |||
| Crystal Structure of the SARS-CoV-2 Receptor Binding Domain in Complex with Antibody ION-360 |
Heteromer | 100.0 | 1×NAG; | |||
| SARS-CoV-2 BA.1 spike RBD in complex bound with VacBB-639 |
Heteromer | 91.67 | ||||
| Fab M2-7 complexed with SARS-Cov2 RBD and human ACE2 |
Heteromer Q9BYF1; | 100.0 | 1×ZN; 3×NAG; | |||
| SARS-COV-2 BA.1 Spike incomplex with VacBB-665 |
Heteromer | 92.49 | ||||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2… |
Heteromer | 100.0 | 1×NAG; | |||
| S-RBD(Omicron BA.3) in complex with PD of ACE2 |
Heteromer Q9BYF1; | 91.02 | 6×NAG; 1×NAG; | |||
| S-RBD (Omicron BA.2.75) in complex with PD of ACE2 |
Heteromer Q9BYF1; | 89.82 | 6×NAG; 1×NAG; | |||
| SARS-CoV-2 RBD in complex with 1F Fab |
Heteromer | 100 | ||||
| Cryo-EM structure of Human ACE2 bound to a high-affinity SARS CoV-2 mutant |
Heteromer Q9BYF1; | 98.8 | 3×NAG; | |||
| SARS-CoV-2 (B.1.1.529/Omicron variant) Spike protein in complex with the single chain fragment scFv… |
Heteromer | 90.45 | 1×NAG; | |||
| Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-… |
Heteromer | 100.0 | 2×NAG; | |||
| Structure of P4A2 Fab in complex with Spike-RBD from SARS-CoV-2 |
Heteromer | 100 | ||||
| The structure of ZCB11 Fab against SARS-CoV-2 Omicron Spike |
Heteromer | 91.53 | ||||
| SARS-CoV-2 Omicron BA.2 spike trimer (6P) in complex with D1F6 Fab, focused refinement of RBD region |
Heteromer | 90.8 | ||||
| SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain |
Heteromer Q9BYF1; | 94.44 | 1×ZN; 3×NAG; | |||
| Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 |
Heteromer P59594; Q9BYF1; | 100 | 3×NAG; 2×NAG; 1×ZN; 1×CL; 1×EDO; 1×NAG; | |||
| SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody Fab fragment (local refinement of … |
Heteromer | 100.0 | ||||
| Cryo-EM structure of the SARS-CoV-2 HR1HR2 fusion core complex with N969K mutation |
Heteromer A0A8B6RKS7; | 100 | ||||
| SARS-CoV2 spike glycoprotein N-terminal heptad repeat domain + SARS-CoV2(QEYKKEKE) |
Heteromer A0A6C0RQ44; | 76.47 | ||||
| Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40… |
Heteromer | 100 | 1×ACT; 5×SO4; 1×GOL; | |||
| Crystal structure of human neutralizing mAb CV3-25 binding to SARS-CoV-2 S MPER peptide 1140-1165 |
Heteromer | 100 | 10×NA; | |||
| fp.006 Fab in complex with SARS-CoV-2 Fusion Peptide |
Heteromer | 100 | 1×PEG; 1×EDO; | |||
| Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody COV3… |
Heteromer | 100 | ||||
| Crystal structure of nanobody H145 bound to SARS-CoV-2 spike stem-helix |
Heteromer | 100 | ||||
| Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody COV8… |
Heteromer | 100 | ||||
| Crystal structure of CV3-25 Fab bound to SARS-CoV-2 spike stem helix peptide |
Heteromer | 100 | 7×GOL; 2×SO4; | |||
| Antibody DH1058 Fab fragment bound to SARS-CoV-2 fusion peptide |
Heteromer | 100 | 2×CA; 1×PO4; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Spike peptide S761-775 |
Heteromer D7RIG0; P01903; | 100 | 5×EDO; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Omicron (BA.1) Spike peptide S7… |
Heteromer D7RIG0; P01903; | 93.33 | 7×EDO; 3×SO4; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Spike peptide S511-530 |
Heteromer D7RIG0; P01903; | 100 | 15×EDO; 2×SO4; 1×MES; | |||
| Crystal structure of SARS-CoV-2 fusion peptide in complex with neutralizing antibody COV44-62 |
Heteromer | 100 | ||||
| Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Omicron (BA.1) Spike peptide S4… |
Heteromer D7RIG0; P01903; | 78.57 | 30×EDO; 1×SO4; 1×DHL; | |||
| Human Leukocyte Antigen class II allotype DR1 presenting SARS-CoV-2 Spike peptide S486-505 |
Heteromer D7RIG0; P01903; | 100 | 10×EDO; 1×DHL; | |||
| Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with Fab of broadly neutralizin… |
Heteromer | 100 | 2×GOL; | |||
| Crystal Structure of VP12E7 Fab in complex with SARS-CoV-2 S fusion peptide |
Heteromer | 100 | ||||
| S2P6 Fab fragment bound to the SARS-CoV/SARS-CoV-2 spike stem helix peptide |
Heteromer | 100 | 4×SO4; | |||
| Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody COV9… |
Heteromer | 100 | ||||
| Crystal structure of the 76E1 Fab in complex with a SARS-CoV-2 spike peptide |
Heteromer | 100 | ||||
| The structure of HLA-A/Pep14 |
Heteromer A0A0G2JPD3; P61769; | 100 | ||||
| Crystal Structure of VN01H1 Fab in complex with SARS-CoV-2 S fusion peptide |
Heteromer | 100 | ||||
| The structure of HLA-A/14-3-D |
Heteromer A0A0G2JL56; P61769; | 91.67 | ||||
| Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV… |
Heteromer P01834; P0DOX5; | 100 | ||||
| Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CHM-… |
Heteromer | 100 | 1×FLC; | |||
| Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV… |
Heteromer | 100 | ||||
| B6 Fab fragment bound to the SARS-CoV/SARS-CoV-2 spike stem helix peptide |
Heteromer | 100 | 3×GOL; | |||
| Crystal structure of HLA B*13:01 in complex with SVLNDIFSRL, an 10-mer epitope from SARS-CoV-2 Spik… |
Heteromer C5IYE8; P61769; | 90.0 | 3×EDO; 2×NA; | |||
| Crystal structure of HLA B*13:01 in complex with SVLNDILARL, an 10-mer epitope from SARS-CoV-2 Spik… |
Heteromer C5IYE8; P61769; | 90.0 | 3×PEG; 4×EDO; 2×NA; | |||
| SARS-CoV-2 S stem helix peptide bound to Fab22 |
Heteromer | 100 | ||||
| Crystal structure of HLA-A*11:01 in complex with SVLNDIFSRL, an 10-mer epitope from SARS-CoV-2 Spik… |
Heteromer P61769; Q5S3G3; | 90.0 | 17×EDO; 3×NA; 1×PEG; 3×CL; 1×MG; | |||
| Crystal structure of SARS-CoV-2 neutralizing antibody WS6 in complex with spike S2 peptide |
Heteromer | 100 | 11×SO4; 2×PEG; | |||
| SARS-CoV-2 Spike-derived peptide S1215-1224 (YIWLGFIAGL) presented by HLA-A*02:01 |
Heteromer P61769; Q53Z42; | 100 | ||||
| Crystal Structure of HLA-A*02:01 in complex with KLNDLCFTNV, an 10-mer epitope from SARS-CoV-2 Spik… |
Heteromer A0A140T913; P61769; | 100 | 1×GOL; | |||
| Crystal structure of HLA-A*11:01 in complex with SVLNDILARL, an 10-mer epitope from SARS-CoV-2 Spik… |
Heteromer P61769; Q5S3G3; | 90.0 | 1×PEG; 8×EDO; 2×CL; 2×SO4; 2×NA; | |||
| Crystal structure of HLA-A*11:01 in complex with SVLNDILSRL, an 10-mer epitope from SARS-CoV-2 Spik… |
Heteromer P61769; Q5S3G3; | 100 | 1×PEG; 1×EDO; | |||
| Crystal Structure of HLA-B*35:01 in complex with IPFAMQMAY, an 9-mer epitope from SARS-CoV-2 spike … |
Heteromer P61769; Q546I9; | 100 | 2×PO4; 3×NA; | |||
| Crystal Structure of HLA-A*11:01 in complex with NSASFSTFK, an 9-mer epitope from SARS-CoV-2 spike … |
Heteromer P61769; U5YJK1; | 100 | 1×GOL; 2×SO4; 2×NA; 2×CL; 1×CA; | |||
| MHC I A02 Allele presenting YLQPRTFLL |
Heteromer A0A140T913; P61769; | 100 | 6×EDO; 1×ACT; 1×CA; | |||
| SARS-CoV-2 Spike-derived peptide S1185-1193 K1191N mutant (RLNEVANNL) presented by HLA-A*02:01 |
Heteromer P61769; Q53Z42; | 88.89 | 1×CD; 1×ZN; 1×NA; 1×ACT; 1×CL; | |||
| The structure of HLA/peptide from virus |
Heteromer A0A143Y4R2; P61769; | 88.89 | ||||
| SARS-CoV-2 Spike-derived peptide S976-984 S982A mutant (VLNDILARL) presented by HLA-A*02:01 |
Heteromer P61769; Q53Z42; | 88.89 | 2×ACT; 2×EDO; 2×CD; 1×PEG; | |||
| Crystal Structure of HLA-B*15:01 in complex with spike derived peptide NQKLIANQF from SARS-CoV-2 vi… |
Heteromer P61769; | 100 | 1×ACT; 1×PEG; | |||
| SARS-CoV-2 spike-derived peptide S1060-1068 (VVFLHVTYV) presented by HLA-A*02:01 |
Heteromer A0A140T913; P61769; | 100 | 2×CD; 1×NA; | |||
| The structure of HLA-A/PT |
Heteromer A0A143Y4R2; P61769; | 100 | ||||
| Complex Structure of HLA-A*2402 with the Peptide from HCoV(CoV-2) spike protein |
Heteromer A0A5H2UYS3; P61769; | 100 | ||||
| SARS-CoV-2 Spike-derived peptide S976-984 (VLNDILSRL) presented by HLA-A*02:01 |
Heteromer P61769; Q861F7; | 100 | 1×ACT; 1×CD; 1×ZN; | |||
| Human leukocyte antigen A*0201 in complex with SARS-CoV-2 epitope YLQPRTFLL |
Heteromer A0A140T913; P61769; | 100 | 4×GOL; | |||
| The structure of HLA-A/peptide from virus |
Heteromer A0A140T955; P61769; | 44.44 | ||||
| MHC I A02 Allele presenting YLQLRTFLL |
Heteromer A0A140T913; P61769; | 88.89 | 12×IOD; 1×PEG; | |||
| The structure of HLA/peptide from virus |
Heteromer A0A143Y4R2; P61769; | 88.89 | ||||
| SARS-CoV-2 Spike-derived peptide S269-277 (YLQPRTFLL) presented by HLA-A*02:01 |
Heteromer P61769; Q53Z42; | 100 | ||||
| SARS-CoV-2 YLQ peptide binds to HLA-A2 |
Heteromer A0A140T913; P61769; | 100 | 1×PG4; | |||
| CRYSTAL STRUCTURE OF A MUTANT MYLU-B-67 FOR 2.2 ANGSTROM, 52M 53Q 54Q 55P 56W DELETED |
Heteromer G1PNR4; L5K3Y9; | 100 | ||||
| The structure of HLA-A/Pep16 |
Heteromer A0A0G2JPD3; P61769; | 100 | ||||
| CRYSTAL STRUCTURE OF BAT MHC CLASS I MYLU-B-67 |
Heteromer G1PNR4; L5K3Y9; | 100 | ||||
| HLA peptide complex |
Heteromer A0A140T913; P61769; | 100 | 4×EDO; | |||
| SARS-CoV-2 RLQ peptide-specific TCR pRLQ3 binds to RLQ-HLA-A2 |
Heteromer A0A140T913; P61769; | 100 | ||||
| HLA A*2402-NF9_5R pMHC complex |
Heteromer A0A411J078; P61769; | 88.89 | ||||
| SARS-CoV-2 Spike-derived peptide S489-497 (YFPLQSYGF) presented by HLA-A*29:02 |
Heteromer B0UXQ0; P61769; | 100 | 3×SO4; 2×MG; 1×NA; | |||
| The structure of HLA/peptide from virus |
Heteromer A0A143Y4R2; P61769; | 77.78 | ||||
| The structure of HLA/peptide from virus |
Heteromer A0A143Y4R2; P61769; | 66.67 | ||||
| SARS-CoV-2 YLQ peptide-specific TCR pYLQ7 binds to YLQ-HLA-A2 |
Heteromer A0A140T913; P61769; | 100 | ||||
| HLA A*2402-NF9_6F pMHC complex |
Heteromer A0A411J078; P61769; | 88.89 | ||||
| YLQ-SG3 TCR in complex with SARS-CoV-2 Spike-derived peptide S269-277 (YLQPRTFLL) presented by HLA-… |
Heteromer P61769; Q53Z42; | 100 | 4×NA; | |||
| Complex structure of HLA2402 with recognizing SARS-CoV-2 Y453F epitope NYNYLFRLF |
Heteromer A0A7T3RIT5; P61769; | 88.89 | 2×EDO; | |||
| SARS-CoV-2 specific private TCR RLQ7 in complex with RLQ-T1006I-HLA-A2 |
Heteromer A0A140T913; P61769; | 88.89 | 1×PG4; | |||
| The structure of FLA-K*00701/KP-CoV-9 |
Heteromer C6ZK69; Q5MGS7; | 100 | ||||
| The structure of HLA-A/peptide from virus |
Heteromer A0A143Y4R2; P61769; | 88.89 | ||||
| SARS-CoV-2 specific private TCR RLQ7 in complex with RLQ-HLA-A2 |
Heteromer A0A140T913; P61769; | 100 | 1×PG4; | |||
| Complex structure of HLA0201 with recognizing SARS-CoV-2 epitope S1 |
Heteromer A0A5H2UU57; P61769; | 100 | ||||
| SARS-CoV-2 RLQ peptide binds to HLA-A2 |
Heteromer A0A140T913; P61769; | 100 | ||||
| Complex structure of HLA2402 with recognizing SARS-CoV-2 epitope QYIKWPWYI |
Heteromer F6IR24; P61769; | 100 | ||||
| Complex structure of HLA2402 with recognizing SARS-CoV-2 epitope pep4 |
Heteromer D9UAY1; P61769; | 100 | ||||
| Emergence of immune escape at dominant SARS-CoV-2 killer T-cell epitope |
Heteromer A0A140T913; P61769; | 100 | 1×PEG; 3×SO4; | |||
| P1-15 T-cell Receptor bound to HLA A*2402-NF9 pMHC complex |
Heteromer A0A5H2UYS3; P61769; | 100 | ||||
| TCR peptide HLA-A2 complex |
Heteromer A0A140T913; P61769; | 100 | ||||
| The complex of TCR NYN-I and HLA-A24 bound to SARS-CoV-2 Spike448-456 peptide NYNYLYRLF |
Heteromer P61769; Q6IVJ7; | 100 | ||||
| SARS-CoV-2 Spike-derived peptide S417-425 K417T mutant (TIADYNYKL) presented by HLA-A*02:01 |
Heteromer P61769; Q53Z42; | 100 | 1×ZN; 1×CD; 1×NA; | |||
| CRYSTAL STRUCTURE OF BAT MHC CLASS I MYLU-B-67 FOR 2.1 ANGSTROM |
Heteromer G1PNR4; L5K3Y9; | 100 | ||||
| CRYSTAL STRUCTURE OF BAT MHC CLASS I MYLU-B-67 FOR 2.2 ANGSTROM |
Heteromer G1PNR4; L5K3Y9; | 100 | ||||
| Epitope-directed anti-SARS CoV 2 scFv engineered against the key spike protein region. |
Heteromer | 100 | ||||
| CRYSTAL STRUCTURE OF A MUTANT MYLU-B-67 FOR 2.4 ANGSTROM, 52M 53Q 54Q 55P 56W DELETED |
Heteromer G1PNR4; L5K3Y9; | 100 | ||||
| 3D1 in complex with 6-mer HR1 peptide from SARS-CoV-2 |
Heteromer | 100 | ||||
| Crystal structure of beta'-COPI-WD40 domain in complex with SARS-CoV-2 spike tail hepta-peptide |
Heteromer P41811; | 100 | ||||
| Crystal structure of beta'-COPI-WD40 domain in complex with SARS-CoV-2 clientized spike tail heptap… |
Heteromer P41811; | 100 | 8×EDO; | |||
| The complex structure of COPI cargo sorting module with SARS-CoV-2 Spike KxHxx sorting motif |
Heteromer P41811; | 100 | ||||
| Crystal structure of beta'-COPI-WD40 domain Y33A mutant in complex with SARS-CoV-2 clientized spike… |
Heteromer P41811; | 100 | ||||
| Crystal structure of neuropilin-1 b1 domain in complex with SARS-CoV-2 S1 C-end rule (CendR) peptide |
Heteromer O14786; | 100 | 1×PEG; | |||
| Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein | homo-6-mer | 99.04 | 36×NAG; 48×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein | homo-6-mer | 99.04 | 36×NAG; 48×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 1 | homo-6-mer | 99.13 | 66×NAG; 6×NAG; 24×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 2 | homo-6-mer | 99.13 | 66×NAG; 6×NAG; 24×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), dimer of S trimer conformation 3 | homo-6-mer | 99.13 | 66×NAG; 6×NAG; 24×NAG; | |||
| Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers | homo-6-mer | 99.82 | 76×NAG; 2×NAG; 2×NAG; 16×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) spike protein (focused refinement of RBD) | homo-6-mer | 99.25 | 12×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484I spike protein (focused refinement of RBD) | homo-6-mer | 99.25 | 12×NAG; | |||
| Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein (closed-1 state) | homo-5-mer | 90.91 | 15×NAG; 60×NAG; | |||
| Structure of the 2019-nCoV HR2 Domain | homo-4-mer | 100 | ||||
| Structure of coiled-coil tetramer from SARS-CoV-2 spike stalk region | homo-4-mer | 96.3 | 3×EDO; 2×ZN; | |||
| Distinct conformational states of SARS-CoV-2 spike protein | homo-3-mer | 100.0 | 21×NAG; 9×NAG; 3×NAG; 3×NAG; 21×NAG; | |||
| SARS-CoV-2 Mu variant spike(close state) | homo-3-mer | 99.27 | ||||
| SARS-CoV-2 C.1.2 variant spike (Close state) | homo-3-mer | 98.17 | 9×NAG; 21×NAG; 3×NAG; 24×NAG; | |||
| Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | homo-3-mer | 100 | 24×NAG; 3×NAG; 6×NAG; 24×NAG; | |||
| Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | homo-3-mer | 100 | 20×NAG; 3×NAG; 6×NAG; 28×NAG; | |||
| Structural and functional impact by SARS-CoV-2 Omicron spike mutations | homo-3-mer | 98.18 | 9×NAG; 21×NAG; 3×NAG; 21×NAG; | |||
| Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | homo-3-mer | 100 | 20×NAG; 3×NAG; 6×NAG; 28×NAG; | |||
| Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | homo-3-mer | 100 | 16×NAG; 3×NAG; 6×NAG; 32×NAG; | |||
| Acidic Omicron Spike Trimer | homo-3-mer | 98.18 | 14×NAG; 5×NAG; 30×NAG; | |||
| Structural and functional impact by SARS-CoV-2 Omicron spike mutations | homo-3-mer | 98.18 | 11×NAG; 3×NAG; 15×NAG; 25×NAG; | |||
| Closed state of SARS-CoV-2 BA.2 variant spike protein | homo-3-mer | 90.0 | 21×NAG; 6×NAG; 3×NAG; 21×NAG; | |||
| Middle state of SARS-CoV-2 BA.2 variant spike protein | homo-3-mer | 90.0 | 18×NAG; 8×NAG; 3×NAG; 20×NAG; | |||
| Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | homo-3-mer | 98.61 | 19×NAG; 3×NAG; 6×NAG; 29×NAG; | |||
| Closed state of pre-fusion SARS-CoV-2 Kappa variant spike protein | homo-3-mer | 99.46 | 6×NAG; 27×NAG; 3×NAG; 21×NAG; | |||
| Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | homo-3-mer | 98.63 | 9×NAG; 21×NAG; 3×NAG; 24×NAG; | |||
| Structural impact on SARS-CoV-2 spike protein by D614G substitution | homo-3-mer | 99.91 | 30×NAG; 3×NAG; 3×NAG; 21×NAG; | |||
| Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | homo-3-mer | 100 | 20×NAG; 3×NAG; 6×NAG; 28×NAG; | |||
| Neutral Omicron Spike Trimer | homo-3-mer | 97.52 | 16×NAG; 5×NAG; 24×NAG; | |||
| One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein | homo-3-mer | 97.76 | 10×NAG; 16×NAG; 3×NAG; 25×NAG; | |||
| Structural impact on SARS-CoV-2 spike protein by D614G substitution | homo-3-mer | 99.91 | 9×NAG; 21×NAG; 3×NAG; 24×NAG; | |||
| SARS-CoV-2 lambda variant spike | homo-3-mer | 100.0 | 15×NAG; 15×NAG; 1×NAG; 17×NAG; | |||
| Structural impact on SARS-CoV-2 spike protein by D614G substitution | homo-3-mer | 99.91 | 20×NAG; 3×NAG; 6×NAG; 28×NAG; | |||
| SARS-CoV-2 B.1.620 variant spike (close state) | homo-3-mer | 98.18 | 9×NAG; 21×NAG; 3×NAG; 22×NAG; | |||
| SARS-COV-2 BETA VARIANT SPIKE PROTEIN IN TRANSITION STATE | homo-3-mer | 98.64 | ||||
| One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein | homo-3-mer | 99.45 | 19×NAG; 3×NAG; 11×NAG; 24×NAG; | |||
| One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein | homo-3-mer | 99.01 | 19×NAG; 3×NAG; 6×NAG; 29×NAG; | |||
| SARS-CoV-2 C.1.2 variant spike (Open state) | homo-3-mer | 98.11 | ||||
| SARS-CoV-2 B.1.620 variant spike (open state) | homo-3-mer | 99.09 | 19×NAG; 3×NAG; 6×NAG; 26×NAG; | |||
| SARS-CoV-2 Mu variant spike (open state) | homo-3-mer | 99.26 | 20×NAG; 3×NAG; 6×NAG; 28×NAG; | |||
| One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein | homo-3-mer | 97.76 | 10×NAG; 17×NAG; 3×NAG; 24×NAG; | |||
| One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein | homo-3-mer | 99.45 | 19×NAG; 3×NAG; 11×NAG; 24×NAG; | |||
| One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein | homo-3-mer | 99.0 | 17×NAG; 3×NAG; 9×NAG; 28×NAG; | |||
| SARS-CoV-2 Spike protein Beta Variant at 4C structural flexibility / heterogeneity analyses | homo-3-mer | 98.64 | ||||
| SARS-CoV-2 Spike protein Beta Variant at 37C structural flexibility / heterogeneity analyses | homo-3-mer | 98.64 | ||||
| SARS-CoV-2 Beta variant spike protein in open state | homo-3-mer | 98.64 | ||||
| One RBD-up state of SARS-CoV-2 BA.2 variant spike protein | homo-3-mer | 90.0 | 18×NAG; 9×NAG; 3×NAG; 21×NAG; | |||
| Closed state of pre-fusion SARS-CoV-2 Delta variant spike protein | homo-3-mer | 97.76 | 27×NAG; 3×NAG; 3×NAG; 21×NAG; | |||
| BANAL-20-52 Spike trimer | homo-3-mer | 97.9 | 24×NAG; 33×NAG; | |||
| Prototypic SARS-CoV-2 spike (containing K417) in the open conformation | homo-3-mer | 99.45 | 4×NAG; 1×MAN; 21×NAG; | |||
| Prototypic SARS-CoV-2 spike (containing V417) in the open conformation | homo-3-mer | 99.34 | 3×NAG; 15×NAG; 1×MAN; | |||
| Prototypic SARS-CoV-2 G614 spike (open form) | homo-3-mer | 99.72 | 4×NAG; 23×NAG; 1×MAN; | |||
| SARS CoV-2 full-length spike protein with Lys1269Ala and His1271Ala substitutions in the coatomer b… | homo-3-mer | 99.71 | 12×NAG; 5×NAG; 8×NAG; 1×NAG; 1×NAG; 2×NAG; 18×NAG; | |||
| Delta variant of SARS-CoV-2 Spike protein | homo-3-mer | 99.34 | 12×NAG; 35×NAG; | |||
| SARS-CoV-2 Kappa variant spike protein in transition state | homo-3-mer | 99.34 | ||||
| Spike of SARS-CoV-2 spike protein(1 up) | homo-3-mer | 99.34 | 31×NAG; | |||
| Delta Spike Trimer(3 RBD Down) | homo-3-mer | 98.52 | 6×NAG; 39×NAG; | |||
| Delta Spike Trimer(1 RBD Up) | homo-3-mer | 98.52 | 13×NAG; 35×NAG; | |||
| SARS-Cov2 S protein at close state | homo-3-mer | 99.82 | ||||
| SARS-CoV-2 Kappa variant spike protein in open state | homo-3-mer | 99.34 | ||||
| Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain | homo-3-mer | 99.33 | 18×NAG; 24×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Alpha (B.1.1.7) spike protein | homo-3-mer | 98.84 | 18×NAG; 24×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 Omicron spike protein | homo-3-mer | 98.18 | 18×NAG; 22×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 XBB.1.5 spike protein | homo-3-mer | 90.0 | 18×NAG; 20×NAG; | |||
| SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 1 (S-RRAR-Omicron-XBB.1.16) | homo-3-mer | 90.91 | 9×NAG; 27×NAG; | |||
| Double deletion S-2P trimer(1 Up) | homo-3-mer | 98.15 | ||||
| Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein | homo-3-mer | 98.65 | 18×NAG; 24×NAG; | |||
| SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 2 (S-RRAR-Omicron-XBB.1.16) | homo-3-mer | 90.91 | 9×NAG; 26×NAG; | |||
| Double deletion S-2P trimer(3 down) | homo-3-mer | 98.15 | ||||
| SARS-Cov2 S protein at open state | homo-3-mer | 99.81 | ||||
| SARS-CoV-2 Omicron S-open | homo-3-mer | 98.18 | ||||
| Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein | homo-3-mer | 98.36 | 18×NAG; 24×NAG; | |||
| SARS-CoV-2 Omicron S-open-2 | homo-3-mer | 98.18 | ||||
| Omicron B.1.1.529 2 RBD up conformation | homo-3-mer | 98.18 | ||||
| Cryo-EM structure of the SARS-CoV-2 D614G mutant spike protein ectodomain | homo-3-mer | 99.33 | 18×NAG; 24×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,L452R mutant spike protein ectodomain | homo-3-mer | 99.23 | 18×NAG; 24×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein | homo-3-mer | 99.23 | 18×NAG; 24×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,N501Y mutant spike protein ectodomain | homo-3-mer | 99.23 | 18×NAG; 24×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain | homo-3-mer | 99.14 | 18×NAG; 24×NAG; | |||
| SARS-CoV-2 spike glycoprotein trimer in closed state | homo-3-mer | 100.0 | 15×NAG; 33×NAG; 3×EIC; 3×BLR; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417N mutant spike protein ectodomain | homo-3-mer | 99.04 | 18×NAG; 24×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain | homo-3-mer | 99.04 | 18×NAG; 24×NAG; | |||
| SARS-CoV-2 BA-2.87.1 Spike ectodomain | homo-3-mer | 100 | 9×NAG; 39×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Delta (B.1.617.2) spike protein | homo-3-mer | 98.41 | 18×NAG; 20×NAG; | |||
| Locked Wuhan SARS-CoV2 Prefusion Spike ectodomain with lipid bound | homo-3-mer | 99.54 | 15×NAG; 36×NAG; 3×STE; | |||
| SARS-CoV-2 S trimer, S-closed | homo-3-mer | 99.82 | 24×NAG; 30×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Kappa (B.1.617.1) Q484A spike protein | homo-3-mer | 99.04 | 18×NAG; 20×NAG; | |||
| Transition state of SARS-CoV-2 Delta variant spike protein | homo-3-mer | 99.25 | ||||
| SARS-CoV-2 (D614G) Spike trimer | homo-3-mer | 99.72 | 34×NAG; | |||
| Spike/Nb2 complex with 1 RBD up | homo-3-mer | 99.35 | 11×NAG; 23×NAG; | |||
| SARS-CoV-2 S trimer, S-open | homo-3-mer | 99.81 | ||||
| SARS-CoV-2 Omicron S-open | homo-3-mer | 98.18 | ||||
| Open state of SARS-CoV-2 Delta variant spike protein | homo-3-mer | 99.25 | ||||
| SARS-CoV-2-6P-Mut7 S protein (asymmetric) | homo-3-mer | 99.28 | 14×NAG; 34×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein | homo-3-mer | 90.0 | 18×NAG; 19×NAG; | |||
| SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer consensus (S-RRAR-Omicron-XBB.1.16) | homo-3-mer | 90.0 | 9×NAG; 28×NAG; | |||
| SARS-CoV-2 Omicron S-close | homo-3-mer | 98.18 | ||||
| Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate | homo-3-mer | 100.0 | 39×NAG; 15×NAG; 3×ELA; 3×VCG; | |||
| SARS-CoV-2-6P-Mut7 S protein (C3 symmetry) | homo-3-mer | 99.27 | 12×NAG; 30×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate | homo-3-mer | 100.0 | 32×NAG; 19×NAG; 3×ELA; | |||
| Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, one RBD-up conformation | homo-3-mer | 98.45 | 31×NAG; 15×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), all RBD-down conformation | homo-3-mer | 99.13 | 34×NAG; 14×NAG; | |||
| Structure of the SARS-CoV-2 A372T spike glycoprotein (open) | homo-3-mer | 99.7 | 35×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 1 | homo-3-mer | 99.13 | 34×NAG; 14×NAG; | |||
| Structure of the SARS-CoV-2 A372T spike glycoprotein (closed) | homo-3-mer | 99.71 | 27×NAG; 24×NAG; | |||
| Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformation | homo-3-mer | 99.82 | 30×NAG; 21×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), one RBD-up conformation 2 | homo-3-mer | 99.13 | 36×NAG; 12×NAG; | |||
| SARS-CoV-2 BA.1 S-6P-no-RBD | homo-3-mer | 98.18 | 12×NAG; 15×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Kappa variant (B.1.617.1), two RBD-up conformation | homo-3-mer | 99.13 | 33×NAG; 15×NAG; | |||
| Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect | homo-3-mer | 99.81 | ||||
| Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation | homo-3-mer | 99.77 | ||||
| Structure of the SARS-CoV spike glycoprotein in complex with a biparatopic Bicycle molecule | homo-3-mer | 99.46 | 24×NAG; 25×NAG; 3×STE; 3×R06; 3×KZ0; | |||
| SARS-CoV-2-6P-Mut2 S protein | homo-3-mer | 99.28 | 18×NAG; 30×NAG; | |||
| Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformation | homo-3-mer | 99.82 | 27×NAG; 24×NAG; | |||
| Structure of SARS-CoV-2 3Q-2P full-length prefusion spike trimer (C3 symmetry) | homo-3-mer | 99.82 | 45×NAG; 3×NAG; 3×VCG; 3×EIC; | |||
| SARS-CoV-2 Delta variant spike protein | homo-3-mer | 98.15 | ||||
| Prototypic SARS-CoV-2 spike (containing K417) in the closed conformation | homo-3-mer | 99.45 | 7×NAG; 19×NAG; | |||
| Closed conformation of D614G SARS-CoV-2 spike protein | homo-3-mer | 99.72 | 15×NAG; 33×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), all RBD-down conformation | homo-3-mer | 97.5 | 1×NAG; 35×NAG; 12×NAG; | |||
| Open conformation of D614G SARS-CoV-2 spike with 1 Erect RBD | homo-3-mer | 99.72 | 7×NAG; 1×NAG; 33×NAG; | |||
| Prototypic SARS-CoV-2 spike (containing V417) in the closed conformation | homo-3-mer | 99.35 | 5×NAG; 19×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 1 | homo-3-mer | 97.5 | 35×NAG; 13×NAG; | |||
| Open conformation of D614G SARS-CoV-2 spike with 2 Erect RBDs | homo-3-mer | 99.72 | 1×NAG; 31×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 2 | homo-3-mer | 97.5 | 36×NAG; 12×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 3 | homo-3-mer | 97.5 | 36×NAG; 12×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 4 | homo-3-mer | 97.5 | 36×NAG; 12×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), one RBD-up conformation 5 | homo-3-mer | 97.5 | 33×NAG; 15×NAG; | |||
| Cryo-EM structure of apo SARS-CoV-2 Omicron spike protein (S-2P-GSAS) | homo-3-mer | 98.15 | 16×NAG; 21×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 1 | homo-3-mer | 97.5 | 35×NAG; 13×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 2 | homo-3-mer | 97.5 | 35×NAG; 13×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Delta variant (B.1.617.2), two RBD-up conformation 3 | homo-3-mer | 97.5 | 36×NAG; 12×NAG; | |||
| Omicron spike at 3.0 A (open form) | homo-3-mer | 98.18 | 12×NAG; 21×NAG; | |||
| Prototypic SARS-CoV-2 G614 spike (closed form) | homo-3-mer | 99.72 | 9×NAG; 24×NAG; | |||
| S protein of SARS-CoV-2 in the locked conformation | homo-3-mer | 99.82 | 11×NAG; 59×NAG; 3×EIC; | |||
| SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect | homo-3-mer | 99.81 | ||||
| Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), uncleavable form, two RBD-up conformation | homo-3-mer | 98.45 | 30×NAG; 17×NAG; | |||
| Mink Variant SARS-CoV-2 Spike in Closed conformation | homo-3-mer | 100 | 6×NAG; 3×NAG; 39×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 1 | homo-3-mer | 98.75 | 34×NAG; 1×NAG; 19×NAG; | |||
| Mink Variant SARS-CoV-2 Spike with 2 Erect RBDs | homo-3-mer | 100 | 4×NAG; 30×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), one RBD-up conformation 2 | homo-3-mer | 98.75 | 33×NAG; 1×NAG; 20×NAG; | |||
| Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation) | homo-3-mer | 99.82 | 30×NAG; 3×BLA; 24×NAG; | |||
| Structure of Covid Spike variant deltaN25 with one erect RBD | homo-3-mer | 100 | 38×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-Gamma variant (P.1), two RBD-up conformation | homo-3-mer | 98.75 | 1×NAG; 31×NAG; 21×NAG; | |||
| Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect) | homo-3-mer | 99.82 | 25×NAG; 3×BLA; 27×NAG; | |||
| Mink Variant SARS-CoV-2 Spike with 1 Erect RBD | homo-3-mer | 100 | 8×NAG; 26×NAG; | |||
| SARS-CoV-2 spike protein in complex with sybody no68 in a 1up/2down conformation | homo-3-mer | 99.53 | ||||
| Cryo-EM structure of SARS-CoV-2 S-Beta variant (B.1.351), Cleavable form, one RBD-up conformation | homo-3-mer | 98.45 | 29×NAG; 17×NAG; | |||
| SARS-CoV-2 Delta variant spike protein | homo-3-mer | 98.15 | ||||
| Structure of the SARS-CoV spike glycoprotein in complex with a homotrimeric Bicycle molecule | homo-3-mer | 99.45 | 9×NAG; 21×NAG; 3×STE; 3×KZ0; | |||
| SARS-CoV-2 spike glycoprotein trimer in closed state after treatment with Cathepsin L | homo-3-mer | 100.0 | 15×NAG; 27×NAG; 3×BLR; | |||
| Cryo-EM structure of the spike of SARS-CoV-2 Omicron variant of concern | homo-3-mer | 98.18 | 15×NAG; 29×NAG; | |||
| SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations… | homo-3-mer | 100 | 10×NAG; 30×NAG; | |||
| SARS-CoV-2 Omicron-BA.2 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations… | homo-3-mer | 100 | 4×NAG; 28×NAG; | |||
| SARS-CoV-2 S protein S:A222V + S:D614G mutant 1-up | homo-3-mer | 99.69 | 10×NAG; 1×NDG; 25×NAG; | |||
| SARS-CoV-2 S-protein:D614G mutant in 1-up conformation | homo-3-mer | 99.84 | 10×NAG; 24×NAG; | |||
| SARS-CoV-2 S protein S:D614G mutant 1-up | homo-3-mer | 99.84 | 10×NAG; 24×NAG; | |||
| SARS-CoV-2 S protein S:D614G mutant in 3-down with binding site of an entry inhibitor | homo-3-mer | 99.84 | 10×NAG; 24×NAG; 3×NA; 1×XIO; | |||
| Cryo-EM structure of S glycoprotein encoded by the Covid-19 mRNA vaccine candidate RQ3013 (Prefusio… | homo-3-mer | 100 | 12×NAG; 21×NAG; | |||
| Structure of the Ancestral Scaffold Antigen-6 of Coronavirus Spike protein | homo-3-mer | 60.42 | 9×NAG; 45×NAG; | |||
| Alpha Variant SARS-CoV-2 Spike with 2 Erect RBDs | homo-3-mer | 100.0 | 3×NAG; 37×NAG; | |||
| SARS-CoV-2 Omicron Variant SPIKE trimer, all RBDs down | homo-3-mer | 100.0 | 7×NAG; 14×NAG; | |||
| Structure of the Ancestral Scaffold Antigen-5 of Coronavirus Spike protein | homo-3-mer | 51.79 | 9×NAG; 39×NAG; | |||
| SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer 1 (S-GSAS-Omicron-EG.5) | homo-3-mer | 100 | 6×NAG; 29×NAG; | |||
| SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-XBB.1.16) | homo-3-mer | 100 | 9×NAG; 29×NAG; | |||
| SARS-CoV-2 Omicron BA.2.13 variant spike | homo-3-mer | 100 | 15×NAG; 27×NAG; | |||
| SARS-CoV-2 Omicron BA.2.12.1 variant spike | homo-3-mer | 100 | 18×NAG; 30×NAG; | |||
| SARS-CoV-2 Omicron BA.2 variant spike (state 2) | homo-3-mer | 100 | 18×NAG; 30×NAG; | |||
| SARS-CoV-2 S Omicron Spike B.1.1.529 | homo-3-mer | 98.0 | 1×NAG; 3×NAG; 18×NAG; 1×NAG; 14×NAG; | |||
| SARS-CoV-2 Omicron BA.2 variant spike (state 1) | homo-3-mer | 100 | 13×NAG; 30×NAG; | |||
| SARS-CoV-2 XBB 1.0 closed conformation. | homo-3-mer | 80.0 | 36×NAG; | |||
| SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-XBB.1.5) | homo-3-mer | 100 | 6×NAG; 25×NAG; | |||
| SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 4 (S-GSAS-Omicron-XBB.1.5) | homo-3-mer | 100 | 6×NAG; 27×NAG; | |||
| Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg… | homo-3-mer | 99.84 | 15×NAG; 39×NAG; 3×BLA; 3×EIC; | |||
| Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg… | homo-3-mer | 99.85 | 14×NAG; 38×NAG; 3×EIC; 3×BLA; | |||
| Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Lock… | homo-3-mer | 99.82 | 15×NAG; 3×BLA; 39×NAG; 3×EIC; | |||
| Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg… | homo-3-mer | 99.85 | 13×NAG; 37×NAG; 3×BLA; 3×EIC; | |||
| SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.5) | homo-3-mer | 100 | 27×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: B.1 variant 1 open RBD | homo-3-mer | 99.81 | 26×NAG; 3×NAG; 19×NAG; | |||
| SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-EG.5) | homo-3-mer | 100 | 6×NAG; 29×NAG; | |||
| SARS-CoV-2 Omicron-XBB.1.16 3-RBD-down Spike Protein Trimer 3 (S-RRAR-Omicron-XBB.1.16) | homo-3-mer | 100 | 9×NAG; 27×NAG; | |||
| SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer 1 (S-GSAS-Omicron-XBB.1.16) | homo-3-mer | 100 | 9×NAG; 30×NAG; | |||
| SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-XBB.1.16) | homo-3-mer | 100 | 6×NAG; 30×NAG; | |||
| SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 1 (S-GSAS-Omicron-XBB.1.5) | homo-3-mer | 100 | 3×NAG; 30×NAG; | |||
| SARS-CoV-2 Omicron-XBB.1.16 3-RBD down Spike Protein Trimer consensus (S-GSAS-Omicron-XBB.1.16) | homo-3-mer | 100 | 9×NAG; 30×NAG; | |||
| SARS-CoV-2 Omicron-XBB.1.5 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-XBB.1.5) | homo-3-mer | 100 | 27×NAG; | |||
| SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-EG.5) | homo-3-mer | 100 | 6×NAG; 29×NAG; | |||
| SARS-CoV-2 Omicron-EG.5 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-EG.5) | homo-3-mer | 100 | 29×NAG; | |||
| SARS-CoV-2 Omicron-EG.5.1 3-RBD down Spike Protein Trimer 1 (S-GSAS-Omicron-EG.5.1) | homo-3-mer | 100 | 30×NAG; | |||
| SARS-CoV-2 Omicron-EG.5.1 3-RBD down Spike Protein Trimer 2 (S-GSAS-Omicron-EG.5.1) | homo-3-mer | 100 | 30×NAG; | |||
| SARS-CoV-2 Omicron-EG.5.1 3-RBD down Spike Protein Trimer 3 (S-GSAS-Omicron-EG.5.1) | homo-3-mer | 100 | 30×NAG; | |||
| Beta Variant SARS-CoV-2 Spike with 1 Erect RBD | homo-3-mer | 99.45 | 6×NAG; 28×NAG; | |||
| Sarbecovirus BANAL-20-52 Spike Trimer in a Locked Conformation | homo-3-mer | 97.86 | 21×NAG; 33×NAG; 3×BLA; 3×EIC; | |||
| Sarbecovirus BANAL-20-236 Spike Trimer in a Locked Conformation | homo-3-mer | 56.36 | 6×NAG; 48×NAG; | |||
| Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and sing… | homo-3-mer | 99.7 | 12×NAG; 39×NAG; 3×BLA; 3×EIC; | |||
| Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg… | homo-3-mer | 99.85 | 12×NAG; 36×NAG; 3×BLA; 3×EIC; | |||
| Structure of the SARS-CoV-2 BA.2.75 spike glycoprotein (closed state 1) | homo-3-mer | 90.0 | 5×NAG; 31×NAG; | |||
| SARS-CoV-2 Spike with ethylbenzamide-tri-iodo Siallyllactose, C3 symmetry | homo-3-mer | 100.0 | 9×NAG; 3×NAG; 36×NAG; 3×GE9; 3×SIA; 3×EIC; | |||
| SARS-CoV-2 Spike, C3 symmetry | homo-3-mer | 100.0 | 9×NAG; 3×NAG; 36×NAG; 3×EIC; | |||
| Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383… | homo-3-mer | 99.84 | 12×NAG; 39×NAG; 3×BLA; | |||
| Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (RBDs down) | homo-3-mer | 99.8 | 12×NAG; 36×NAG; | |||
| SARS CoV-2 full-length spike protein with Lys1269Ala and His1271Ala substitutions in the coatomer b… | homo-3-mer | 99.71 | 12×NAG; 16×NAG; 1×NAG; 1×NAG; 2×NAG; 1×NAG; 18×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Delta variant spike proteins on intact virions: 3 Closed RBD | homo-3-mer | 99.61 | 15×NAG; 33×NAG; | |||
| BA.2.86 Spike Trimer in complex with heparan sulfate | homo-3-mer | 75.0 | 1×NAG; 13×NAG; 34×NAG; 1×IDU; | |||
| JN.1 Spike Trimer in complex with heparan sulfate | homo-3-mer | 75.0 | 54×NAG; 1×IDU; | |||
| Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs | homo-3-mer | 99.9 | 15×NAG; 33×NAG; | |||
| SARS CoV-2 Spike protein, Closed conformation, C1 symmetry | homo-3-mer | 100.0 | 1×NAG; 25×NAG; 3×EIC; | |||
| SARS CoV-2 Spike protein, Closed conformation, C3 symmetry | homo-3-mer | 100.0 | 3×NAG; 20×NAG; 3×EIC; | |||
| Gaussian mixture model based single particle refinement - SARS (SARS-CoV-2 Spike Proteins on intact… | homo-3-mer | 99.9 | 15×NAG; 33×NAG; | |||
| Structure of SARS-CoV-2 full-length WT spike protein with internal tag, 2RBD-up conformation (SPIKE… | homo-3-mer | 99.71 | 11×NAG; 7×NAG; 7×NAG; 2×NAG; 2×NAG; 2×NAG; 1×NAG; 1×NAG; 1×NAG; 15×NAG; | |||
| SARS-CoV-2 full-length spike protein with His1271Lys substitution in the coatomer binding motif, 1R… | homo-3-mer | 99.71 | 10×NAG; 12×NAG; 2×NAG; 1×NAG; 2×NAG; 3×NAG; 2×NAG; 1×NAG; 17×NAG; | |||
| Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg… | homo-3-mer | 99.84 | 12×NAG; 39×NAG; 3×BLA; | |||
| Structure of the SARS-CoV-2 EG.5.1 spike glycoprotein (closed-2 state) | homo-3-mer | 87.5 | 33×NAG; | |||
| SARS CoV-2 Spike protein Ectodomain with internal tag, all RBD-down conformation -C1 | homo-3-mer | 99.72 | 3×NAG; 9×NAG; 11×NAG; 1×NAG; 15×NAG; | |||
| Cryo-EM structure of CX1 spike protein (6P) | homo-3-mer | 97.63 | 5×NAG; 39×NAG; | |||
| Structure of the SARS-CoV-2 XBB.1 spike glycoprotein (closed-1 state) | homo-3-mer | 87.5 | 9×NAG; 36×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike protein Ecto-domain with internal tag, 1UP RBD conformation | homo-3-mer | 99.71 | 6×NAG; 8×NAG; 3×NAG; 5×NAG; 24×NAG; | |||
| Structure of the SARS-CoV-2 XBB.1 spike glycoprotein (closed-2 state) | homo-3-mer | 87.5 | 6×NAG; 36×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron EG.5.1 spike protein(6P), RBD-closed state | homo-3-mer | 83.33 | 27×NAG; | |||
| SARS CoV-2 Spike protein Ectodomain with internal tag, 1RBD-up conformation | homo-3-mer | 99.71 | 1×NAG; 10×NAG; 14×NAG; 1×NAG; 1×NAG; 18×NAG; | |||
| SARS CoV-2 Spike protein Ectodomain with internal tag, all RBD-down conformation | homo-3-mer | 99.72 | 3×NAG; 5×NAG; 12×NAG; 5×NAG; 17×NAG; | |||
| SARS-CoV-2 spike protein in one-RBD weak state after CTSL-treatment | homo-3-mer | 99.81 | ||||
| SARS-CoV-2 spike protein in two-RBD weak state after CTSL-treatment | homo-3-mer | 99.77 | ||||
| SARS-CoV-2 spike protein in one-RBD open state | homo-3-mer | 99.81 | ||||
| Cryo-EM structure of bat RaTG13 spike glycoprotein | homo-3-mer | 95.95 | 9×NAG; 36×NAG; | |||
| SARS-CoV-2 S (Spike Glycoprotein) D614G with One(1) RBD Up | homo-3-mer | 99.71 | 3×NAG; 45×NAG; | |||
| SARS-CoV-2 Omicron Spike trimer | homo-3-mer | 97.78 | 28×NAG; | |||
| SARS CoV-2 full-length WT spike protein, 1RBD-up conformation (SPIKE-WT) | homo-3-mer | 99.71 | 7×NAG; 12×NAG; 8×NAG; 3×NAG; 1×NAG; 1×NAG; 1×NAG; 1×NAG; 1×NAG; 16×NAG; | |||
| SARS-CoV-2 full-length spike protein with His1271Lys substitution in the coatomer binding motif, 2R… | homo-3-mer | 99.71 | 9×NAG; 11×NAG; 2×NAG; 5×NAG; 1×NAG; 1×NAG; 21×NAG; | |||
| Structure of Covid Spike variant deltaN135 with one erect RBD | homo-3-mer | 100.0 | 48×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Alpha (B.1.1.7) variant 3 closed … | homo-3-mer | 100.0 | 27×NAG; 3×NAG; 18×NAG; 1×ZN; | |||
| SARS-CoV-2 BA.2.75 Spike with K356T mutation (3 RBD down) | homo-3-mer | 100 | 21×NAG; 21×NAG; | |||
| SARS-CoV-2 BA.2.75 Spike with K356T mutation (1 RBD up) | homo-3-mer | 100 | 21×NAG; 21×NAG; | |||
| SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up) | homo-3-mer | 100 | 9×NAG; 45×NAG; | |||
| pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up) | homo-3-mer | 100 | 9×NAG; 45×NAG; | |||
| Prefusion-stabilized SARS-CoV-2 spike protein | homo-3-mer | 98.85 | ||||
| Alpha Variant SARS-CoV-2 Spike in Closed conformation | homo-3-mer | 100 | 9×NAG; 39×NAG; | |||
| Structure of Covid Spike variant deltaN135 in fully closed form | homo-3-mer | 100.0 | 48×NAG; | |||
| Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody | homo-3-mer | 99.22 | 15×NAG; 30×NAG; | |||
| SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down) | homo-3-mer | 100 | 6×NAG; 36×NAG; | |||
| SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down) | homo-3-mer | 100 | 6×NAG; 9×NAG; 33×NAG; | |||
| BA.2.86 Spike Trimer with T356K mutation (1 RBD up) | homo-3-mer | 86.96 | 15×NAG; 30×NAG; | |||
| SARS-CoV-2 JN.1 Spike | homo-3-mer | 86.96 | 18×NAG; 30×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Delta (B.1.617.2) variant 3 close… | homo-3-mer | 98.11 | 21×NAG; 3×NAG; 24×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike protein Ecto-domain with internal tag, 1RBD UP, State-2 | homo-3-mer | 99.69 | 10×NAG; 8×NAG; 15×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Mu (B.1.621) variant 3 closed RBDs | homo-3-mer | 99.31 | 27×NAG; 3×NAG; 18×NAG; | |||
| Cryo-EM structure of prefusion SARS-CoV-2 spike omicron B.1.1.529 variant | homo-3-mer | 97.67 | 38×NAG; | |||
| SARS-CoV-2 Omicron BA.4 variant spike | homo-3-mer | 100 | 18×NAG; 33×NAG; | |||
| SARS-CoV-2 spike glycoprotein trimer in Intermediate state | homo-3-mer | 100.0 | 8×NAG; 15×NAG; | |||
| SARS-CoV-2 Omicron BA.3 variant spike | homo-3-mer | 97.5 | 12×NAG; 23×NAG; | |||
| BA.2.86 Spike Trimer with ins483V mutation (3 RBD down) | homo-3-mer | 86.96 | 18×NAG; 30×NAG; | |||
| Cryo-EM Structure of Full-Length Spike Protein of Omicron XBB.1.5 | homo-3-mer | 100 | 3×NAG; 19×NAG; | |||
| Beta Variant SARS-CoV-2 Spike with 2 Erect RBDs | homo-3-mer | 99.42 | 1×NAG; 20×NAG; | |||
| BA.2.86 Spike Trimer with ins483V mutation (1 RBD up) | homo-3-mer | 86.96 | 17×NAG; 31×NAG; | |||
| SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up closed conformation) | homo-3-mer | 99.8 | 16×NAG; 4×NAG; 7×NAG; 18×NAG; 2×MAN; 3×DMS; | |||
| Alpha Variant SARS-CoV-2 Spike with 1 Erect RBD | homo-3-mer | 100.0 | 7×NAG; 1×NAG; 33×NAG; | |||
| SARS-CoV-2 spike in prefusion state (flexibility analysis, 1-up open conformation) | homo-3-mer | 99.8 | 16×NAG; 4×NAG; 7×NAG; 18×NAG; 2×MAN; 3×DMS; | |||
| BA.2.86 Spike Trimer with T356K mutation (3 RBD down) | homo-3-mer | 86.96 | 15×NAG; 30×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: B.1 variant 3 closed RBDs | homo-3-mer | 99.8 | 27×NAG; 3×NAG; 18×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Sub… | homo-3-mer | 99.03 | 12×NAG; 34×NAG; | |||
| Structure of SARS-CoV-2 Spike Protein Trimer (single Arg S1/S2 cleavage site) in Closed State | homo-3-mer | 100.0 | 12×NAG; 36×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; S… | homo-3-mer | 99.06 | 14×NAG; 33×NAG; | |||
| Cryo-EM structure of a biotinylated SARS-CoV-2 spike probe in the prefusion state (1 RBD up) | homo-3-mer | 99.8 | 12×NAG; 35×NAG; | |||
| Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformat… | homo-3-mer | 99.18 | ||||
| SARS-CoV-2 Omicron 1-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-G… | homo-3-mer | 97.62 | 9×NAG; 22×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Sub… | homo-3-mer | 99.03 | 12×NAG; 34×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 1 | homo-3-mer | 100.0 | 32×NAG; 1×NAG; 15×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Sub… | homo-3-mer | 99.03 | 12×NAG; 34×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Alpha (B.1.1.7) variant 1 open RBD | homo-3-mer | 100 | 26×NAG; 3×NAG; 18×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 2 | homo-3-mer | 100.0 | 29×NAG; 1×NAG; 18×NAG; | |||
| SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) | homo-3-mer | 100.0 | 15×NAG; 33×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: Gamma (P.1) variant 3 closed RBDs | homo-3-mer | 99.29 | 27×NAG; 3×NAG; 18×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 3 | homo-3-mer | 100.0 | 29×NAG; 1×NAG; 16×NAG; | |||
| SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS) | homo-3-mer | 100.0 | 58×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 2-RBD-up conformation - D3 | homo-3-mer | 100.0 | 8×NAG; 36×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), two RBD-up conformation | homo-3-mer | 100.0 | 31×NAG; 16×NAG; | |||
| SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabi… | homo-3-mer | 99.9 | 15×NAG; 33×NAG; | |||
| SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSA… | homo-3-mer | 97.62 | 11×NAG; 8×NAG; 14×NAG; 15×NAG; | |||
| SARS-CoV-2 u1S2q All Down RBD State Spike Protein Trimer - asymmetric refinement | homo-3-mer | 99.38 | ||||
| Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformat… | homo-3-mer | 100 | 30×NAG; | |||
| SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabili… | homo-3-mer | 99.79 | 12×NAG; 35×NAG; | |||
| Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformat… | homo-3-mer | 100 | 30×NAG; | |||
| Cryo-EM structure of Brazil (P.1) SARS-CoV-2 spike glycoprotein variant in the prefusion state (1 R… | homo-3-mer | 99.02 | 11×NAG; 29×NAG; | |||
| SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSA… | homo-3-mer | 99.9 | 15×NAG; 33×NAG; | |||
| S1-S2 deletion S-2P trimer(3 down) | homo-3-mer | 100.0 | ||||
| Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformat… | homo-3-mer | 100 | 30×NAG; | |||
| South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 2-RBD-up conformat… | homo-3-mer | 99.4 | 25×NAG; | |||
| SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-… | homo-3-mer | 99.9 | 12×NAG; 35×NAG; | |||
| Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformat… | homo-3-mer | 100 | 30×NAG; | |||
| South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformat… | homo-3-mer | 99.3 | 28×NAG; | |||
| Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation | homo-3-mer | 100 | 3×NAG; 31×NAG; | |||
| South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the RBD-down conformat… | homo-3-mer | 99.3 | 33×NAG; | |||
| Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and… | homo-3-mer | 99.58 | 3×NAG; 15×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike trimer S2D14 in the 3-RBD Down conformation | homo-3-mer | 97.69 | 18×NAG; 15×NAG; 15×NAG; | |||
| Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation | homo-3-mer | 100 | 5×NAG; 27×NAG; | |||
| South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformat… | homo-3-mer | 99.4 | 38×NAG; | |||
| Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation | homo-3-mer | 100 | 3×NAG; 30×NAG; | |||
| South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformat… | homo-3-mer | 99.4 | 40×NAG; | |||
| Characterization of the SARS-CoV-2 S Protein: Biophysical, Biochemical, Structural, and Antigenic A… | homo-3-mer | 99.8 | 12×NAG; 33×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike trimer S2D14 with two RBDs in the open conformation | homo-3-mer | 97.72 | 9×NAG; 3×NAG; 3×NAG; 24×NAG; | |||
| Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 2-RBD up conformation | homo-3-mer | 100.0 | 31×NAG; | |||
| South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformat… | homo-3-mer | 99.4 | 28×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike trimer S2D14 with two RBDs exposed | homo-3-mer | 97.73 | 11×NAG; 4×NAG; 32×NAG; | |||
| South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformat… | homo-3-mer | 99.4 | 38×NAG; | |||
| UK (B.1.1.7) SARS-CoV-2 S-GSAS-D614G variant spike protein in the 3-RBD-down conformation | homo-3-mer | 100 | 18×NAG; 27×NAG; | |||
| SARS-CoV-2 B.1.1.7 Spike Glycoprotein trimer | homo-3-mer | 100 | 9×NAG; 23×NAG; | |||
| UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation | homo-3-mer | 100 | 9×NAG; 30×NAG; | |||
| Structure of SARS-CoV-2 spike at pH 4.0 | homo-3-mer | 99.81 | 15×NAG; 32×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; c… | homo-3-mer | 99.06 | 14×NAG; 33×NAG; | |||
| UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation | homo-3-mer | 100 | 35×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; con… | homo-3-mer | 99.03 | 12×NAG; 34×NAG; | |||
| UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation | homo-3-mer | 100 | 34×NAG; | |||
| Apo spike protein from SARS-CoV2 | homo-3-mer | 99.47 | ||||
| Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 1-RBD-up conformation (S-GSAS-D61… | homo-3-mer | 99.6 | 12×NAG; 26×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; S… | homo-3-mer | 99.06 | 14×NAG; 33×NAG; | |||
| Structure of the SARS-CoV-2 spike glycoprotein (closed state) | homo-3-mer | 99.79 | 15×NAG; 33×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; S… | homo-3-mer | 99.06 | 14×NAG; 33×NAG; | |||
| Structure of SARS-CoV-2 spike at pH 4.5 | homo-3-mer | 99.81 | 17×NAG; 30×NAG; | |||
| Structure of formaldehyde cross-linked SARS-CoV-2 S glycoprotein | homo-3-mer | 99.79 | 15×NAG; 33×NAG; | |||
| SARS-CoV-2 spike glycoprotein trimer in open state | homo-3-mer | 100.0 | 5×NAG; 15×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; S… | homo-3-mer | 99.06 | 14×NAG; 32×NAG; | |||
| SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSA… | homo-3-mer | 99.9 | 15×NAG; 33×NAG; | |||
| SARS-CoV-2 spike protein in closed state | homo-3-mer | 99.8 | ||||
| SARS-CoV-2 Spike H655Y variant, One RBD Open | homo-3-mer | 99.63 | ||||
| Structure of SARS-CoV-2 spike at pH 5.5, all RBDs down | homo-3-mer | 99.81 | 16×NAG; 26×NAG; | |||
| SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSA… | homo-3-mer | 99.9 | 15×NAG; 33×NAG; | |||
| Structure of the prefusion SARS-CoV-2 spike glycoprotein | homo-3-mer | 99.8 | 11×NAG; 27×NAG; | |||
| Cryo-EM structure of the Sars-Cov2 S trimer without RBDs | homo-3-mer | 100.0 | ||||
| Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 1 | homo-3-mer | 99.81 | 17×NAG; 26×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Sub… | homo-3-mer | 99.03 | 12×NAG; 34×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; S… | homo-3-mer | 99.06 | 14×NAG; 33×NAG; | |||
| Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and… | homo-3-mer | 99.58 | 10×NAG; 10×NAG; | |||
| SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSA… | homo-3-mer | 99.9 | 15×NAG; 33×NAG; | |||
| Cryo-EM structure of the SARS-CoV-2 spike glycoprotein in complex with all-trans retinoic acid | homo-3-mer | 99.79 | 27×NAG; 3×REA; | |||
| Structure of SARS-CoV-2 spike at pH 5.5, single RBD up, conformation 2 | homo-3-mer | 99.81 | 18×NAG; 25×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 spike protein Ecto-domain with internal tag, All RBD down conformat… | homo-3-mer | 99.69 | 10×NAG; 4×NAG; 33×NAG; | |||
| SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-G… | homo-3-mer | 97.62 | 4×NAG; 1×NAG; 26×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 3-RBD-down conformation; S… | homo-3-mer | 99.06 | 14×NAG; 33×NAG; | |||
| SARS-CoV-2 Spike Glycoprotein, prefusion with one RBD up conformation | homo-3-mer | 99.79 | 12×NAG; 35×NAG; | |||
| Consensus structure of SARS-CoV-2 spike at pH 5.5 | homo-3-mer | 99.81 | 14×NAG; 28×NAG; | |||
| SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSA… | homo-3-mer | 99.9 | 15×NAG; 33×NAG; | |||
| SARS-CoV-2 Omicron 3-RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-G… | homo-3-mer | 97.62 | 6×NAG; 3×NAG; 4×NAG; 3×NAG; 25×NAG; | |||
| SARS-CoV-2 rS2d Down State Spike Protein Trimer | homo-3-mer | 99.59 | ||||
| SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-… | homo-3-mer | 99.9 | 12×NAG; 35×NAG; | |||
| SARS-CoV-2 Omicron 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSA… | homo-3-mer | 97.62 | 15×NAG; 2×NAG; 1×NAG; 21×NAG; | |||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Sub… | homo-3-mer | 99.03 | 12×NAG; 34×NAG; | |||
| SARS-CoV-2 u1S2q 1-RBD Up Spike Protein Trimer | homo-3-mer | 99.38 | ||||
| SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-… | homo-3-mer | 99.9 | 12×NAG; 34×NAG; | |||
| Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 1 | homo-3-mer | 99.59 | ||||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Sub… | homo-3-mer | 99.03 | 12×NAG; 34×NAG; | |||
| Triple mutant (K417N-E484K-N501Y) SARS-CoV-2 spike protein in the 3-RBD-Down conformation (S-GSAS-D… | homo-3-mer | 99.6 | ||||
| SARS-CoV-2 u1S2q 2-RBD Up Spike Protein Trimer | homo-3-mer | 99.38 | ||||
| SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D… | homo-3-mer | 99.9 | 12×NAG; 35×NAG; | |||
| Down-state locked rS2d SARS-CoV-2 spike ectodomain in the RBD-down conformation, State 2 | homo-3-mer | 99.59 | ||||
| SARS-CoV-2 spike ectodomain structure (open state) | homo-3-mer | 99.69 | 12×NAG; 35×NAG; | |||
| SARS-CoV-2 u1S2q All Down RBD State Spike Protein Trimer | homo-3-mer | 99.38 | ||||
| SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-… | homo-3-mer | 99.9 | 12×NAG; 33×NAG; | |||
| Down-state locked, S2 stabilized rS2d-HexaPro SARS-CoV-2 spike ectodomain in the RBD-down conformat… | homo-3-mer | 99.18 | ||||
| Delta (B.1.617.2) SARS-CoV-2 variant spike protein (S-GSAS-Delta) in the 1-RBD-up conformation; Sub… | homo-3-mer | 99.03 | 12×NAG; 34×NAG; | |||
| VAS5 Spike (3 RBD down) | homo-3-mer | 100.0 | 14×NAG; 29×NAG; | |||
| Cryo-EM structure of protein encoded by vaccine candidate BNT162b2 | homo-3-mer | 99.79 | ||||
| SARS-CoV-2 HexaPro S One RBD up | homo-3-mer | 99.38 | 11×NAG; 28×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1 | homo-3-mer | 99.7 | 2×NAG; 30×NAG; 16×NAG; | |||
| S protein of SARS-CoV-2 in the active conformation | homo-3-mer | 99.8 | 22×NAG; 27×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 3 | homo-3-mer | 99.7 | 1×NAG; 29×NAG; 18×NAG; | |||
| Trypsin-digested S protein of SARS-CoV-2 | homo-3-mer | 99.79 | 22×NAG; 27×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 1 | homo-3-mer | 99.7 | 1×NAG; 28×NAG; 16×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 2 | homo-3-mer | 99.7 | 3×NAG; 26×NAG; 19×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike D614G variant, two RBD-up conformation 2 | homo-3-mer | 99.71 | 27×NAG; 20×NAG; | |||
| S protein of SARS-CoV-2 D614G mutant | homo-3-mer | 99.69 | 22×NAG; 27×NAG; | |||
| Trypsin-digested S protein of SARS-CoV-2 D614G mutant | homo-3-mer | 99.69 | 22×NAG; 27×NAG; | |||
| CryoEM structure of del68-76/del679-688 prefusion-stabilized spike | homo-3-mer | 100.0 | 9×NAG; 28×NAG; | |||
| S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and no PD bound) | homo-3-mer | 99.79 | 22×NAG; 27×NAG; | |||
| Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up | homo-3-mer | 99.79 | 17×NAG; 27×NAG; | |||
| SARS-CoV-2 E406W mutant Spike ectodomain | homo-3-mer | 99.27 | 6×NAG; 42×NAG; | |||
| Structure of apo SARS-CoV-2 spike protein with one RBD up | homo-3-mer | 99.8 | 13×NAG; | |||
| Structure of aged SARS-CoV-2 S2P spike at pH 7.4 | homo-3-mer | 99.75 | 14×NAG; 13×NAG; | |||
| Complex structure of a small molecule (SPC-14) bound SARS-CoV-2 spike protein, closed state | homo-3-mer | 99.81 | 3×Q83; 15×NAG; | |||
| Structure of SARS-CoV-2 S2P spike at pH 7.4 refolded by low-pH treatment | homo-3-mer | 99.78 | 14×NAG; 14×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron JN.1 spike protein | homo-3-mer | 100 | 3×NAG; 1×NAG; 26×NAG; | |||
| XBB.1.5 Spike Trimer in complex with heparan sulfate | homo-3-mer | 100 | 48×NAG; 1×IDU; | |||
| Structure of freshly purified SARS-CoV-2 S2P spike at pH 7.4 | homo-3-mer | 99.78 | 14×NAG; 14×NAG; | |||
| Spike Trimer of BA.2.86 with three RBDs down | homo-3-mer | 97.56 | 18×NAG; 30×NAG; | |||
| Spike Trimer of BA.2.86 with single RBD up | homo-3-mer | 97.56 | 17×NAG; 31×NAG; | |||
| Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutraliz… | homo-3-mer | 99.68 | 35×NAG; | |||
| Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutraliz… | homo-3-mer | 99.33 | 1×NAG; 27×NAG; | |||
| Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x2 disulphide-bond mutant, G413… | homo-3-mer | 99.83 | 15×NAG; 33×NAG; | |||
| Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383… | homo-3-mer | 99.83 | 12×NAG; 36×NAG; | |||
| Structure of SARS-CoV-2 Spike Protein Trimer (K986P, V987P, single Arg S1/S2 cleavage site) in Clos… | homo-3-mer | 100.0 | 15×NAG; 33×NAG; | |||
| Structure of SARS-CoV-2 D614G Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and sing… | homo-3-mer | 99.61 | 6×NAG; 3×BLA; 30×NAG; | |||
| Structure of SARS-CoV-2 Spike Protein with Engineered x3 Disulfide (x3(D427C, V987C) and single Arg… | homo-3-mer | 99.83 | 9×NAG; 3×BLA; 27×NAG; | |||
| Prefusion SARS-CoV-2 S ectodomain trimer covalently stabilized in the closed conformation | homo-3-mer | 99.58 | 9×NAG; 33×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Spike ectodomain | homo-3-mer | 99.8 | 8×NAG; 1×NAG; 2×NAG; 2×NAG; 23×NAG; | |||
| One RBD up state of Spike glycoprotein, SARS-CoV-2 | homo-3-mer | 100.0 | 15×NAG; 1×NAG; 5×NAG; 21×NAG; | |||
| SARS CoV-2 Spike protein, Bristol UK Deletion variant, Closed conformation, C1 symmetry | homo-3-mer | 100.0 | 3×EIC; 30×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2.86 spike protein(6P), 1-RBD-up state | homo-3-mer | 97.37 | 6×NAG; 24×NAG; | |||
| SARS CoV-2 Spike protein, Bristol UK Deletion variant, Closed conformation, C3 symmetry | homo-3-mer | 100.0 | 3×EIC; 33×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron HV.1 spike protein(6P), RBD-closed state | homo-3-mer | 97.17 | 38×NAG; | |||
| Structure of the SARS-CoV-2 XBB.1.5 spike glycoprotein (closed state 1) | homo-3-mer | 98.11 | 9×NAG; 36×NAG; | |||
| Structure of the SARS-CoV-2 BA.2.86 spike glycoprotein (closed state) | homo-3-mer | 97.5 | 6×NAG; 39×NAG; | |||
| Structure of the SARS-CoV-2 XBB.1.5 spike glycoprotein (closed state 2) | homo-3-mer | 98.0 | 6×NAG; 36×NAG; | |||
| Structure of the SARS-CoV-2 BA.2.86 spike protein (1-up state) | homo-3-mer | 97.44 | 7×NAG; 35×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron EG.5 spike protein(6P), RBD-closed state | homo-3-mer | 98.09 | 27×NAG; | |||
| SARS-CoV-2 Spike D614G variant, minus RBD | homo-3-mer | 99.72 | ||||
| Cryo-EM structure of BANAL-20-52 spike protein (6P) | homo-3-mer | 97.99 | 3×NAG; 45×NAG; 3×EIC; | |||
| Cryo-EM structure of SARS-CoV-2 S trimer in the early fusion intermediate conformation (E-FIC) (foc… | homo-3-mer | 99.64 | 3×NAG; 6×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane | homo-3-mer | 100.0 | 6×NAG; 3×NAG; 6×NAG; 3×MAN; 9×NAG; | |||
| Nanometer resolution in situ structure of SARS-CoV-2 post-fusion spike | homo-3-mer | 100.0 | 3×NAG; 9×NAG; 9×NAG; | |||
| Cryo-EM structure of S glycoprotein encoded by the Covid-19 mRNA vaccine candidate RQ3013 (Postfusi… | homo-3-mer | 100.0 | 6×NAG; 6×NAG; 3×NAG; 9×NAG; 3×MAN; | |||
| Distinct conformational states of SARS-CoV-2 spike protein | homo-3-mer | 100.0 | 6×NAG; 6×NAG; 3×NAG; 9×NAG; 3×MAN; | |||
| Structure of the SARS-CoV-2 spike glycoprotein S2 subunit | homo-3-mer | 98.2 | 18×NAG; | |||
| Cryo-EM structure of SARS-CoV-2 S trimer in the early fusion intermediate conformation (E-FIC) (foc… | homo-3-mer | 100 | 18×NAG; | |||
| Prefusion stabilized structure of the SARS-CoV-2 fusion machinery | homo-3-mer | 96.99 | 12×NAG; 6×NAG; | |||
| Prefusion stabilized structure of the SARS-CoV-2 fusion machinery | homo-3-mer | 98.12 | 9×NAG; 9×NAG; | |||
| Prefusion stabilized structure of the SARS-CoV-2 fusion machinery | homo-3-mer | 96.05 | 12×NAG; 6×NAG; | |||
| Prefusion-stabilized SARS-CoV-2 S2 subunit | homo-3-mer | 98.28 | ||||
| Simulation-driven design of prefusion stabilized SARS-CoV-2 spike S2 antigen | homo-3-mer | 97.48 | 9×NAG; | |||
| Structure of post fusion core of SARS-CoV-2 S2 subunit | homo-3-mer | 100.0 | ||||
| Structure of post fusion core of 2019-nCoV S2 subunit | homo-3-mer | 100 | 2×PG4; 4×ZN; | |||
| Crystal structure of post fusion core of 2019-nCoV S2 subunit | homo-3-mer | 100 | ||||
| Crystal Structure of SARS-CoV-2 HR1 motif in complex with pan-CoVs inhibitor EK1 | homo-3-mer | 100.0 | ||||
| SARS-CoV-2 spike Protein TM domain | homo-3-mer | 76.19 | ||||
| Crystal structure of the recombinant protein HR121 from the S2 protein of SARS-CoV-2 | homo-2-mer | 100.0 | ||||
| Cryo-EM structure of S protein trimer of SARS-CoV2 | monomer | 100 | ||||
| BA.2.86-T356K Spike Trimer in complex with heparan sulfate (Local refinement) | monomer | 75.0 | 1×NAG; 6×NAG; 1×IDU; | |||
| Crystal structure of SARS-CoV-2 spike protein N-terminal domain in complex with biliverdin | monomer | 100 | 1×BLA; 7×NAG; 2×PG4; 3×PEG; 3×PGE; 1×1PE; | |||
| Cryo-EM structure of SARS-CoV-2 Omicron BA.2 spike protein (focused refinement of NTD) | monomer | 90.0 | 1×NAG; 4×NAG; | |||
| Local CryoEM structure del68-76/del679-688 prefusion-stabilized spike | monomer | 100 | ||||
| SARS-CoV-2 Omicron BA.3 variant spike (local) | monomer | 94.38 | 2×NAG; | |||
| Crystal structure of SARS-CoV-2 S RBD in complex with a stapled peptide | monomer | 100 | 3×GOL; 1×KZ0; | |||
| Crystal structure of the SARS-CoV-2 receptor binding domain | monomer | 100 | 1×NAG; 2×NAG; 1×FUC; 5×GOL; | |||
| SARS-CoV-2 E406W mutant RBD - Local Refinement | monomer | 99.48 | 1×NAG; | |||
| Cryo-EM structure of locally refined up conformation of SARS-CoV-2 spike protein Receptor Binding D… | monomer | 100.0 | ||||
| Membrane bound structure of HR1 domain of SARS-CoV-2 spike protein | monomer | 100 | ||||
| Fusion Peptide of SARS-CoV-2 Spike Rearranges into a Wedge Inserted in Bilayered Micelles | monomer | 97.62 | ||||
| NMR structure of a peptide deriving from SARS-CoV-2 S RBD 482-506 fragment in HFIP/H2O | monomer | 100 | ||||
| NMR structure of a peptide deriving from SARS-CoV-2 Lineage B.1.1.7 S RBD 482-506 fragment in HFIP/… | monomer | 96.0 | ||||
| NMR structure of a peptide deriving from SARS-CoV-2 Lineages P.1 and B.1.351 S RBD 482-506 fragment… | monomer | 92.0 | ||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7mjm.1 |
Heteromer P0DTC2; Q9BYF1; | 0.77 | 99.45 | |||
| 6xr8.1.A | homo-3-mer | 0.74 | 6×NAG; 2×NAG; 1×NAG; 2×NAG; | 100.00 | ||
| 7kj2.1 |
Heteromer P0DTC2; Q9BYF1; | 0.72 | 4×NAG; 10×NAG; | 99.67 | ||